CONSOLIDATED SCHEDULE OF INVESTMENTS € in Thousands, £ in Thousands, $ in Thousands |
3 Months Ended |
12 Months Ended |
|
|
Mar. 31, 2025
USD ($)
shares
|
Dec. 31, 2024
USD ($)
shares
|
Mar. 31, 2025
GBP (£)
shares
|
Mar. 31, 2025
EUR (€)
shares
|
Dec. 31, 2024
GBP (£)
shares
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment, basis spread, variable rate |
|
7.50%
|
|
7.50%
|
|
7.50%
|
|
7.50%
|
|
7.50%
|
|
Investment cost |
|
$ 3,995,082
|
|
$ 3,708,877
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
3,924,450
|
|
$ 3,659,978
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Series Class A Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
238
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 0
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Dec. 27, 2022
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
69,239
|
|
|
|
69,239
|
|
69,239
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Communications & Networking (1.38%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.38%
|
|
|
|
|
|
1.38%
|
|
Investment cost |
[5] |
|
|
$ 27,693
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 27,491
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services (18.03%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
18.03%
|
|
|
|
|
|
18.03%
|
|
Investment cost |
[5] |
|
|
$ 358,347
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 358,786
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Altumint, Inc., Senior Secured, Maturity Date December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6] |
|
|
2027-12
|
|
|
|
|
|
2027-12
|
|
Investment, basis spread, variable rate |
[6],[7] |
|
|
3.65%
|
|
|
|
|
|
3.65%
|
|
Investment, interest rate, floor |
[6],[7] |
|
|
12.15%
|
|
|
|
|
|
12.15%
|
|
Investment exit fee |
[6],[7] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
Principal amount |
[6] |
|
|
$ 10,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
9,916
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 10,140
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Carwow LTD, Senior Secured, Maturity Date December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[10] |
|
|
2027-12
|
|
|
|
|
|
2027-12
|
|
Investment, basis spread, variable rate |
[7],[8],[9],[10] |
|
|
4.70%
|
|
|
|
|
|
4.70%
|
|
Investment, interest rate, floor |
[7],[8],[9],[10] |
|
|
11.45%
|
|
|
|
|
|
11.45%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9],[10] |
|
|
1.45%
|
|
|
|
|
|
1.45%
|
|
Investment exit fee |
[7],[8],[9],[10] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
Principal amount | £ |
[8],[9],[10] |
|
|
|
|
|
|
|
|
£ 20,361
|
|
Investment cost |
[5],[8],[9],[10] |
|
|
$ 27,818
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[9],[10] |
|
|
$ 25,264
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and GoEuro Travel GmbH, Senior Secured, Maturity Date November 2029, Prime + 3.45%, Floor rate 10.45%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[10],[11] |
|
|
2029-11
|
|
|
|
|
|
2029-11
|
|
Investment, basis spread, variable rate |
[7],[9],[10],[11] |
|
|
3.45%
|
|
|
|
|
|
3.45%
|
|
Investment, interest rate, floor |
[7],[9],[10],[11] |
|
|
10.45%
|
|
|
|
|
|
10.45%
|
|
Investment exit fee |
[7],[9],[10],[11] |
|
|
4.50%
|
|
|
|
|
|
4.50%
|
|
Principal amount |
[9],[10],[11] |
|
|
$ 48,750
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[10],[11] |
|
|
48,276
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10],[11] |
|
|
$ 48,276
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[12],[13] |
|
|
2026-07
|
|
|
|
|
|
2026-07
|
|
Investment, basis spread, variable rate |
[7],[8],[12],[13] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
Investment, interest rate, floor |
[7],[8],[12],[13] |
|
|
10.75%
|
|
|
|
|
|
10.75%
|
|
Investment, interest rate, paid in kind |
[7],[8],[12],[13] |
|
|
0.50%
|
|
|
|
|
|
0.50%
|
|
Investment exit fee |
[7],[8],[12],[13] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
Principal amount |
[8],[12],[13] |
|
|
$ 78,038
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[12],[13] |
|
|
77,438
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[12],[13] |
|
|
$ 79,691
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[13],[14] |
|
|
2026-05
|
|
|
|
|
|
2026-05
|
|
Investment, basis spread, variable rate |
[7],[8],[13],[14] |
|
|
7.00%
|
|
|
|
|
|
7.00%
|
|
Investment, interest rate, floor |
[7],[8],[13],[14] |
|
|
10.50%
|
|
|
|
|
|
10.50%
|
|
Investment, interest rate, paid in kind |
[7],[8],[13],[14] |
|
|
0.50%
|
|
|
|
|
|
0.50%
|
|
Investment exit fee |
[7],[8],[13],[14] |
|
|
4.00%
|
|
|
|
|
|
4.00%
|
|
Principal amount |
[8],[13],[14] |
|
|
$ 25,327
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[13],[14] |
|
|
25,413
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[13],[14] |
|
|
$ 25,821
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Skyword, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[15] |
|
|
2027-11
|
|
|
|
|
|
2027-11
|
|
Investment, basis spread, variable rate |
[7],[8],[15] |
|
|
2.75%
|
|
|
|
|
|
2.75%
|
|
Investment, interest rate, floor |
[7],[8],[15] |
|
|
9.25%
|
|
|
|
|
|
9.25%
|
|
Investment, interest rate, paid in kind |
[7],[8],[15] |
|
|
1.75%
|
|
|
|
|
|
1.75%
|
|
Investment exit fee |
[7],[8],[15] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
Principal amount |
[8],[15] |
|
|
$ 6,587
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[15] |
|
|
6,715
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[15] |
|
|
$ 6,637
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date January 2027, FIXED 8.25% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[16] |
|
|
2027-01
|
|
|
|
|
|
2027-01
|
|
Investment, interest rate, paid in cash |
[7],[16] |
|
|
8.25%
|
|
|
|
|
|
8.25%
|
|
Principal amount |
[16] |
|
|
$ 8,250
|
|
|
|
|
|
|
|
Investment cost |
[5],[16] |
|
|
8,250
|
|
|
|
|
|
|
|
Investments, at fair value: |
[16] |
|
|
$ 8,027
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Thumbtack, Inc., Senior Secured, Maturity Date March 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[11],[14] |
|
|
2028-03
|
|
|
|
|
|
2028-03
|
|
Investment, basis spread, variable rate |
[7],[8],[11],[14] |
|
|
2.45%
|
|
|
|
|
|
2.45%
|
|
Investment, interest rate, floor |
[7],[8],[11],[14] |
|
|
10.95%
|
|
|
|
|
|
10.95%
|
|
Investment, interest rate, paid in kind |
[7],[8],[11],[14] |
|
|
1.50%
|
|
|
|
|
|
1.50%
|
|
Principal amount |
[8],[11],[14] |
|
|
$ 20,918
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[11],[14] |
|
|
20,561
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[11],[14] |
|
|
21,192
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total SeatGeek, Inc |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
103,365
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
102,851
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
105,512
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total Veem, Inc., |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
10,360
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
10,720
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 10,664
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.00%, Floor rate 12.00%, PIK Interest 1.25%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[15] |
|
|
2027-03
|
|
|
|
|
|
2027-03
|
|
Investment, basis spread, variable rate |
[7],[8],[15] |
|
|
4.00%
|
|
|
|
|
|
4.00%
|
|
Investment, interest rate, floor |
[7],[8],[15] |
|
|
12.00%
|
|
|
|
|
|
12.00%
|
|
Investment, interest rate, paid in kind |
[7],[8],[15] |
|
|
1.25%
|
|
|
|
|
|
1.25%
|
|
Investment exit fee |
[7],[8],[15] |
|
|
4.50%
|
|
|
|
|
|
4.50%
|
|
Principal amount |
[8],[15] |
|
|
$ 5,172
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[15] |
|
|
5,350
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[15] |
|
|
$ 5,322
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.70%, Floor rate 12.70%, PIK Interest 1.50%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[12] |
|
|
2027-03
|
|
|
|
|
|
2027-03
|
|
Investment, basis spread, variable rate |
[7],[8],[12] |
|
|
4.70%
|
|
|
|
|
|
4.70%
|
|
Investment, interest rate, floor |
[7],[8],[12] |
|
|
12.70%
|
|
|
|
|
|
12.70%
|
|
Investment, interest rate, paid in kind |
[7],[8],[12] |
|
|
1.50%
|
|
|
|
|
|
1.50%
|
|
Investment exit fee |
[7],[8],[12] |
|
|
4.50%
|
|
|
|
|
|
4.50%
|
|
Principal amount |
[8],[12] |
|
|
$ 5,188
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[12] |
|
|
5,370
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[12] |
|
|
$ 5,342
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services (2.98%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
2.98%
|
|
|
|
|
|
2.98%
|
|
Investment cost |
[5] |
|
|
$ 59,130
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 59,386
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[16],[17] |
|
|
2025-06
|
|
|
|
|
|
2025-06
|
|
Investment, interest rate, paid in cash |
[7],[16],[17] |
|
|
5.00%
|
|
|
|
|
|
5.00%
|
|
Principal amount |
[16],[17] |
|
|
$ 12,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[16],[17] |
|
|
12,000
|
|
|
|
|
|
|
|
Investments, at fair value: |
[16],[17] |
|
|
$ 12,000
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Next Insurance, Inc., Senior Secured, Maturity Date February 2028, Prime - 1.50%, Floor rate 4.75%, PIK Interest 5.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[15],[18] |
|
|
2028-02
|
|
|
|
|
|
2028-02
|
|
Investment, basis spread, variable rate |
[7],[8],[15],[18] |
|
|
(1.50%)
|
|
|
|
|
|
(1.50%)
|
|
Investment, interest rate, floor |
[7],[8],[15],[18] |
|
|
4.75%
|
|
|
|
|
|
4.75%
|
|
Investment, interest rate, paid in kind |
[7],[8],[15],[18] |
|
|
5.50%
|
|
|
|
|
|
5.50%
|
|
Principal amount |
[8],[15],[18] |
|
|
$ 11,070
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[15],[18] |
|
|
10,918
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[15],[18] |
|
|
11,174
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Total Gibraltar Acquisition, LLC |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
36,569
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
36,212
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 36,212
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Akero Therapeutics, Inc., Senior Secured, Maturity Date March 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[11],[15] |
|
|
2027-03
|
|
|
|
|
|
2027-03
|
|
Investment, basis spread, variable rate |
[7],[9],[11],[15] |
|
|
3.65%
|
|
|
|
|
|
3.65%
|
|
Investment, interest rate, floor |
[7],[9],[11],[15] |
|
|
7.65%
|
|
|
|
|
|
7.65%
|
|
Investment exit fee |
[7],[9],[11],[15] |
|
|
5.85%
|
|
|
|
|
|
5.85%
|
|
Principal amount |
[9],[11],[15] |
|
|
$ 17,500
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[11],[15] |
|
|
17,706
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[11],[15] |
|
|
$ 18,005
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6] |
|
|
2027-01
|
|
|
|
|
|
2027-01
|
|
Investment, basis spread, variable rate |
[6],[7] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
Investment, interest rate, floor |
[6],[7] |
|
|
9.50%
|
|
|
|
|
|
9.50%
|
|
Investment, interest rate, cap |
[6],[7] |
|
|
10.75%
|
|
|
|
|
|
10.75%
|
|
Investment exit fee |
[6],[7] |
|
|
5.85%
|
|
|
|
|
|
5.85%
|
|
Principal amount |
[6] |
|
|
$ 24,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
24,640
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 24,940
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Modern Life, Inc., Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[15] |
|
|
2027-02
|
|
|
|
|
|
2027-02
|
|
Investment, basis spread, variable rate |
[7],[15] |
|
|
2.75%
|
|
|
|
|
|
2.75%
|
|
Investment, interest rate, floor |
[7],[15] |
|
|
8.75%
|
|
|
|
|
|
8.75%
|
|
Investment exit fee |
[7],[15] |
|
|
5.00%
|
|
|
|
|
|
5.00%
|
|
Principal amount |
[15] |
|
|
$ 18,200
|
|
|
|
|
|
|
|
Investment cost |
[5],[15] |
|
|
18,299
|
|
|
|
|
|
|
|
Investments, at fair value: |
[15] |
|
|
$ 18,340
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Recover Together, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[15] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7],[15] |
|
|
1.90%
|
|
|
|
|
|
1.90%
|
|
Investment, interest rate, floor |
[7],[15] |
|
|
10.15%
|
|
|
|
|
|
10.15%
|
|
Investment exit fee |
[7],[15] |
|
|
7.50%
|
|
|
|
|
|
7.50%
|
|
Principal amount |
[15] |
|
|
$ 45,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[15] |
|
|
45,431
|
|
|
|
|
|
|
|
Investments, at fair value: |
[15] |
|
|
$ 45,741
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[11] |
|
|
2027-09
|
|
|
|
|
|
2027-09
|
|
Investment, basis spread, variable rate |
[6],[7],[11] |
|
|
0.70%
|
|
|
|
|
|
0.70%
|
|
Investment, interest rate, floor |
[6],[7],[11] |
|
|
9.20%
|
|
|
|
|
|
9.20%
|
|
Investment exit fee |
[6],[7],[11] |
|
|
5.95%
|
|
|
|
|
|
5.95%
|
|
Principal amount |
[6],[11] |
|
|
$ 30,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[11] |
|
|
29,742
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[11] |
|
|
$ 30,587
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[11],[19] |
|
|
2028-03
|
|
|
|
|
|
2028-03
|
|
Investment, basis spread, variable rate |
[7],[11],[19] |
|
|
7.88%
|
|
|
|
|
|
7.88%
|
|
Investment, interest rate, floor |
[7],[11],[19] |
|
|
8.88%
|
|
|
|
|
|
8.88%
|
|
Principal amount |
[11],[19] |
|
|
$ 27,206
|
|
|
|
|
|
|
|
Investment cost |
[5],[11],[19] |
|
|
26,726
|
|
|
|
|
|
|
|
Investments, at fair value: |
[11],[19] |
|
|
$ 27,399
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and LogicSource, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.93%, Floor rate 9.93% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[11],[19] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7],[11],[19] |
|
|
8.93%
|
|
|
|
|
|
8.93%
|
|
Investment, interest rate, floor |
[7],[11],[19] |
|
|
9.93%
|
|
|
|
|
|
9.93%
|
|
Principal amount |
[11],[19] |
|
|
$ 13,145
|
|
|
|
|
|
|
|
Investment cost |
[5],[11],[19] |
|
|
12,974
|
|
|
|
|
|
|
|
Investments, at fair value: |
[11],[19] |
|
|
13,145
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Total 3GTMS, LLC |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
19,473
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
19,453
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 19,453
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments (186.90%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
186.90%
|
|
|
|
186.90%
|
|
186.90%
|
|
|
|
Investment cost |
[2] |
$ 3,785,290
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,739,234
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (1.69%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
1.69%
|
|
|
|
1.69%
|
|
1.69%
|
|
|
|
Investment cost |
[2] |
$ 33,032
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 33,739
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (1.70%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.70%
|
|
|
|
|
|
1.70%
|
|
Investment cost |
[5] |
|
|
$ 32,801
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 33,788
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 7.85% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-01
|
[21],[22] |
2027-01
|
[12],[15] |
2027-01
|
[21],[22] |
2027-01
|
[21],[22] |
2027-01
|
[12],[15] |
Investment, basis spread, variable rate |
|
2.15%
|
[21],[22],[23] |
2.15%
|
[7],[12],[15] |
2.15%
|
[21],[22],[23] |
2.15%
|
[21],[22],[23] |
2.15%
|
[7],[12],[15] |
Investment, interest rate, floor |
|
9.15%
|
[21],[22],[23] |
9.15%
|
[7],[12],[15] |
9.15%
|
[21],[22],[23] |
9.15%
|
[21],[22],[23] |
9.15%
|
[7],[12],[15] |
Investment exit fee |
|
7.85%
|
[21],[22],[23] |
7.85%
|
[7],[12],[15] |
7.85%
|
[21],[22],[23] |
7.85%
|
[21],[22],[23] |
7.85%
|
[7],[12],[15] |
Principal amount |
|
$ 32,000
|
[21],[22] |
$ 32,000
|
[12],[15] |
|
|
|
|
|
|
Investment cost |
|
33,032
|
[2],[21],[22] |
32,801
|
[5],[12],[15] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 33,739
|
[21],[22] |
$ 33,788
|
[12],[15] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Communications & Networking (1.37%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
1.37%
|
|
|
|
1.37%
|
|
1.37%
|
|
|
|
Investment cost |
[2] |
$ 27,886
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 27,443
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date December 2028, Prime + 1.80%, Floor rate 9.30%, PIK Interest 1.25%, 6.73% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[24],[25],[26] |
2028-12
|
|
|
|
2028-12
|
|
2028-12
|
|
|
|
Investment, basis spread, variable rate |
[22],[23],[24],[25],[26] |
1.80%
|
|
|
|
1.80%
|
|
1.80%
|
|
|
|
Investment, interest rate, floor |
[22],[23],[24],[25],[26] |
9.30%
|
|
|
|
9.30%
|
|
9.30%
|
|
|
|
Investment, interest rate, paid in kind |
[22],[23],[24],[25],[26] |
1.25%
|
|
|
|
1.25%
|
|
1.25%
|
|
|
|
Investment exit fee |
[22],[23],[24],[25],[26] |
6.73%
|
|
|
|
6.73%
|
|
6.73%
|
|
|
|
Principal amount |
[22],[24],[25],[26] |
$ 28,003
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[22],[24],[25],[26] |
27,886
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[22],[24],[25],[26] |
$ 27,443
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Communications and Networking and Aryaka Networks, Inc., Senior Secured, Maturity Date December 2028, Prime + 1.80%, Floor rate 9.30%, PIK Interest 1.25%, 6.73% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[11],[18] |
|
|
2028-12
|
|
|
|
|
|
2028-12
|
|
Investment, basis spread, variable rate |
[7],[11],[18] |
|
|
1.80%
|
|
|
|
|
|
1.80%
|
|
Investment, interest rate, floor |
[7],[11],[18] |
|
|
9.30%
|
|
|
|
|
|
9.30%
|
|
Investment, interest rate, paid in kind |
[7],[11],[18] |
|
|
1.25%
|
|
|
|
|
|
1.25%
|
|
Investment exit fee |
[7],[11],[18] |
|
|
6.73%
|
|
|
|
|
|
6.73%
|
|
Principal amount |
[11],[18] |
|
|
$ 27,926
|
|
|
|
|
|
|
|
Investment cost |
[5],[11],[18] |
|
|
27,693
|
|
|
|
|
|
|
|
Investments, at fair value: |
[11],[18] |
|
|
$ 27,491
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (18.03%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
18.03%
|
|
|
|
18.03%
|
|
18.03%
|
|
|
|
Investment cost |
[2] |
$ 360,998
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 360,788
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Altumint, Inc. Senior Secured, Maturity Date December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2027-12
|
|
|
|
2027-12
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[23] |
3.65%
|
|
|
|
3.65%
|
|
3.65%
|
|
|
|
Investment, interest rate, floor |
[1],[23] |
12.15%
|
|
|
|
12.15%
|
|
12.15%
|
|
|
|
Investment exit fee |
[1],[23] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
Principal amount |
[1] |
$ 10,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
9,940
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 10,127
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[27],[28] |
2027-12
|
|
|
|
2027-12
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[23],[25],[27],[28] |
4.70%
|
|
|
|
4.70%
|
|
4.70%
|
|
|
|
Investment, interest rate, floor |
[23],[25],[27],[28] |
11.45%
|
|
|
|
11.45%
|
|
11.45%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[25],[27],[28] |
1.45%
|
|
|
|
1.45%
|
|
1.45%
|
|
|
|
Investment exit fee |
[23],[25],[27],[28] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
Principal amount | £ |
[25],[27],[28] |
|
|
|
|
£ 20,435
|
|
|
|
|
|
Investment cost |
[2],[25],[27],[28] |
$ 27,981
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[27],[28] |
$ 26,219
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and GoEuro Travel GmbH. Senior Secured, Maturity Date November 2029, Prime + 3.45%, Floor rate 10.45%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[26],[27],[28] |
2029-11
|
|
|
|
2029-11
|
|
2029-11
|
|
|
|
Investment, basis spread, variable rate |
[23],[26],[27],[28] |
3.45%
|
|
|
|
3.45%
|
|
3.45%
|
|
|
|
Investment, interest rate, floor |
[23],[26],[27],[28] |
10.45%
|
|
|
|
10.45%
|
|
10.45%
|
|
|
|
Investment exit fee |
[23],[26],[27],[28] |
4.50%
|
|
|
|
4.50%
|
|
4.50%
|
|
|
|
Principal amount |
[26],[27],[28] |
$ 48,750
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[26],[27],[28] |
48,387
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[26],[27],[28] |
$ 48,387
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 11.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[29] |
2028-05
|
|
|
|
2028-05
|
|
2028-05
|
|
|
|
Investment, interest rate, paid in kind |
[23],[25],[29] |
11.50%
|
|
|
|
11.50%
|
|
11.50%
|
|
|
|
Principal amount |
[25],[29] |
$ 26,426
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[29] |
26,425
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[29] |
$ 27,673
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc., Convertible Debt, Maturity Date May 2028, PIK Interest 11.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[30] |
|
|
2028-05
|
|
|
|
|
|
2028-05
|
|
Investment, interest rate, paid in kind |
[7],[8],[30] |
|
|
11.50%
|
|
|
|
|
|
11.50%
|
|
Principal amount |
[8],[30] |
|
|
$ 25,687
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[30] |
|
|
25,687
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[30] |
|
|
$ 26,869
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date October 2028, 1-month SOFR + 0.00%, Floor rate 1.00%, PIK Interest 7.00%, 5.33% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[27],[28] |
2028-10
|
|
|
|
2028-10
|
|
2028-10
|
|
|
|
Investment, basis spread, variable rate |
[23],[25],[27],[28] |
0.00%
|
|
|
|
0.00%
|
|
0.00%
|
|
|
|
Investment, interest rate, floor |
[23],[25],[27],[28] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[25],[27],[28] |
7.00%
|
|
|
|
7.00%
|
|
7.00%
|
|
|
|
Investment exit fee |
[23],[25],[27],[28] |
5.33%
|
|
|
|
5.33%
|
|
5.33%
|
|
|
|
Principal amount |
[25],[27],[28] |
$ 13,536
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[27],[28] |
13,874
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[27],[28] |
$ 13,148
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, Maturity Date August 2025, 1-month SOFR + 8.86% Floor rate 9.75%, 2.89% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[10] |
|
|
2025-08
|
|
|
|
|
|
2025-08
|
|
Investment, basis spread, variable rate |
[7],[9],[10] |
|
|
8.86%
|
|
|
|
|
|
8.86%
|
|
Investment, interest rate, floor |
[7],[9],[10] |
|
|
9.75%
|
|
|
|
|
|
9.75%
|
|
Investment exit fee |
[7],[9],[10] |
|
|
2.89%
|
|
|
|
|
|
2.89%
|
|
Principal amount |
[9],[10] |
|
|
$ 13,011
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[10] |
|
|
13,276
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10] |
|
|
$ 12,994
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Plentific Ltd, Senior Secured, Maturity Date October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[10],[15] |
|
|
2026-10
|
|
|
|
|
|
2026-10
|
|
Investment, basis spread, variable rate |
[7],[9],[10],[15] |
|
|
2.55%
|
|
|
|
|
|
2.55%
|
|
Investment, interest rate, floor |
[7],[9],[10],[15] |
|
|
11.05%
|
|
|
|
|
|
11.05%
|
|
Investment exit fee |
[7],[9],[10],[15] |
|
|
2.95%
|
|
|
|
|
|
2.95%
|
|
Principal amount |
[9],[10],[15] |
|
|
$ 3,325
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[10],[15] |
|
|
3,282
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10],[15] |
|
|
$ 3,340
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Plentific Ltd. Senior Secured, Maturity Date October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[27],[28] |
2026-10
|
|
|
|
2026-10
|
|
2026-10
|
|
|
|
Investment, basis spread, variable rate |
[21],[23],[27],[28] |
2.55%
|
|
|
|
2.55%
|
|
2.55%
|
|
|
|
Investment, interest rate, floor |
[21],[23],[27],[28] |
11.05%
|
|
|
|
11.05%
|
|
11.05%
|
|
|
|
Investment exit fee |
[21],[23],[27],[28] |
2.95%
|
|
|
|
2.95%
|
|
2.95%
|
|
|
|
Principal amount |
[21],[27],[28] |
$ 3,325
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[27],[28] |
3,300
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[27],[28] |
$ 3,347
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-12
|
[1] |
2026-12
|
[6] |
2026-12
|
[1] |
2026-12
|
[1] |
2026-12
|
[6] |
Investment, basis spread, variable rate |
|
4.40%
|
[1],[23] |
4.40%
|
[6],[7] |
4.40%
|
[1],[23] |
4.40%
|
[1],[23] |
4.40%
|
[6],[7] |
Investment, interest rate, floor |
|
10.65%
|
[1],[23] |
10.65%
|
[6],[7] |
10.65%
|
[1],[23] |
10.65%
|
[1],[23] |
10.65%
|
[6],[7] |
Investment exit fee |
|
2.95%
|
[1],[23] |
2.95%
|
[6],[7] |
2.95%
|
[1],[23] |
2.95%
|
[1],[23] |
2.95%
|
[6],[7] |
Principal amount |
|
$ 15,000
|
[1] |
$ 15,000
|
[6] |
|
|
|
|
|
|
Investment cost |
|
15,145
|
[1],[2] |
15,093
|
[5],[6] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 15,198
|
[1] |
$ 15,176
|
[6] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-12
|
[1],[21],[25] |
2026-12
|
[6],[8],[15] |
2026-12
|
[1],[21],[25] |
2026-12
|
[1],[21],[25] |
2026-12
|
[6],[8],[15] |
Investment, basis spread, variable rate |
|
5.50%
|
[1],[21],[23],[25] |
5.50%
|
[6],[7],[8],[15] |
5.50%
|
[1],[21],[23],[25] |
5.50%
|
[1],[21],[23],[25] |
5.50%
|
[6],[7],[8],[15] |
Investment, interest rate, floor |
|
6.50%
|
[1],[21],[23],[25] |
6.50%
|
[6],[7],[8],[15] |
6.50%
|
[1],[21],[23],[25] |
6.50%
|
[1],[21],[23],[25] |
6.50%
|
[6],[7],[8],[15] |
Investment, interest rate, paid in kind |
|
4.00%
|
[1],[21],[23],[25] |
4.00%
|
[6],[7],[8],[15] |
4.00%
|
[1],[21],[23],[25] |
4.00%
|
[1],[21],[23],[25] |
4.00%
|
[6],[7],[8],[15] |
Principal amount |
|
$ 30,374
|
[1],[21],[25] |
$ 30,073
|
[6],[8],[15] |
|
|
|
|
|
|
Investment cost |
|
30,148
|
[1],[2],[21],[25] |
29,798
|
[5],[6],[8],[15] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 29,473
|
[1],[21],[25] |
$ 29,678
|
[6],[8],[15] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Riviera Partners LLC, Senior Secured, Maturity Date April 2027, 3-month SOFR + 8.27%, Floor rate 9.27% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[19] |
|
|
2027-04
|
|
|
|
|
|
2027-04
|
|
Investment, basis spread, variable rate |
[7],[19] |
|
|
8.27%
|
|
|
|
|
|
8.27%
|
|
Investment, interest rate, floor |
[7],[19] |
|
|
9.27%
|
|
|
|
|
|
9.27%
|
|
Principal amount |
[19] |
|
|
$ 36,493
|
|
|
|
|
|
|
|
Investment cost |
[5],[19] |
|
|
36,104
|
|
|
|
|
|
|
|
Investments, at fair value: |
[19] |
|
|
$ 35,017
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Riviera Partners LLC. Senior Secured, Maturity Date March 2028, 3-month SOFR + 8.27%, Floor rate 9.27% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[31] |
2028-03
|
|
|
|
2028-03
|
|
2028-03
|
|
|
|
Investment, basis spread, variable rate |
[23],[31] |
8.27%
|
|
|
|
8.27%
|
|
8.27%
|
|
|
|
Investment, interest rate, floor |
[23],[31] |
9.27%
|
|
|
|
9.27%
|
|
9.27%
|
|
|
|
Principal amount |
[31] |
$ 36,401
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[31] |
36,047
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[31] |
$ 35,175
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[32],[33] |
2026-05
|
|
|
|
2026-05
|
|
2026-05
|
|
|
|
Investment, basis spread, variable rate |
[23],[25],[32],[33] |
7.00%
|
|
|
|
7.00%
|
|
7.00%
|
|
|
|
Investment, interest rate, floor |
[23],[25],[32],[33] |
10.50%
|
|
|
|
10.50%
|
|
10.50%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[25],[32],[33] |
0.50%
|
|
|
|
0.50%
|
|
0.50%
|
|
|
|
Investment exit fee |
[23],[25],[32],[33] |
4.00%
|
|
|
|
4.00%
|
|
4.00%
|
|
|
|
Principal amount |
[25],[32],[33] |
$ 25,359
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[32],[33] |
25,514
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[32],[33] |
$ 25,832
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[25] |
2027-11
|
|
|
|
2027-11
|
|
2027-11
|
|
|
|
Investment, basis spread, variable rate |
[21],[23],[25] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
Investment, interest rate, floor |
[21],[23],[25] |
9.25%
|
|
|
|
9.25%
|
|
9.25%
|
|
|
|
Investment, interest rate, paid in kind |
[21],[23],[25] |
1.75%
|
|
|
|
1.75%
|
|
1.75%
|
|
|
|
Investment exit fee |
[21],[23],[25] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
Principal amount |
[21],[25] |
$ 6,616
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[25] |
6,760
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[25] |
$ 6,691
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date January 2027, FIXED 8.25% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[34] |
2027-01
|
|
|
|
2027-01
|
|
2027-01
|
|
|
|
Investment, interest rate, paid in cash |
[23],[34] |
8.25%
|
|
|
|
8.25%
|
|
8.25%
|
|
|
|
Principal amount |
[34] |
$ 8,250
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[34] |
8,250
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[34] |
$ 8,032
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date March 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[26],[32] |
2028-03
|
|
|
|
2028-03
|
|
2028-03
|
|
|
|
Investment, basis spread, variable rate |
[23],[25],[26],[32] |
2.45%
|
|
|
|
2.45%
|
|
2.45%
|
|
|
|
Investment, interest rate, floor |
[23],[25],[26],[32] |
10.95%
|
|
|
|
10.95%
|
|
10.95%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[25],[26],[32] |
1.50%
|
|
|
|
1.50%
|
|
1.50%
|
|
|
|
Principal amount |
[25],[26],[32] |
$ 20,996
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[26],[32] |
20,661
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[26],[32] |
21,208
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total SeatGeek, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
103,494
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
103,258
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 105,402
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.00%, Floor rate 12.00%, PIK Interest 1.25% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[25] |
2027-03
|
|
|
|
2027-03
|
|
2027-03
|
|
|
|
Investment, basis spread, variable rate |
[21],[23],[25] |
4.00%
|
|
|
|
4.00%
|
|
4.00%
|
|
|
|
Investment, interest rate, floor |
[21],[23],[25] |
12.00%
|
|
|
|
12.00%
|
|
12.00%
|
|
|
|
Investment, interest rate, paid in kind |
[21],[23],[25] |
1.25%
|
|
|
|
1.25%
|
|
1.25%
|
|
|
|
Principal amount |
[21],[25] |
$ 5,413
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[25] |
5,401
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[25] |
$ 5,342
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.70%, Floor rate 12.70%, PIK Interest 1.50%. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[25] |
2027-03
|
|
|
|
2027-03
|
|
2027-03
|
|
|
|
Investment, basis spread, variable rate |
[22],[23],[25] |
4.70%
|
|
|
|
4.70%
|
|
4.70%
|
|
|
|
Investment, interest rate, floor |
[22],[23],[25] |
12.70%
|
|
|
|
12.70%
|
|
12.70%
|
|
|
|
Investment, interest rate, paid in kind |
[22],[23],[25] |
1.50%
|
|
|
|
1.50%
|
|
1.50%
|
|
|
|
Principal amount |
[22],[25] |
$ 5,433
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[22],[25] |
5,421
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[22],[25] |
$ 5,366
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Senior Secured, Maturity Date July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[25],[33] |
2026-07
|
|
|
|
2026-07
|
|
2026-07
|
|
|
|
Investment, basis spread, variable rate |
[22],[23],[25],[33] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
Investment, interest rate, floor |
[22],[23],[25],[33] |
10.75%
|
|
|
|
10.75%
|
|
10.75%
|
|
|
|
Investment, interest rate, paid in kind |
[22],[23],[25],[33] |
0.50%
|
|
|
|
0.50%
|
|
0.50%
|
|
|
|
Investment exit fee |
[22],[23],[25],[33] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
Principal amount |
[22],[25],[33] |
$ 78,135
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[22],[25],[33] |
77,744
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[22],[25],[33] |
79,570
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, and Total Veem, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
10,846
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
10,822
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 10,708
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (2.42%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
2.42%
|
|
|
|
2.42%
|
|
2.42%
|
|
|
|
Investment cost |
[2] |
$ 47,870
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 48,452
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Unsecured, Maturity Date September 2026, FIXED 11.95% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[16],[35] |
|
|
2026-09
|
|
|
|
|
|
2026-09
|
|
Investment, interest rate, paid in cash |
[7],[16],[35] |
|
|
11.95%
|
|
|
|
|
|
11.95%
|
|
Principal amount |
[16],[35] |
|
|
$ 10,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[16],[35] |
|
|
9,875
|
|
|
|
|
|
|
|
Investments, at fair value: |
[16],[35] |
|
|
$ 9,875
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Unsecured, Maturity Date September 2026, FIXED 3.45%, PIK Interest 8.05% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
[25],[34],[36] |
2026-09
|
[8],[16],[35] |
2026-09
|
[25],[34],[36] |
2026-09
|
[25],[34],[36] |
2026-09
|
[8],[16],[35] |
Investment, interest rate, paid in kind |
|
8.05%
|
[23],[25],[34],[36] |
8.05%
|
[7],[8],[16],[35] |
8.05%
|
[23],[25],[34],[36] |
8.05%
|
[23],[25],[34],[36] |
8.05%
|
[7],[8],[16],[35] |
Investment, interest rate, paid in cash |
|
3.45%
|
[23],[25],[34],[36] |
3.45%
|
[7],[8],[16],[35] |
3.45%
|
[23],[25],[34],[36] |
3.45%
|
[23],[25],[34],[36] |
3.45%
|
[7],[8],[16],[35] |
Principal amount |
|
$ 27,104
|
[25],[34],[36] |
$ 26,569
|
[8],[16],[35] |
|
|
|
|
|
|
Investment cost |
|
26,899
|
[2],[25],[34],[36] |
26,337
|
[5],[8],[16],[35] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 26,899
|
[25],[34],[36] |
$ 26,337
|
[8],[16],[35] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime -(1.50%), Floor rate 4.75%, PIK Interest 5.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[24],[25] |
2028-02
|
|
|
|
2028-02
|
|
2028-02
|
|
|
|
Investment, basis spread, variable rate |
[21],[23],[24],[25] |
(1.50%)
|
|
|
|
(1.50%)
|
|
(1.50%)
|
|
|
|
Investment, interest rate, floor |
[21],[23],[24],[25] |
4.75%
|
|
|
|
4.75%
|
|
4.75%
|
|
|
|
Investment, interest rate, paid in kind |
[21],[23],[24],[25] |
5.50%
|
|
|
|
5.50%
|
|
5.50%
|
|
|
|
Principal amount |
[21],[24],[25] |
$ 11,223
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[24],[25] |
11,080
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[24],[25] |
11,662
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Total Gibraltar Acquisition, LLC,. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
37,104
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
36,790
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 36,790
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services, Unsecured, Maturity Date September 2026, Fixed 11.95% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[34],[36] |
2026-09
|
|
|
|
2026-09
|
|
2026-09
|
|
|
|
Investment, interest rate, paid in cash |
[23],[34],[36] |
11.95%
|
|
|
|
11.95%
|
|
11.95%
|
|
|
|
Principal amount |
[34],[36] |
$ 10,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[34],[36] |
9,891
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[34],[36] |
$ 9,891
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (52.10%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
52.10%
|
|
|
|
|
|
52.10%
|
|
Investment cost |
[5] |
|
|
$ 1,022,084
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 1,036,554
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (53.38%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
53.38%
|
|
|
|
53.38%
|
|
53.38%
|
|
|
|
Investment cost |
[2] |
$ 1,066,208
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,067,984
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V., Senior Secured, Maturity Date August 2026, Prime + 4.30%, Floor rate 9.05%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-08
|
[27],[28] |
2026-08
|
[9],[10],[11] |
2026-08
|
[27],[28] |
2026-08
|
[27],[28] |
2026-08
|
[9],[10],[11] |
Investment, basis spread, variable rate |
|
4.30%
|
[23],[27],[28] |
4.30%
|
[7],[9],[10],[11] |
4.30%
|
[23],[27],[28] |
4.30%
|
[23],[27],[28] |
4.30%
|
[7],[9],[10],[11] |
Investment, interest rate, floor |
|
9.05%
|
[23],[27],[28] |
9.05%
|
[7],[9],[10],[11] |
9.05%
|
[23],[27],[28] |
9.05%
|
[23],[27],[28] |
9.05%
|
[7],[9],[10],[11] |
Investment exit fee |
|
6.95%
|
[23],[27],[28] |
6.95%
|
[7],[9],[10],[11] |
6.95%
|
[23],[27],[28] |
6.95%
|
[23],[27],[28] |
6.95%
|
[7],[9],[10],[11] |
Principal amount |
|
$ 14,000
|
[27],[28] |
$ 14,000
|
[9],[10],[11] |
|
|
|
|
|
|
Investment cost |
|
14,538
|
[2],[27],[28] |
14,442
|
[5],[9],[10],[11] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 14,452
|
[27],[28] |
$ 14,385
|
[9],[10],[11] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Adaptimmune Therapeutics plc, Inc., Senior Secured, Maturity Date June 2029, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.00%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[10],[14] |
|
|
2029-06
|
|
|
|
|
|
2029-06
|
|
Investment, basis spread, variable rate |
[7],[8],[9],[10],[14] |
|
|
1.15%
|
|
|
|
|
|
1.15%
|
|
Investment, interest rate, floor |
[7],[8],[9],[10],[14] |
|
|
9.65%
|
|
|
|
|
|
9.65%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9],[10],[14] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
Investment exit fee |
[7],[8],[9],[10],[14] |
|
|
5.85%
|
|
|
|
|
|
5.85%
|
|
Principal amount |
[8],[9],[10],[14] |
|
|
$ 30,260
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[9],[10],[14] |
|
|
30,121
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[9],[10],[14] |
|
|
$ 31,198
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Adaptimmune Therapeutics plc. Senior Secured, Maturity Date June 2029, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.00%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[27],[28],[32] |
2029-06
|
|
|
|
2029-06
|
|
2029-06
|
|
|
|
Investment, basis spread, variable rate |
[23],[25],[27],[28],[32] |
1.15%
|
|
|
|
1.15%
|
|
1.15%
|
|
|
|
Investment, interest rate, floor |
[23],[25],[27],[28],[32] |
9.65%
|
|
|
|
9.65%
|
|
9.65%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[25],[27],[28],[32] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
Investment exit fee |
[23],[25],[27],[28],[32] |
5.85%
|
|
|
|
5.85%
|
|
5.85%
|
|
|
|
Principal amount |
[25],[27],[28],[32] |
$ 15,167
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[27],[28],[32] |
15,126
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[27],[28],[32] |
$ 15,050
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date March 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[26],[27] |
2027-03
|
|
|
|
2027-03
|
|
2027-03
|
|
|
|
Investment, basis spread, variable rate |
[21],[23],[26],[27] |
3.65%
|
|
|
|
3.65%
|
|
3.65%
|
|
|
|
Investment, interest rate, floor |
[21],[23],[26],[27] |
7.65%
|
|
|
|
7.65%
|
|
7.65%
|
|
|
|
Investment exit fee |
[21],[23],[26],[27] |
5.85%
|
|
|
|
5.85%
|
|
5.85%
|
|
|
|
Principal amount |
[21],[26],[27] |
$ 17,500
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[26],[27] |
17,811
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[26],[27] |
$ 17,994
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date April 2026, Prime + 3.10%, Floor rate 11.10%, 8.90% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[32] |
2026-04
|
|
|
|
2026-04
|
|
2026-04
|
|
|
|
Investment, basis spread, variable rate |
[23],[32] |
3.10%
|
|
|
|
3.10%
|
|
3.10%
|
|
|
|
Investment, interest rate, floor |
[23],[32] |
11.10%
|
|
|
|
11.10%
|
|
11.10%
|
|
|
|
Investment exit fee |
[23],[32] |
8.90%
|
|
|
|
8.90%
|
|
8.90%
|
|
|
|
Principal amount |
[32] |
$ 15,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[32] |
15,093
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32] |
$ 15,134
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc., Senior Secured, Maturity Date April 2026, Prime + 3.10%, Floor rate 11.10%, 8.90% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
|
|
2026-04
|
|
|
|
|
|
2026-04
|
|
Investment, basis spread, variable rate |
[7],[14] |
|
|
3.10%
|
|
|
|
|
|
3.10%
|
|
Investment, interest rate, floor |
[7],[14] |
|
|
11.10%
|
|
|
|
|
|
11.10%
|
|
Investment exit fee |
[7],[14] |
|
|
8.90%
|
|
|
|
|
|
8.90%
|
|
Principal amount |
[14] |
|
|
$ 15,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
15,046
|
|
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 15,153
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alector, Inc., Senior Secured, Maturity Date December 2028, Prime + 1.05%, Floor rate 8.05%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[9],[11],[37] |
|
|
2028-12
|
|
|
|
|
|
2028-12
|
|
Investment, basis spread, variable rate |
[6],[7],[9],[11],[37] |
|
|
1.05%
|
|
|
|
|
|
1.05%
|
|
Investment, interest rate, floor |
[6],[7],[9],[11],[37] |
|
|
8.05%
|
|
|
|
|
|
8.05%
|
|
Investment exit fee |
[6],[7],[9],[11],[37] |
|
|
4.75%
|
|
|
|
|
|
4.75%
|
|
Principal amount |
[6],[9],[11],[37] |
|
|
$ 7,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[9],[11],[37] |
|
|
6,930
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[9],[11],[37] |
|
|
$ 6,930
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alector, Inc.. Senior Secured, Maturity Date December 2028, Prime + 1.05%, Floor rate 8.05%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[26],[27],[38] |
2028-12
|
|
|
|
2028-12
|
|
2028-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[26],[27],[38] |
1.05%
|
|
|
|
1.05%
|
|
1.05%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[26],[27],[38] |
8.05%
|
|
|
|
8.05%
|
|
8.05%
|
|
|
|
Investment exit fee |
[1],[23],[26],[27],[38] |
4.75%
|
|
|
|
4.75%
|
|
4.75%
|
|
|
|
Principal amount |
[1],[26],[27],[38] |
$ 7,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[26],[27],[38] |
6,957
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[26],[27],[38] |
$ 6,957
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[25] |
2027-01
|
|
|
|
2027-01
|
|
2027-01
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[25] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[25] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
Investment, interest rate, cap |
[1],[23],[25] |
10.75%
|
|
|
|
10.75%
|
|
10.75%
|
|
|
|
Investment exit fee |
[1],[23],[25] |
5.85%
|
|
|
|
5.85%
|
|
5.85%
|
|
|
|
Principal amount |
[1],[25] |
$ 22,458
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[25] |
23,247
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[25] |
$ 13,095
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Arcus Biosciences, Inc., Senior Secured, Maturity Date September 2029, Prime + 1.95%, Floor rate 10.45%, 7.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[26],[27],[38] |
2029-09
|
|
|
|
2029-09
|
|
2029-09
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[26],[27],[38] |
1.95%
|
|
|
|
1.95%
|
|
1.95%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[26],[27],[38] |
10.45%
|
|
|
|
10.45%
|
|
10.45%
|
|
|
|
Investment exit fee |
[1],[23],[26],[27],[38] |
7.75%
|
|
|
|
7.75%
|
|
7.75%
|
|
|
|
Principal amount |
[1],[26],[27],[38] |
$ 37,500
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[26],[27],[38] |
37,511
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[26],[27],[38] |
$ 38,913
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Arcus Biosciences, Inc., Senior Secured, Maturity Date September 2029, Prime + 1.95%, Floor rate 10.45%, 7.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[9],[11],[37] |
|
|
2029-09
|
|
|
|
|
|
2029-09
|
|
Investment, basis spread, variable rate |
[6],[7],[9],[11],[37] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
Investment, interest rate, floor |
[6],[7],[9],[11],[37] |
|
|
10.45%
|
|
|
|
|
|
10.45%
|
|
Investment exit fee |
[6],[7],[9],[11],[37] |
|
|
7.75%
|
|
|
|
|
|
7.75%
|
|
Principal amount |
[6],[9],[11],[37] |
|
|
$ 37,500
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[9],[11],[37] |
|
|
37,379
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[9],[11],[37] |
|
|
$ 37,379
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[27],[32],[33] |
2028-01
|
|
|
|
2028-01
|
|
2028-01
|
|
|
|
Investment, basis spread, variable rate |
[22],[23],[27],[32],[33] |
2.20%
|
|
|
|
2.20%
|
|
2.20%
|
|
|
|
Investment, interest rate, floor |
[22],[23],[27],[32],[33] |
9.95%
|
|
|
|
9.95%
|
|
9.95%
|
|
|
|
Investment, interest rate, cap |
[22],[23],[27],[32],[33] |
10.70%
|
|
|
|
10.70%
|
|
10.70%
|
|
|
|
Investment exit fee |
[22],[23],[27],[32],[33] |
5.78%
|
|
|
|
5.78%
|
|
5.78%
|
|
|
|
Principal amount |
[22],[27],[32],[33] |
$ 143,350
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[22],[27],[32],[33] |
145,929
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[22],[27],[32],[33] |
$ 153,070
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Senior Secured, Maturity Date January 2028, Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[12],[13],[14] |
|
|
2028-01
|
|
|
|
|
|
2028-01
|
|
Investment, basis spread, variable rate |
[7],[9],[12],[13],[14] |
|
|
2.20%
|
|
|
|
|
|
2.20%
|
|
Investment, interest rate, floor |
[7],[9],[12],[13],[14] |
|
|
9.95%
|
|
|
|
|
|
9.95%
|
|
Investment, interest rate, cap |
[7],[9],[12],[13],[14] |
|
|
10.70%
|
|
|
|
|
|
10.70%
|
|
Investment exit fee |
[7],[9],[12],[13],[14] |
|
|
5.78%
|
|
|
|
|
|
5.78%
|
|
Principal amount |
[9],[12],[13],[14] |
|
|
$ 143,350
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[12],[13],[14] |
|
|
145,451
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[12],[13],[14] |
|
|
$ 152,945
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-10
|
[25] |
2028-10
|
[8] |
2028-10
|
[25] |
2028-10
|
[25] |
2028-10
|
[8] |
Investment, basis spread, variable rate |
|
2.45%
|
[23],[25] |
2.45%
|
[7],[8] |
2.45%
|
[23],[25] |
2.45%
|
[23],[25] |
2.45%
|
[7],[8] |
Investment, interest rate, floor |
|
10.95%
|
[23],[25] |
10.95%
|
[7],[8] |
10.95%
|
[23],[25] |
10.95%
|
[23],[25] |
10.95%
|
[7],[8] |
Investment, interest rate, paid in kind |
|
1.10%
|
[23],[25] |
1.10%
|
[7],[8] |
1.10%
|
[23],[25] |
1.10%
|
[23],[25] |
1.10%
|
[7],[8] |
Investment exit fee |
|
5.45%
|
[23],[25] |
5.45%
|
[7],[8] |
5.45%
|
[23],[25] |
5.45%
|
[23],[25] |
5.45%
|
[7],[8] |
Principal amount |
|
$ 53,339
|
[25] |
$ 53,192
|
[8] |
|
|
|
|
|
|
Investment cost |
|
53,669
|
[2],[25] |
53,374
|
[5],[8] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 55,350
|
[25] |
$ 55,626
|
[8] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and COMPASS Pathways plc, Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
[25],[27],[28],[32] |
2027-07
|
[8],[9],[10],[14] |
2027-07
|
[25],[27],[28],[32] |
2027-07
|
[25],[27],[28],[32] |
2027-07
|
[8],[9],[10],[14] |
Investment, basis spread, variable rate |
|
1.50%
|
[23],[25],[27],[28],[32] |
1.50%
|
[7],[8],[9],[10],[14] |
1.50%
|
[23],[25],[27],[28],[32] |
1.50%
|
[23],[25],[27],[28],[32] |
1.50%
|
[7],[8],[9],[10],[14] |
Investment, interest rate, floor |
|
9.75%
|
[23],[25],[27],[28],[32] |
9.75%
|
[7],[8],[9],[10],[14] |
9.75%
|
[23],[25],[27],[28],[32] |
9.75%
|
[23],[25],[27],[28],[32] |
9.75%
|
[7],[8],[9],[10],[14] |
Investment, interest rate, paid in kind |
|
1.40%
|
[23],[25],[27],[28],[32] |
1.40%
|
[7],[8],[9],[10],[14] |
1.40%
|
[23],[25],[27],[28],[32] |
1.40%
|
[23],[25],[27],[28],[32] |
1.40%
|
[7],[8],[9],[10],[14] |
Investment exit fee |
|
4.75%
|
[23],[25],[27],[28],[32] |
4.75%
|
[7],[8],[9],[10],[14] |
4.75%
|
[23],[25],[27],[28],[32] |
4.75%
|
[23],[25],[27],[28],[32] |
4.75%
|
[7],[8],[9],[10],[14] |
Principal amount |
|
$ 24,576
|
[25],[27],[28],[32] |
$ 24,490
|
[8],[9],[10],[14] |
|
|
|
|
|
|
Investment cost |
|
24,826
|
[2],[25],[27],[28],[32] |
24,613
|
[5],[8],[9],[10],[14] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 25,453
|
[25],[27],[28],[32] |
$ 25,608
|
[8],[9],[10],[14] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21] |
2026-09
|
|
|
|
2026-09
|
|
2026-09
|
|
|
|
Investment, basis spread, variable rate |
[21],[23] |
5.70%
|
|
|
|
5.70%
|
|
5.70%
|
|
|
|
Investment, interest rate, floor |
[21],[23] |
8.95%
|
|
|
|
8.95%
|
|
8.95%
|
|
|
|
Investment exit fee |
[21],[23] |
7.75%
|
|
|
|
7.75%
|
|
7.75%
|
|
|
|
Principal amount |
[21] |
$ 86,925
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21] |
90,906
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21] |
$ 90,279
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc., Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[13],[15] |
|
|
2026-09
|
|
|
|
|
|
2026-09
|
|
Investment, basis spread, variable rate |
[7],[13],[15] |
|
|
5.70%
|
|
|
|
|
|
5.70%
|
|
Investment, interest rate, floor |
[7],[13],[15] |
|
|
8.95%
|
|
|
|
|
|
8.95%
|
|
Investment exit fee |
[7],[13],[15] |
|
|
7.75%
|
|
|
|
|
|
7.75%
|
|
Principal amount |
[13],[15] |
|
|
$ 105,225
|
|
|
|
|
|
|
|
Investment cost |
[5],[13],[15] |
|
|
109,543
|
|
|
|
|
|
|
|
Investments, at fair value: |
[13],[15] |
|
|
$ 109,178
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Disc Medicine, Inc., Senior Secured, Maturity Date December 2029, Prime + 1.75%, Floor rate 8.25%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2029-12
|
[1],[26],[27],[38] |
2029-12
|
[6],[9],[11],[37] |
2029-12
|
[1],[26],[27],[38] |
2029-12
|
[1],[26],[27],[38] |
2029-12
|
[6],[9],[11],[37] |
Investment, basis spread, variable rate |
|
1.75%
|
[1],[23],[26],[27],[38] |
1.75%
|
[6],[7],[9],[11],[37] |
1.75%
|
[1],[23],[26],[27],[38] |
1.75%
|
[1],[23],[26],[27],[38] |
1.75%
|
[6],[7],[9],[11],[37] |
Investment, interest rate, floor |
|
8.25%
|
[1],[23],[26],[27],[38] |
8.25%
|
[6],[7],[9],[11],[37] |
8.25%
|
[1],[23],[26],[27],[38] |
8.25%
|
[1],[23],[26],[27],[38] |
8.25%
|
[6],[7],[9],[11],[37] |
Investment exit fee |
|
6.75%
|
[1],[23],[26],[27],[38] |
6.75%
|
[6],[7],[9],[11],[37] |
6.75%
|
[1],[23],[26],[27],[38] |
6.75%
|
[1],[23],[26],[27],[38] |
6.75%
|
[6],[7],[9],[11],[37] |
Principal amount |
|
$ 22,500
|
[1],[26],[27],[38] |
$ 22,500
|
[6],[9],[11],[37] |
|
|
|
|
|
|
Investment cost |
|
22,433
|
[1],[2],[26],[27],[38] |
22,363
|
[5],[6],[9],[11],[37] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 22,755
|
[1],[26],[27],[38] |
$ 22,363
|
[6],[9],[11],[37] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc., Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6] |
|
|
2025-04
|
|
|
|
|
|
2025-04
|
|
Investment, basis spread, variable rate |
[6],[7] |
|
|
6.25%
|
|
|
|
|
|
6.25%
|
|
Investment, interest rate, floor |
[6],[7] |
|
|
9.50%
|
|
|
|
|
|
9.50%
|
|
Investment exit fee |
[6],[7] |
|
|
4.00%
|
|
|
|
|
|
4.00%
|
|
Principal amount |
[6] |
|
|
$ 489
|
|
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
988
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 988
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, Maturity Date February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[8],[11] |
|
|
2026-02
|
|
|
|
|
|
2026-02
|
|
Investment, basis spread, variable rate |
[6],[7],[8],[11] |
|
|
1.70%
|
|
|
|
|
|
1.70%
|
|
Investment, interest rate, floor |
[6],[7],[8],[11] |
|
|
9.95%
|
|
|
|
|
|
9.95%
|
|
Investment, interest rate, paid in kind |
[6],[7],[8],[11] |
|
|
1.50%
|
|
|
|
|
|
1.50%
|
|
Investment exit fee |
[6],[7],[8],[11] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
Principal amount |
[6],[8],[11] |
|
|
$ 20,404
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[8],[11] |
|
|
20,484
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[8],[11] |
|
|
$ 21,014
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc.. Senior Secured, Maturity Date May 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[25],[26] |
2026-05
|
|
|
|
2026-05
|
|
2026-05
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[25],[26] |
1.70%
|
|
|
|
1.70%
|
|
1.70%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[25],[26] |
9.95%
|
|
|
|
9.95%
|
|
9.95%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[23],[25],[26] |
1.50%
|
|
|
|
1.50%
|
|
1.50%
|
|
|
|
Investment exit fee |
[1],[23],[25],[26] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
Principal amount |
[1],[25],[26] |
$ 20,480
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[25],[26] |
20,654
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[25],[26] |
$ 20,660
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[21] |
2025-05
|
|
|
|
2025-05
|
|
2025-05
|
|
|
|
Investment, basis spread, variable rate |
[1],[21],[23] |
5.40%
|
|
|
|
5.40%
|
|
5.40%
|
|
|
|
Investment, interest rate, floor |
[1],[21],[23] |
8.65%
|
|
|
|
8.65%
|
|
8.65%
|
|
|
|
Investment exit fee |
[1],[21],[23] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
Principal amount |
[1],[21] |
$ 1,612
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[21] |
2,442
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[21] |
$ 2,442
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc., Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[15] |
|
|
2025-05
|
|
|
|
|
|
2025-05
|
|
Investment, basis spread, variable rate |
[6],[7],[15] |
|
|
5.40%
|
|
|
|
|
|
5.40%
|
|
Investment, interest rate, floor |
[6],[7],[15] |
|
|
8.65%
|
|
|
|
|
|
8.65%
|
|
Investment exit fee |
[6],[7],[15] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
Principal amount |
[6],[15] |
|
|
$ 3,963
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[15] |
|
|
4,755
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[15] |
|
|
$ 4,749
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 6.05% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[27] |
2027-11
|
|
|
|
2027-11
|
|
2027-11
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[27] |
2.40%
|
|
|
|
2.40%
|
|
2.40%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[27] |
8.65%
|
|
|
|
8.65%
|
|
8.65%
|
|
|
|
Investment exit fee |
[1],[23],[27] |
6.05%
|
|
|
|
6.05%
|
|
6.05%
|
|
|
|
Principal amount |
[1],[27] |
$ 5,500
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[27] |
5,646
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[27] |
$ 5,707
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 6.05% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[9] |
|
|
2027-11
|
|
|
|
|
|
2027-11
|
|
Investment, basis spread, variable rate |
[6],[7],[9] |
|
|
2.40%
|
|
|
|
|
|
2.40%
|
|
Investment, interest rate, floor |
[6],[7],[9] |
|
|
8.65%
|
|
|
|
|
|
8.65%
|
|
Investment exit fee |
[6],[7],[9] |
|
|
6.05%
|
|
|
|
|
|
6.05%
|
|
Principal amount |
[6],[9] |
|
|
$ 5,500
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[9] |
|
|
5,622
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[9] |
|
|
$ 5,721
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2027, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[27] |
2027-05
|
|
|
|
2027-05
|
|
2027-05
|
|
|
|
Investment, basis spread, variable rate |
[21],[23],[27] |
2.45%
|
|
|
|
2.45%
|
|
2.45%
|
|
|
|
Investment, interest rate, floor |
[21],[23],[27] |
8.25%
|
|
|
|
8.25%
|
|
8.25%
|
|
|
|
Investment exit fee |
[21],[23],[27] |
5.35%
|
|
|
|
5.35%
|
|
5.35%
|
|
|
|
Principal amount |
[21],[27] |
$ 78,200
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[27] |
80,159
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[27] |
$ 82,430
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Senior Secured, Maturity Date May 2027, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[15] |
|
|
2027-05
|
|
|
|
|
|
2027-05
|
|
Investment, basis spread, variable rate |
[7],[9],[15] |
|
|
2.45%
|
|
|
|
|
|
2.45%
|
|
Investment, interest rate, floor |
[7],[9],[15] |
|
|
8.25%
|
|
|
|
|
|
8.25%
|
|
Investment exit fee |
[7],[9],[15] |
|
|
5.35%
|
|
|
|
|
|
5.35%
|
|
Principal amount |
[9],[15] |
|
|
$ 78,200
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[15] |
|
|
79,896
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[15] |
|
|
$ 82,775
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and MoonLake Immunotherapeutics, Senior Secured, Maturity Date April 2030, Prime + 1.45%, Floor rate 8.45%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[28] |
2030-04
|
|
|
|
2030-04
|
|
2030-04
|
|
|
|
Investment, basis spread, variable rate |
[23],[27],[28] |
1.45%
|
|
|
|
1.45%
|
|
1.45%
|
|
|
|
Investment, interest rate, floor |
[23],[27],[28] |
8.45%
|
|
|
|
8.45%
|
|
8.45%
|
|
|
|
Investment exit fee |
[23],[27],[28] |
6.95%
|
|
|
|
6.95%
|
|
6.95%
|
|
|
|
Principal amount |
[27],[28] |
$ 57,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28] |
56,421
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28] |
$ 56,421
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and NorthSea Therapeutics, Convertible Debt, Maturity Date December 2025, FIXED 6.00% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-12
|
[27],[28],[29] |
2025-12
|
[9],[10],[30] |
2025-12
|
[27],[28],[29] |
2025-12
|
[27],[28],[29] |
2025-12
|
[9],[10],[30] |
Investment, interest rate, paid in cash |
|
6.00%
|
[23],[27],[28],[29] |
6.00%
|
[7],[9],[10],[30] |
6.00%
|
[23],[27],[28],[29] |
6.00%
|
[23],[27],[28],[29] |
6.00%
|
[7],[9],[10],[30] |
Principal amount |
|
$ 273
|
[27],[28],[29] |
$ 273
|
[9],[10],[30] |
|
|
|
|
|
|
Investment cost |
|
273
|
[2],[27],[28],[29] |
273
|
[5],[9],[10],[30] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 273
|
[27],[28],[29] |
$ 273
|
[9],[10],[30] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[25],[33] |
2027-12
|
|
|
|
2027-12
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[25],[33] |
1.35%
|
|
|
|
1.35%
|
|
1.35%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[25],[33] |
9.85%
|
|
|
|
9.85%
|
|
9.85%
|
|
|
|
Investment, interest rate, cap |
[1],[23],[25],[33] |
10.35%
|
|
|
|
10.35%
|
|
10.35%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[23],[25],[33] |
2.15%
|
|
|
|
2.15%
|
|
2.15%
|
|
|
|
Investment exit fee |
[1],[23],[25],[33] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
Principal amount |
[1],[25],[33] |
$ 31,385
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[25],[33] |
31,224
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[25],[33] |
$ 31,510
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 6.22% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[8],[9],[12],[13],[37],[39] |
|
|
2027-12
|
|
|
|
|
|
2027-12
|
|
Investment, basis spread, variable rate |
[6],[7],[8],[9],[12],[13],[37],[39] |
|
|
1.35%
|
|
|
|
|
|
1.35%
|
|
Investment, interest rate, floor |
[6],[7],[8],[9],[12],[13],[37],[39] |
|
|
9.85%
|
|
|
|
|
|
9.85%
|
|
Investment, interest rate, cap |
[6],[7],[8],[9],[12],[13],[37],[39] |
|
|
10.35%
|
|
|
|
|
|
10.35%
|
|
Investment, interest rate, paid in kind |
[6],[7],[8],[9],[12],[13],[37],[39] |
|
|
2.15%
|
|
|
|
|
|
2.15%
|
|
Investment exit fee |
[6],[7],[8],[9],[12],[13],[37],[39] |
|
|
6.22%
|
|
|
|
|
|
6.22%
|
|
Principal amount |
[6],[8],[9],[12],[13],[37],[39] |
|
|
$ 169,234
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[8],[9],[12],[13],[37],[39] |
|
|
171,805
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[8],[9],[12],[13],[37],[39] |
|
|
$ 176,130
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 7.06% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[22],[25],[27],[33],[38],[40] |
2027-12
|
|
|
|
2027-12
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[22],[23],[25],[27],[33],[38],[40] |
1.35%
|
|
|
|
1.35%
|
|
1.35%
|
|
|
|
Investment, interest rate, floor |
[1],[22],[23],[25],[27],[33],[38],[40] |
9.85%
|
|
|
|
9.85%
|
|
9.85%
|
|
|
|
Investment, interest rate, cap |
[1],[22],[23],[25],[27],[33],[38],[40] |
10.35%
|
|
|
|
10.35%
|
|
10.35%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[22],[23],[25],[27],[33],[38],[40] |
2.15%
|
|
|
|
2.15%
|
|
2.15%
|
|
|
|
Investment exit fee |
[1],[22],[23],[25],[27],[33],[38],[40] |
7.06%
|
|
|
|
7.06%
|
|
7.06%
|
|
|
|
Principal amount |
[1],[22],[25],[27],[33],[38],[40] |
$ 138,620
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[22],[25],[27],[33],[38],[40] |
141,882
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[22],[25],[27],[33],[38],[40] |
$ 142,910
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[22],[25],[27] |
2027-10
|
|
|
|
2027-10
|
|
2027-10
|
|
|
|
Investment, basis spread, variable rate |
[21],[22],[23],[25],[27] |
1.75%
|
|
|
|
1.75%
|
|
1.75%
|
|
|
|
Investment, interest rate, floor |
[21],[22],[23],[25],[27] |
7.25%
|
|
|
|
7.25%
|
|
7.25%
|
|
|
|
Investment, interest rate, cap |
[21],[22],[23],[25],[27] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
Investment, interest rate, paid in kind |
[21],[22],[23],[25],[27] |
1.50%
|
|
|
|
1.50%
|
|
1.50%
|
|
|
|
Investment exit fee |
[21],[22],[23],[25],[27] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
Principal amount |
[21],[22],[25],[27] |
$ 32,009
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[22],[25],[27] |
32,513
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[22],[25],[27] |
$ 33,866
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc., Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[12],[15] |
|
|
2027-10
|
|
|
|
|
|
2027-10
|
|
Investment, basis spread, variable rate |
[7],[8],[9],[12],[15] |
|
|
1.75%
|
|
|
|
|
|
1.75%
|
|
Investment, interest rate, floor |
[7],[8],[9],[12],[15] |
|
|
7.25%
|
|
|
|
|
|
7.25%
|
|
Investment, interest rate, cap |
[7],[8],[9],[12],[15] |
|
|
9.00%
|
|
|
|
|
|
9.00%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9],[12],[15] |
|
|
1.50%
|
|
|
|
|
|
1.50%
|
|
Investment exit fee |
[7],[8],[9],[12],[15] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
Principal amount |
[8],[9],[12],[15] |
|
|
$ 31,889
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[9],[12],[15] |
|
|
32,294
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[9],[12],[15] |
|
|
$ 33,745
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Savara, Inc.. Senior Secured, Maturity Date April 2030, Prime + 1.45%, Floor rate 7.45%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[27],[38] |
2030-04
|
|
|
|
2030-04
|
|
2030-04
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[27],[38] |
1.45%
|
|
|
|
1.45%
|
|
1.45%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[27],[38] |
7.45%
|
|
|
|
7.45%
|
|
7.45%
|
|
|
|
Investment exit fee |
[1],[23],[27],[38] |
6.95%
|
|
|
|
6.95%
|
|
6.95%
|
|
|
|
Principal amount |
[1],[27],[38] |
$ 21,450
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[27],[38] |
21,334
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[27],[38] |
$ 21,334
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and SynOx Therapeutics Limited, Senior Secured, Maturity Date May 2027, Prime + 1.40%, Floor rate 9.90%, 7.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-05
|
[27],[28],[32] |
2027-05
|
[9],[10],[14] |
2027-05
|
[27],[28],[32] |
2027-05
|
[27],[28],[32] |
2027-05
|
[9],[10],[14] |
Investment, basis spread, variable rate |
|
1.40%
|
[23],[27],[28],[32] |
1.40%
|
[7],[9],[10],[14] |
1.40%
|
[23],[27],[28],[32] |
1.40%
|
[23],[27],[28],[32] |
1.40%
|
[7],[9],[10],[14] |
Investment, interest rate, floor |
|
9.90%
|
[23],[27],[28],[32] |
9.90%
|
[7],[9],[10],[14] |
9.90%
|
[23],[27],[28],[32] |
9.90%
|
[23],[27],[28],[32] |
9.90%
|
[7],[9],[10],[14] |
Investment exit fee |
|
7.25%
|
[23],[27],[28],[32] |
7.25%
|
[7],[9],[10],[14] |
7.25%
|
[23],[27],[28],[32] |
7.25%
|
[23],[27],[28],[32] |
7.25%
|
[7],[9],[10],[14] |
Principal amount |
|
$ 4,500
|
[27],[28],[32] |
$ 4,500
|
[9],[10],[14] |
|
|
|
|
|
|
Investment cost |
|
4,511
|
[2],[27],[28],[32] |
4,471
|
[5],[9],[10],[14] |
|
|
|
|
|
|
Investments, at fair value: |
|
4,579
|
[27],[28],[32] |
$ 4,573
|
[9],[10],[14] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Total Phathom Pharmaceuticals, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
170,005
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
173,106
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 174,420
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-10
|
[21],[27] |
2026-10
|
[9],[11],[15] |
2026-10
|
[21],[27] |
2026-10
|
[21],[27] |
2026-10
|
[9],[11],[15] |
Investment, basis spread, variable rate |
|
4.20%
|
[21],[23],[27] |
4.20%
|
[7],[9],[11],[15] |
4.20%
|
[21],[23],[27] |
4.20%
|
[21],[23],[27] |
4.20%
|
[7],[9],[11],[15] |
Investment, interest rate, floor |
|
7.45%
|
[21],[23],[27] |
7.45%
|
[7],[9],[11],[15] |
7.45%
|
[21],[23],[27] |
7.45%
|
[21],[23],[27] |
7.45%
|
[7],[9],[11],[15] |
Investment, interest rate, cap |
|
8.95%
|
[21],[23],[27] |
8.95%
|
[7],[9],[11],[15] |
8.95%
|
[21],[23],[27] |
8.95%
|
[21],[23],[27] |
8.95%
|
[7],[9],[11],[15] |
Investment exit fee |
|
6.00%
|
[21],[23],[27] |
6.00%
|
[7],[9],[11],[15] |
6.00%
|
[21],[23],[27] |
6.00%
|
[21],[23],[27] |
6.00%
|
[7],[9],[11],[15] |
Principal amount |
|
$ 8,000
|
[21],[27] |
$ 8,000
|
[9],[11],[15] |
|
|
|
|
|
|
Investment cost |
|
8,268
|
[2],[21],[27] |
8,231
|
[5],[9],[11],[15] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 8,481
|
[21],[27] |
$ 8,523
|
[9],[11],[15] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 10.15%, 3.72% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[22],[32] |
2027-07
|
|
|
|
2027-07
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[21],[22],[23],[32] |
3.15%
|
|
|
|
3.15%
|
|
3.15%
|
|
|
|
Investment, interest rate, floor |
[21],[22],[23],[32] |
10.15%
|
|
|
|
10.15%
|
|
10.15%
|
|
|
|
Investment exit fee |
[21],[22],[23],[32] |
3.72%
|
|
|
|
3.72%
|
|
3.72%
|
|
|
|
Principal amount |
[21],[22],[32] |
$ 75,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[22],[32] |
75,735
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[22],[32] |
$ 74,933
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 10.15%, 3.72% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[14],[15] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7],[12],[14],[15] |
|
|
3.15%
|
|
|
|
|
|
3.15%
|
|
Investment, interest rate, floor |
[7],[12],[14],[15] |
|
|
10.15%
|
|
|
|
|
|
10.15%
|
|
Investment exit fee |
[7],[12],[14],[15] |
|
|
3.72%
|
|
|
|
|
|
3.72%
|
|
Principal amount |
[12],[14],[15] |
|
|
$ 75,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[12],[14],[15] |
|
|
75,512
|
|
|
|
|
|
|
|
Investments, at fair value: |
[12],[14],[15] |
|
|
$ 75,725
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and bluebird bio, Inc. Senior Secured, Maturity Date April 2029, Prime + 1.45%, Floor rate 9.95%, PIK Interest 2.45%, 6.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[25] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
Investment, basis spread, variable rate |
[23],[25] |
1.45%
|
|
|
|
1.45%
|
|
1.45%
|
|
|
|
Investment, interest rate, floor |
[23],[25] |
9.95%
|
|
|
|
9.95%
|
|
9.95%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[25] |
2.45%
|
|
|
|
2.45%
|
|
2.45%
|
|
|
|
Investment exit fee |
[23],[25] |
6.45%
|
|
|
|
6.45%
|
|
6.45%
|
|
|
|
Principal amount |
[25] |
$ 66,058
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
64,724
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25] |
$ 60,624
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and bluebird bio, Inc., Senior Secured, Maturity Date April 2029, Prime + 1.45%, Floor rate 9.95%, PIK Interest 2.45%, 6.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8] |
|
|
2029-04
|
|
|
|
|
|
2029-04
|
|
Investment, basis spread, variable rate |
[7],[8] |
|
|
1.45%
|
|
|
|
|
|
1.45%
|
|
Investment, interest rate, floor |
[7],[8] |
|
|
9.95%
|
|
|
|
|
|
9.95%
|
|
Investment, interest rate, paid in kind |
[7],[8] |
|
|
2.45%
|
|
|
|
|
|
2.45%
|
|
Investment exit fee |
[7],[8] |
|
|
6.45%
|
|
|
|
|
|
6.45%
|
|
Principal amount |
[8] |
|
|
$ 65,655
|
|
|
|
|
|
|
|
Investment cost |
[5],[8] |
|
|
64,028
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8] |
|
|
$ 55,344
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[27],[28] |
2028-01
|
|
|
|
2028-01
|
|
2028-01
|
|
|
|
Investment, basis spread, variable rate |
[23],[25],[27],[28] |
0.75%
|
|
|
|
0.75%
|
|
0.75%
|
|
|
|
Investment, interest rate, floor |
[23],[25],[27],[28] |
9.25%
|
|
|
|
9.25%
|
|
9.25%
|
|
|
|
Investment, interest rate, cap |
[23],[25],[27],[28] |
9.75%
|
|
|
|
9.75%
|
|
9.75%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[25],[27],[28] |
1.15%
|
|
|
|
1.15%
|
|
1.15%
|
|
|
|
Investment exit fee |
[23],[25],[27],[28] |
5.50%
|
|
|
|
5.50%
|
|
5.50%
|
|
|
|
Principal amount |
[25],[27],[28] |
$ 15,970
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[27],[28] |
16,133
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[27],[28] |
$ 16,177
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc., Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[10] |
|
|
2028-01
|
|
|
|
|
|
2028-01
|
|
Investment, basis spread, variable rate |
[7],[8],[9],[10] |
|
|
0.75%
|
|
|
|
|
|
0.75%
|
|
Investment, interest rate, floor |
[7],[8],[9],[10] |
|
|
9.25%
|
|
|
|
|
|
9.25%
|
|
Investment, interest rate, cap |
[7],[8],[9],[10] |
|
|
9.75%
|
|
|
|
|
|
9.75%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9],[10] |
|
|
1.15%
|
|
|
|
|
|
1.15%
|
|
Investment exit fee |
[7],[8],[9],[10] |
|
|
5.50%
|
|
|
|
|
|
5.50%
|
|
Principal amount |
[8],[9],[10] |
|
|
$ 15,924
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[9],[10] |
|
|
16,015
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[9],[10] |
|
|
$ 16,149
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V., Senior Secured, Maturity Date January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-01
|
[22],[27],[28],[32] |
2027-01
|
[9],[10],[12],[14] |
2027-01
|
[22],[27],[28],[32] |
2027-01
|
[22],[27],[28],[32] |
2027-01
|
[9],[10],[12],[14] |
Investment, basis spread, variable rate |
|
4.70%
|
[22],[23],[27],[28],[32] |
4.70%
|
[7],[9],[10],[12],[14] |
4.70%
|
[22],[23],[27],[28],[32] |
4.70%
|
[22],[23],[27],[28],[32] |
4.70%
|
[7],[9],[10],[12],[14] |
Investment, interest rate, floor |
|
7.95%
|
[22],[23],[27],[28],[32] |
7.95%
|
[7],[9],[10],[12],[14] |
7.95%
|
[22],[23],[27],[28],[32] |
7.95%
|
[22],[23],[27],[28],[32] |
7.95%
|
[7],[9],[10],[12],[14] |
Investment exit fee |
|
6.10%
|
[22],[23],[27],[28],[32] |
6.10%
|
[7],[9],[10],[12],[14] |
6.10%
|
[22],[23],[27],[28],[32] |
6.10%
|
[22],[23],[27],[28],[32] |
6.10%
|
[7],[9],[10],[12],[14] |
Principal amount |
|
$ 35,000
|
[22],[27],[28],[32] |
$ 35,000
|
[9],[10],[12],[14] |
|
|
|
|
|
|
Investment cost |
|
36,243
|
[2],[22],[27],[28],[32] |
36,102
|
[5],[9],[10],[12],[14] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 37,135
|
[22],[27],[28],[32] |
$ 37,135
|
[9],[10],[12],[14] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (8.13%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
8.13%
|
|
|
|
|
|
8.13%
|
|
Investment cost |
[5] |
|
|
$ 161,468
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 161,687
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (8.20%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
8.20%
|
|
|
|
8.20%
|
|
8.20%
|
|
|
|
Investment cost |
[2] |
$ 162,447
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 164,043
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, Maturity Date December 2028, Prime + 3.00%, Floor rate 9.50%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-12
|
[1],[26],[38] |
2028-12
|
[6],[11],[37] |
2028-12
|
[1],[26],[38] |
2028-12
|
[1],[26],[38] |
2028-12
|
[6],[11],[37] |
Investment, basis spread, variable rate |
|
3.00%
|
[1],[23],[26],[38] |
3.00%
|
[6],[7],[11],[37] |
3.00%
|
[1],[23],[26],[38] |
3.00%
|
[1],[23],[26],[38] |
3.00%
|
[6],[7],[11],[37] |
Investment, interest rate, floor |
|
9.50%
|
[1],[23],[26],[38] |
9.50%
|
[6],[7],[11],[37] |
9.50%
|
[1],[23],[26],[38] |
9.50%
|
[1],[23],[26],[38] |
9.50%
|
[6],[7],[11],[37] |
Investment exit fee |
|
4.00%
|
[1],[23],[26],[38] |
4.00%
|
[6],[7],[11],[37] |
4.00%
|
[1],[23],[26],[38] |
4.00%
|
[1],[23],[26],[38] |
4.00%
|
[6],[7],[11],[37] |
Principal amount |
|
$ 48,750
|
[1],[26],[38] |
$ 48,750
|
[6],[11],[37] |
|
|
|
|
|
|
Investment cost |
|
48,665
|
[1],[2],[26],[38] |
48,557
|
[5],[6],[11],[37] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 48,981
|
[1],[26],[38] |
$ 47,986
|
[6],[11],[37] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Shield AI, Inc., Senior Secured, Maturity Date February 2029, Prime + 0.85%, Floor rate 6.85%, Cap rate 9.60%, PIK Interest 2.50%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2029-02
|
[22],[25],[33] |
2029-02
|
[8],[12],[13] |
2029-02
|
[22],[25],[33] |
2029-02
|
[22],[25],[33] |
2029-02
|
[8],[12],[13] |
Investment, basis spread, variable rate |
|
0.85%
|
[22],[23],[25],[33] |
0.85%
|
[7],[8],[12],[13] |
0.85%
|
[22],[23],[25],[33] |
0.85%
|
[22],[23],[25],[33] |
0.85%
|
[7],[8],[12],[13] |
Investment, interest rate, floor |
|
6.85%
|
[22],[23],[25],[33] |
6.85%
|
[7],[8],[12],[13] |
6.85%
|
[22],[23],[25],[33] |
6.85%
|
[22],[23],[25],[33] |
6.85%
|
[7],[8],[12],[13] |
Investment, interest rate, cap |
|
9.60%
|
[22],[23],[25],[33] |
9.60%
|
[7],[8],[12],[13] |
9.60%
|
[22],[23],[25],[33] |
9.60%
|
[22],[23],[25],[33] |
9.60%
|
[7],[8],[12],[13] |
Investment, interest rate, paid in kind |
|
2.50%
|
[22],[23],[25],[33] |
2.50%
|
[7],[8],[12],[13] |
2.50%
|
[22],[23],[25],[33] |
2.50%
|
[22],[23],[25],[33] |
2.50%
|
[7],[8],[12],[13] |
Investment exit fee |
|
2.50%
|
[22],[23],[25],[33] |
2.50%
|
[7],[8],[12],[13] |
2.50%
|
[22],[23],[25],[33] |
2.50%
|
[22],[23],[25],[33] |
2.50%
|
[7],[8],[12],[13] |
Principal amount |
|
$ 114,471
|
[22],[25],[33] |
$ 113,766
|
[8],[12],[13] |
|
|
|
|
|
|
Investment cost |
|
113,782
|
[2],[22],[25],[33] |
112,911
|
[5],[8],[12],[13] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 115,062
|
[22],[25],[33] |
$ 113,701
|
[8],[12],[13] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (30.19%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
30.19%
|
|
|
|
|
|
30.19%
|
|
Investment cost |
[5] |
|
|
$ 599,140
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 600,582
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (30.79%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
30.79%
|
|
|
|
30.79%
|
|
30.79%
|
|
|
|
Investment cost |
[2] |
$ 619,669
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 615,911
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 3-month SOFR + 5.26%, Floor rate 6.00%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[22],[25],[32] |
2026-11
|
|
|
|
2026-11
|
|
2026-11
|
|
|
|
Investment, basis spread, variable rate |
[21],[22],[23],[25],[32] |
5.26%
|
|
|
|
5.26%
|
|
5.26%
|
|
|
|
Investment, interest rate, floor |
[21],[22],[23],[25],[32] |
6.00%
|
|
|
|
6.00%
|
|
6.00%
|
|
|
|
Investment, interest rate, paid in kind |
[21],[22],[23],[25],[32] |
4.45%
|
|
|
|
4.45%
|
|
4.45%
|
|
|
|
Principal amount |
[21],[22],[25],[32] |
$ 73,027
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[22],[25],[32] |
72,543
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[22],[25],[32] |
$ 71,114
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, Maturity Date November 2026, 3-month SOFR + 5.26%, Floor rate 6.00%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[12],[14],[15] |
|
|
2026-11
|
|
|
|
|
|
2026-11
|
|
Investment, basis spread, variable rate |
[7],[8],[12],[14],[15] |
|
|
5.26%
|
|
|
|
|
|
5.26%
|
|
Investment, interest rate, floor |
[7],[8],[12],[14],[15] |
|
|
6.00%
|
|
|
|
|
|
6.00%
|
|
Investment, interest rate, paid in kind |
[7],[8],[12],[14],[15] |
|
|
4.45%
|
|
|
|
|
|
4.45%
|
|
Principal amount |
[8],[12],[14],[15] |
|
|
$ 72,220
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[12],[14],[15] |
|
|
71,677
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[12],[14],[15] |
|
|
$ 70,459
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Convertible Debt, Maturity Date December 2025, FIXED 12.00% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[30] |
|
|
2025-12
|
|
|
|
|
|
2025-12
|
|
Investment, interest rate, paid in cash |
[7],[30] |
|
|
12.00%
|
|
|
|
|
|
12.00%
|
|
Principal amount |
[30] |
|
|
$ 202
|
|
|
|
|
|
|
|
Investment cost |
[5],[30] |
|
|
202
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30] |
|
|
$ 202
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, Maturity Date February 2028, Prime + 3.10%, Floor rate 8.10%, 3.78% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[25],[32] |
2028-02
|
|
|
|
2028-02
|
|
2028-02
|
|
|
|
Investment, basis spread, variable rate |
[21],[23],[25],[32] |
3.10%
|
|
|
|
3.10%
|
|
3.10%
|
|
|
|
Investment, interest rate, floor |
[21],[23],[25],[32] |
8.10%
|
|
|
|
8.10%
|
|
8.10%
|
|
|
|
Investment exit fee |
[21],[23],[25],[32] |
3.78%
|
|
|
|
3.78%
|
|
3.78%
|
|
|
|
Principal amount |
[21],[25],[32] |
$ 42,125
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[25],[32] |
42,482
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[25],[32] |
$ 40,351
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, Maturity Date June 2026, Prime -1.50%, Floor rate 7.00%, PIK Interest 7.00%, 5.64% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[14],[15] |
|
|
2026-06
|
|
|
|
|
|
2026-06
|
|
Investment, basis spread, variable rate |
[7],[8],[14],[15] |
|
|
(1.50%)
|
|
|
|
|
|
(1.50%)
|
|
Investment, interest rate, floor |
[7],[8],[14],[15] |
|
|
7.00%
|
|
|
|
|
|
7.00%
|
|
Investment, interest rate, paid in kind |
[7],[8],[14],[15] |
|
|
7.00%
|
|
|
|
|
|
7.00%
|
|
Investment exit fee |
[7],[8],[14],[15] |
|
|
5.64%
|
|
|
|
|
|
5.64%
|
|
Principal amount |
[8],[14],[15] |
|
|
$ 41,473
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[14],[15] |
|
|
43,348
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[14],[15] |
|
|
$ 41,610
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Curana Health Holdings, LLC, Senior Secured, Maturity Date January 2028, Prime + 1.45%, Floor rate 9.20%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-01
|
[21],[24],[26] |
2028-01
|
[11],[15],[18] |
2028-01
|
[21],[24],[26] |
2028-01
|
[21],[24],[26] |
2028-01
|
[11],[15],[18] |
Investment, basis spread, variable rate |
|
1.45%
|
[21],[23],[24],[26] |
1.45%
|
[7],[11],[15],[18] |
1.45%
|
[21],[23],[24],[26] |
1.45%
|
[21],[23],[24],[26] |
1.45%
|
[7],[11],[15],[18] |
Investment, interest rate, floor |
|
9.20%
|
[21],[23],[24],[26] |
9.20%
|
[7],[11],[15],[18] |
9.20%
|
[21],[23],[24],[26] |
9.20%
|
[21],[23],[24],[26] |
9.20%
|
[7],[11],[15],[18] |
Investment exit fee |
|
4.95%
|
[21],[23],[24],[26] |
4.95%
|
[7],[11],[15],[18] |
4.95%
|
[21],[23],[24],[26] |
4.95%
|
[21],[23],[24],[26] |
4.95%
|
[7],[11],[15],[18] |
Principal amount |
|
$ 27,500
|
[21],[24],[26] |
$ 27,500
|
[11],[15],[18] |
|
|
|
|
|
|
Investment cost |
|
27,814
|
[2],[21],[24],[26] |
27,722
|
[5],[11],[15],[18] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 28,113
|
[21],[24],[26] |
$ 28,207
|
[11],[15],[18] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Ennoble Care LLC, Senior Secured, Maturity Date February 2030, Prime + 2.60%, Floor rate 10.35%, 7.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2030-02
|
|
|
|
2030-02
|
|
2030-02
|
|
|
|
Investment, basis spread, variable rate |
[23] |
2.60%
|
|
|
|
2.60%
|
|
2.60%
|
|
|
|
Investment, interest rate, floor |
[23] |
10.35%
|
|
|
|
10.35%
|
|
10.35%
|
|
|
|
Investment exit fee |
[23] |
7.95%
|
|
|
|
7.95%
|
|
7.95%
|
|
|
|
Principal amount |
|
$ 9,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
8,916
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 8,916
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 4.25%, Floor rate 9.50%, PIK Interest 1.55% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[25],[32] |
2026-02
|
|
|
|
2026-02
|
|
2026-02
|
|
|
|
Investment, basis spread, variable rate |
[22],[23],[25],[32] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
Investment, interest rate, floor |
[22],[23],[25],[32] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
Investment, interest rate, paid in kind |
[22],[23],[25],[32] |
1.55%
|
|
|
|
1.55%
|
|
1.55%
|
|
|
|
Principal amount |
[22],[25],[32] |
$ 70,952
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[22],[25],[32] |
70,976
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[22],[25],[32] |
$ 70,976
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 4.25%, Floor rate 9.50%, PIK Interest 1.55%, 1.11% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[12],[14] |
|
|
2026-02
|
|
|
|
|
|
2026-02
|
|
Investment, basis spread, variable rate |
[7],[8],[12],[14] |
|
|
4.25%
|
|
|
|
|
|
4.25%
|
|
Investment, interest rate, floor |
[7],[8],[12],[14] |
|
|
9.50%
|
|
|
|
|
|
9.50%
|
|
Investment, interest rate, paid in kind |
[7],[8],[12],[14] |
|
|
1.55%
|
|
|
|
|
|
1.55%
|
|
Investment exit fee |
[7],[8],[12],[14] |
|
|
1.11%
|
|
|
|
|
|
1.11%
|
|
Principal amount |
[8],[12],[14] |
|
|
$ 70,678
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[12],[14] |
|
|
70,473
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[12],[14] |
|
|
$ 70,062
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc. Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[21],[26] |
2027-07
|
|
|
|
2027-07
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[1],[21],[23],[26] |
1.95%
|
|
|
|
1.95%
|
|
1.95%
|
|
|
|
Investment, interest rate, floor |
[1],[21],[23],[26] |
9.95%
|
|
|
|
9.95%
|
|
9.95%
|
|
|
|
Investment exit fee |
[1],[21],[23],[26] |
6.85%
|
|
|
|
6.85%
|
|
6.85%
|
|
|
|
Principal amount |
[1],[21],[26] |
$ 38,500
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[21],[26] |
39,321
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[21],[26] |
$ 39,614
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[11],[15] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[6],[7],[11],[15] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
Investment, interest rate, floor |
[6],[7],[11],[15] |
|
|
9.95%
|
|
|
|
|
|
9.95%
|
|
Investment exit fee |
[6],[7],[11],[15] |
|
|
6.85%
|
|
|
|
|
|
6.85%
|
|
Principal amount |
[6],[11],[15] |
|
|
$ 38,500
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[11],[15] |
|
|
39,089
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[11],[15] |
|
|
$ 39,582
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime + 0.75%, Floor rate 8.75%, PIK Interest 2.25%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[26],[33] |
2029-02
|
|
|
|
2029-02
|
|
2029-02
|
|
|
|
Investment, basis spread, variable rate |
[23],[25],[26],[33] |
0.75%
|
|
|
|
0.75%
|
|
0.75%
|
|
|
|
Investment, interest rate, floor |
[23],[25],[26],[33] |
8.75%
|
|
|
|
8.75%
|
|
8.75%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[25],[26],[33] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
Investment exit fee |
[23],[25],[26],[33] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
Principal amount |
[25],[26],[33] |
$ 168,301
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[26],[33] |
167,702
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[26],[33] |
$ 168,880
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime + 3.00%, Floor rate 11.00% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2029-02
|
[26],[33] |
2029-02
|
[11],[13] |
2029-02
|
[26],[33] |
2029-02
|
[26],[33] |
2029-02
|
[11],[13] |
Investment, basis spread, variable rate |
|
3.00%
|
[23],[26],[33] |
3.00%
|
[7],[11],[13] |
3.00%
|
[23],[26],[33] |
3.00%
|
[23],[26],[33] |
3.00%
|
[7],[11],[13] |
Investment, interest rate, floor |
|
11.00%
|
[23],[26],[33] |
11.00%
|
[7],[11],[13] |
11.00%
|
[23],[26],[33] |
11.00%
|
[23],[26],[33] |
11.00%
|
[7],[11],[13] |
Principal amount |
|
$ 5,000
|
[26],[33] |
$ 5,000
|
[11],[13] |
|
|
|
|
|
|
Investment cost |
|
5,000
|
[2],[26],[33] |
5,000
|
[5],[11],[13] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 5,000
|
[26],[33] |
$ 5,000
|
[11],[13] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime - 0.90%, Floor rate 7.10%, PIK Interest 4.00%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[11],[13] |
|
|
2029-02
|
|
|
|
|
|
2029-02
|
|
Investment, basis spread, variable rate |
[7],[8],[11],[13] |
|
|
(0.90%)
|
|
|
|
|
|
(0.90%)
|
|
Investment, interest rate, floor |
[7],[8],[11],[13] |
|
|
7.10%
|
|
|
|
|
|
7.10%
|
|
Investment, interest rate, paid in kind |
[7],[8],[11],[13] |
|
|
4.00%
|
|
|
|
|
|
4.00%
|
|
Investment exit fee |
[7],[8],[11],[13] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
Principal amount |
[8],[11],[13] |
|
|
$ 159,176
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[11],[13] |
|
|
158,410
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[11],[13] |
|
|
161,882
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
164,176
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
163,410
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 166,882
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Modern Life, Inc. Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21] |
2027-02
|
|
|
|
2027-02
|
|
2027-02
|
|
|
|
Investment, basis spread, variable rate |
[21],[23] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
Investment, interest rate, floor |
[21],[23] |
8.75%
|
|
|
|
8.75%
|
|
8.75%
|
|
|
|
Investment exit fee |
[21],[23] |
5.00%
|
|
|
|
5.00%
|
|
5.00%
|
|
|
|
Principal amount |
[21] |
$ 18,200
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21] |
18,391
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21] |
$ 18,402
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and NeueHealth, Inc. Senior Secured, Maturity Date June 2028, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.50%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[25] |
2028-06
|
|
|
|
2028-06
|
|
2028-06
|
|
|
|
Investment, basis spread, variable rate |
[22],[23],[25] |
1.15%
|
|
|
|
1.15%
|
|
1.15%
|
|
|
|
Investment, interest rate, floor |
[22],[23],[25] |
9.65%
|
|
|
|
9.65%
|
|
9.65%
|
|
|
|
Investment, interest rate, paid in kind |
[22],[23],[25] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
Investment exit fee |
[22],[23],[25] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
Principal amount |
[22],[25] |
$ 25,188
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[22],[25] |
24,483
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[22],[25] |
$ 24,449
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and NeueHealth, Inc., Maturity Date June 2028, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.50%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[12] |
|
|
2028-06
|
|
|
|
|
|
2028-06
|
|
Investment, basis spread, variable rate |
[7],[8],[12] |
|
|
1.15%
|
|
|
|
|
|
1.15%
|
|
Investment, interest rate, floor |
[7],[8],[12] |
|
|
9.65%
|
|
|
|
|
|
9.65%
|
|
Investment, interest rate, paid in kind |
[7],[8],[12] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
Investment exit fee |
[7],[8],[12] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
Principal amount |
[8],[12] |
|
|
$ 25,031
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[12] |
|
|
24,236
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[12] |
|
|
24,587
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Recover Together, Inc. Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21] |
2027-07
|
|
|
|
2027-07
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[21],[23] |
1.90%
|
|
|
|
1.90%
|
|
1.90%
|
|
|
|
Investment, interest rate, floor |
[21],[23] |
10.15%
|
|
|
|
10.15%
|
|
10.15%
|
|
|
|
Investment exit fee |
[21],[23] |
7.50%
|
|
|
|
7.50%
|
|
7.50%
|
|
|
|
Principal amount |
[21] |
$ 45,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21] |
45,705
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21] |
$ 44,769
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2027-09
|
|
|
|
2027-09
|
|
2027-09
|
|
|
|
Investment, basis spread, variable rate |
[1],[23] |
0.70%
|
|
|
|
0.70%
|
|
0.70%
|
|
|
|
Investment, interest rate, floor |
[1],[23] |
9.20%
|
|
|
|
9.20%
|
|
9.20%
|
|
|
|
Investment exit fee |
[1],[23] |
5.95%
|
|
|
|
5.95%
|
|
5.95%
|
|
|
|
Principal amount |
[1] |
$ 30,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
29,905
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 30,521
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Total Carbon Health Technologies, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
41,675
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
43,550
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 41,812
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date July 2026, Prime - 2.75% Floor rate 5.75%, PIK Interest 5.35%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[32] |
2026-10
|
|
|
|
2026-10
|
|
2026-10
|
|
|
|
Investment, basis spread, variable rate |
[23],[25],[32] |
(2.75%)
|
|
|
|
(2.75%)
|
|
(2.75%)
|
|
|
|
Investment, interest rate, floor |
[23],[25],[32] |
5.75%
|
|
|
|
5.75%
|
|
5.75%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[25],[32] |
5.35%
|
|
|
|
5.35%
|
|
5.35%
|
|
|
|
Investment exit fee |
[23],[25],[32] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
Principal amount |
[25],[32] |
$ 37,248
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[32] |
38,018
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[32] |
$ 37,396
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc., Senior Secured, Maturity Date October 2026, Prime - 2.75%, Floor rate 5.75%, PIK Interest 5.35%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[14] |
|
|
2026-10
|
|
|
|
|
|
2026-10
|
|
Investment, basis spread, variable rate |
[7],[8],[14] |
|
|
(2.75%)
|
|
|
|
|
|
(2.75%)
|
|
Investment, interest rate, floor |
[7],[8],[14] |
|
|
5.75%
|
|
|
|
|
|
5.75%
|
|
Investment, interest rate, paid in kind |
[7],[8],[14] |
|
|
5.35%
|
|
|
|
|
|
5.35%
|
|
Investment exit fee |
[7],[8],[14] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
Principal amount |
[8],[14] |
|
|
$ 36,761
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[14] |
|
|
37,367
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[14] |
|
|
$ 36,772
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and WellBe Senior Medical LLC, Senior Secured, Maturity Date May 2029, Prime + 0.75%, Floor rate 7.75%, PIK Interest 2.65%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[8],[11] |
|
|
2029-05
|
|
|
|
|
|
2029-05
|
|
Investment, basis spread, variable rate |
[6],[7],[8],[11] |
|
|
0.75%
|
|
|
|
|
|
0.75%
|
|
Investment, interest rate, floor |
[6],[7],[8],[11] |
|
|
7.75%
|
|
|
|
|
|
7.75%
|
|
Investment, interest rate, paid in kind |
[6],[7],[8],[11] |
|
|
2.65%
|
|
|
|
|
|
2.65%
|
|
Investment exit fee |
[6],[7],[8],[11] |
|
|
6.75%
|
|
|
|
|
|
6.75%
|
|
Principal amount |
[6],[8],[11] |
|
|
$ 28,283
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[8],[11] |
|
|
28,144
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[8],[11] |
|
|
$ 27,551
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and WellBe Senior Medical, LLC, Senior Secured, Maturity Date May 2029, Prime + 0.75%, Floor rate 7.75%, PIK Interest 2.65%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[25],[26] |
2029-05
|
|
|
|
2029-05
|
|
2029-05
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[25],[26] |
0.75%
|
|
|
|
0.75%
|
|
0.75%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[25],[26] |
7.75%
|
|
|
|
7.75%
|
|
7.75%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[23],[25],[26] |
2.65%
|
|
|
|
2.65%
|
|
2.65%
|
|
|
|
Investment exit fee |
[1],[23],[25],[26] |
6.75%
|
|
|
|
6.75%
|
|
6.75%
|
|
|
|
Principal amount |
[1],[25],[26] |
$ 28,468
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[25],[26] |
28,413
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[25],[26] |
$ 27,410
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services (1.02%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
1.02%
|
|
|
|
1.02%
|
|
1.02%
|
|
|
|
Investment cost |
[2] |
$ 19,891
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 20,313
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services (1.03%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.03%
|
|
|
|
|
|
1.03%
|
|
Investment cost |
[5] |
|
|
$ 19,741
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 20,445
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services and Saama Technologies, LLC, Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
[22],[25] |
2027-07
|
[8],[11],[12] |
2027-07
|
[22],[25] |
2027-07
|
[22],[25] |
2027-07
|
[8],[11],[12] |
Investment, basis spread, variable rate |
|
0.70%
|
[22],[23],[25] |
0.70%
|
[7],[8],[11],[12] |
0.70%
|
[22],[23],[25] |
0.70%
|
[22],[23],[25] |
0.70%
|
[7],[8],[11],[12] |
Investment, interest rate, floor |
|
8.95%
|
[22],[23],[25] |
8.95%
|
[7],[8],[11],[12] |
8.95%
|
[22],[23],[25] |
8.95%
|
[22],[23],[25] |
8.95%
|
[7],[8],[11],[12] |
Investment, interest rate, paid in kind |
|
2.00%
|
[22],[23],[25] |
2.00%
|
[7],[8],[11],[12] |
2.00%
|
[22],[23],[25] |
2.00%
|
[22],[23],[25] |
2.00%
|
[7],[8],[11],[12] |
Investment exit fee |
|
2.95%
|
[22],[23],[25] |
2.95%
|
[7],[8],[11],[12] |
2.95%
|
[22],[23],[25] |
2.95%
|
[22],[23],[25] |
2.95%
|
[7],[8],[11],[12] |
Principal amount |
|
$ 19,878
|
[22],[25] |
$ 19,779
|
[8],[11],[12] |
|
|
|
|
|
|
Investment cost |
|
19,891
|
[2],[22],[25] |
19,741
|
[5],[8],[11],[12] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 20,313
|
[22],[25] |
$ 20,445
|
[8],[11],[12] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (0.99%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.99%
|
|
|
|
0.99%
|
|
0.99%
|
|
|
|
Investment cost |
[2] |
$ 19,860
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 19,860
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and VulcanForms Inc. Secured, Maturity Date January 2028, Prime + 4.25%, Floor rate 11.25%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[24] |
2028-01
|
|
|
|
2028-01
|
|
2028-01
|
|
|
|
Investment, basis spread, variable rate |
[23],[24] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
Investment, interest rate, floor |
[23],[24] |
11.25%
|
|
|
|
11.25%
|
|
11.25%
|
|
|
|
Investment exit fee |
[23],[24] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
Principal amount |
[24] |
$ 20,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[24] |
19,860
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[24] |
$ 19,860
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment (3.73%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
3.73%
|
|
|
|
3.73%
|
|
3.73%
|
|
|
|
Investment cost |
[2] |
$ 73,799
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 74,672
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment (3.74%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
3.74%
|
|
|
|
|
|
3.74%
|
|
Investment cost |
[5] |
|
|
$ 73,400
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 74,386
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Secured, Maturity Date November 2028, Prime + 2.00%, Floor rate 9.50%, 6.35% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[38] |
2028-11
|
|
|
|
2028-11
|
|
2028-11
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[38] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[38] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
Investment exit fee |
[1],[23],[38] |
6.35%
|
|
|
|
6.35%
|
|
6.35%
|
|
|
|
Principal amount |
[1],[38] |
$ 15,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[38] |
14,821
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[38] |
$ 14,821
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Senior Secured, Maturity Date November 2028, Prime + 2.00%, Floor rate 9.50%, 6.35% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[37] |
|
|
2028-11
|
|
|
|
|
|
2028-11
|
|
Investment, basis spread, variable rate |
[6],[7],[37] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
Investment, interest rate, floor |
[6],[7],[37] |
|
|
9.50%
|
|
|
|
|
|
9.50%
|
|
Investment exit fee |
[6],[7],[37] |
|
|
6.35%
|
|
|
|
|
|
6.35%
|
|
Principal amount |
[6],[37] |
|
|
$ 15,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[37] |
|
|
14,740
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[37] |
|
|
$ 14,740
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc., Senior Secured, Maturity Date September 2027 Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[32] |
2027-09
|
|
|
|
2027-09
|
|
2027-09
|
|
|
|
Investment, basis spread, variable rate |
[23],[32] |
1.40%
|
|
|
|
1.40%
|
|
1.40%
|
|
|
|
Investment, interest rate, floor |
[23],[32] |
9.90%
|
|
|
|
9.90%
|
|
9.90%
|
|
|
|
Investment exit fee |
[23],[32] |
6.95%
|
|
|
|
6.95%
|
|
6.95%
|
|
|
|
Principal amount |
[32] |
$ 30,625
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[32] |
31,011
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32] |
$ 31,621
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc., Senior Secured, Maturity Date September 2027, Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
|
|
2027-09
|
|
|
|
|
|
2027-09
|
|
Investment, basis spread, variable rate |
[7],[14] |
|
|
1.40%
|
|
|
|
|
|
1.40%
|
|
Investment, interest rate, floor |
[7],[14] |
|
|
9.90%
|
|
|
|
|
|
9.90%
|
|
Investment exit fee |
[7],[14] |
|
|
6.95%
|
|
|
|
|
|
6.95%
|
|
Principal amount |
[14] |
|
|
$ 30,625
|
|
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
30,830
|
|
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 31,519
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Sight Sciences, Inc., Senior Secured, Maturity Date July 2028, Prime + 2.35%, Floor rate 10.35%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-07
|
[38] |
2028-07
|
[37] |
2028-07
|
[38] |
2028-07
|
[38] |
2028-07
|
[37] |
Investment, basis spread, variable rate |
|
2.35%
|
[23],[38] |
2.35%
|
[7],[37] |
2.35%
|
[23],[38] |
2.35%
|
[23],[38] |
2.35%
|
[7],[37] |
Investment, interest rate, floor |
|
10.35%
|
[23],[38] |
10.35%
|
[7],[37] |
10.35%
|
[23],[38] |
10.35%
|
[23],[38] |
10.35%
|
[7],[37] |
Investment exit fee |
|
5.95%
|
[23],[38] |
5.95%
|
[7],[37] |
5.95%
|
[23],[38] |
5.95%
|
[23],[38] |
5.95%
|
[7],[37] |
Principal amount |
|
$ 28,000
|
[38] |
$ 28,000
|
[37] |
|
|
|
|
|
|
Investment cost |
|
27,967
|
[2],[38] |
27,830
|
[5],[37] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 28,230
|
[38] |
$ 28,127
|
[37] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Smartsheet Inc.., Senior Secured, Maturity Date January 2031 , 3-month SOFR + 6.50%, Floor rate 7.25% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[26] |
2031-01
|
|
|
|
2031-01
|
|
2031-01
|
|
|
|
Investment, basis spread, variable rate |
[23],[26] |
6.50%
|
|
|
|
6.50%
|
|
6.50%
|
|
|
|
Investment, interest rate, floor |
[23],[26] |
7.25%
|
|
|
|
7.25%
|
|
7.25%
|
|
|
|
Principal amount |
[26] |
$ 46,785
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[26] |
45,870
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[26] |
$ 45,870
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Snappt, Inc., Senior Secured, Maturity Date April 2029, Prime + 2.35%, Floor rate 8.85%, PIK Interest 1.00%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[38] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[38] |
2.35%
|
|
|
|
2.35%
|
|
2.35%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[38] |
8.85%
|
|
|
|
8.85%
|
|
8.85%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[23],[38] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
Investment exit fee |
[1],[23],[38] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
Principal amount |
[1],[38] |
$ 20,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[38] |
19,769
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[38] |
$ 19,769
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software (52.80%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
52.80%
|
|
|
|
|
|
52.80%
|
|
Investment cost |
[5] |
|
|
$ 1,091,349
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 1,050,563
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software (61.81%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
61.81%
|
|
|
|
61.81%
|
|
61.81%
|
|
|
|
Investment cost |
[2] |
$ 1,287,997
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,236,621
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Reveleer, Senior Secured, Maturity Date February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.05% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[25],[26] |
2027-02
|
|
|
|
2027-02
|
|
2027-02
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[25],[26] |
0.65%
|
|
|
|
0.65%
|
|
0.65%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[25],[26] |
9.15%
|
|
|
|
9.15%
|
|
9.15%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[23],[25],[26] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
Investment exit fee |
[1],[23],[25],[26] |
5.05%
|
|
|
|
5.05%
|
|
5.05%
|
|
|
|
Principal amount |
[1],[25],[26] |
$ 36,528
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[25],[26] |
36,765
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[25],[26] |
$ 36,825
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 10.40%, Floor rate 11.30% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[11],[14],[19] |
|
|
2025-02
|
|
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[7],[11],[14],[19] |
|
|
10.40%
|
|
|
|
|
|
10.40%
|
|
Investment, interest rate, floor |
[7],[11],[14],[19] |
|
|
11.30%
|
|
|
|
|
|
11.30%
|
|
Principal amount |
[11],[14],[19] |
|
|
$ 13,279
|
|
|
|
|
|
|
|
Investment cost |
[5],[11],[14],[19] |
|
|
13,268
|
|
|
|
|
|
|
|
Investments, at fair value: |
[11],[14],[19] |
|
|
$ 13,268
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 7.25%, Floor rate 8.15% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[11],[19] |
|
|
2025-02
|
|
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[7],[11],[19] |
|
|
7.25%
|
|
|
|
|
|
7.25%
|
|
Investment, interest rate, floor |
[7],[11],[19] |
|
|
8.15%
|
|
|
|
|
|
8.15%
|
|
Principal amount |
[11],[19] |
|
|
$ 6,194
|
|
|
|
|
|
|
|
Investment cost |
[5],[11],[19] |
|
|
6,185
|
|
|
|
|
|
|
|
Investments, at fair value: |
[11],[19] |
|
|
$ 6,185
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[26],[31] |
2028-05
|
|
|
|
2028-05
|
|
2028-05
|
|
|
|
Investment, basis spread, variable rate |
[21],[23],[26],[31] |
8.14%
|
|
|
|
8.14%
|
|
8.14%
|
|
|
|
Investment, interest rate, floor |
[21],[23],[26],[31] |
9.14%
|
|
|
|
9.14%
|
|
9.14%
|
|
|
|
Principal amount |
[21],[26],[31] |
$ 20,310
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[26],[31] |
20,002
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[26],[31] |
$ 20,310
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 3-month SOFR + 8.14%, Floor rate 9.14% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[15],[19] |
|
|
2028-05
|
|
|
|
|
|
2028-05
|
|
Investment, basis spread, variable rate |
[7],[15],[19] |
|
|
8.14%
|
|
|
|
|
|
8.14%
|
|
Investment, interest rate, floor |
[7],[15],[19] |
|
|
9.14%
|
|
|
|
|
|
9.14%
|
|
Principal amount |
[15],[19] |
|
|
$ 21,251
|
|
|
|
|
|
|
|
Investment cost |
[5],[15],[19] |
|
|
20,923
|
|
|
|
|
|
|
|
Investments, at fair value: |
[15],[19] |
|
|
$ 21,251
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 3-month SOFR + 6.25%, Floor rate 7.25% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[11] |
|
|
2029-09
|
|
|
|
|
|
2029-09
|
|
Investment, basis spread, variable rate |
[7],[11] |
|
|
6.25%
|
|
|
|
|
|
6.25%
|
|
Investment, interest rate, floor |
[7],[11] |
|
|
7.25%
|
|
|
|
|
|
7.25%
|
|
Principal amount |
[11] |
|
|
$ 42,564
|
|
|
|
|
|
|
|
Investment cost |
[5],[11] |
|
|
41,704
|
|
|
|
|
|
|
|
Investments, at fair value: |
[11] |
|
|
$ 41,628
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 3-month SOFR + 6.50%, Floor rate 7.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[26] |
2029-09
|
|
|
|
2029-09
|
|
2029-09
|
|
|
|
Investment, basis spread, variable rate |
[23],[26] |
6.50%
|
|
|
|
6.50%
|
|
6.50%
|
|
|
|
Investment, interest rate, floor |
[23],[26] |
7.50%
|
|
|
|
7.50%
|
|
7.50%
|
|
|
|
Principal amount |
[26] |
$ 42,564
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[26] |
41,738
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[26] |
$ 41,783
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and AlphaSense, Inc., Senior Secured, Maturity Date June 2029, 3-month SOFR + 6.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2029-06
|
[26],[32] |
2029-06
|
[11] |
2029-06
|
[26],[32] |
2029-06
|
[26],[32] |
2029-06
|
[11] |
Investment, basis spread, variable rate |
|
6.25%
|
[23],[26],[32] |
6.25%
|
[7],[11] |
6.25%
|
[23],[26],[32] |
6.25%
|
[23],[26],[32] |
6.25%
|
[7],[11] |
Investment, interest rate, floor |
|
8.25%
|
[23],[26],[32] |
8.25%
|
[7],[11] |
8.25%
|
[23],[26],[32] |
8.25%
|
[23],[26],[32] |
8.25%
|
[7],[11] |
Principal amount |
|
$ 20,000
|
[26],[32] |
$ 20,000
|
[11] |
|
|
|
|
|
|
Investment cost |
|
19,823
|
[2],[26],[32] |
19,816
|
[5],[11] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 19,824
|
[26],[32] |
$ 19,578
|
[11] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 3-month SOFR + 10.00%, Floor rate 11.00% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-02
|
[21],[31],[41] |
2027-02
|
[15],[19] |
2027-02
|
[21],[31],[41] |
2027-02
|
[21],[31],[41] |
2027-02
|
[15],[19] |
Investment, basis spread, variable rate |
|
10.00%
|
[21],[23],[31],[41] |
10.00%
|
[7],[15],[19] |
10.00%
|
[21],[23],[31],[41] |
10.00%
|
[21],[23],[31],[41] |
10.00%
|
[7],[15],[19] |
Investment, interest rate, floor |
|
11.00%
|
[21],[23],[31],[41] |
11.00%
|
[7],[15],[19] |
11.00%
|
[21],[23],[31],[41] |
11.00%
|
[21],[23],[31],[41] |
11.00%
|
[7],[15],[19] |
Principal amount |
|
$ 11,007
|
[21],[31],[41] |
$ 11,338
|
[15],[19] |
|
|
|
|
|
|
Investment cost |
|
10,874
|
[2],[21],[31],[41] |
11,205
|
[5],[15],[19] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,404
|
[21],[31],[41] |
$ 10,556
|
[15],[19] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime + 0.00%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-03
|
[22],[25],[26] |
2028-03
|
[8],[11],[12] |
2028-03
|
[22],[25],[26] |
2028-03
|
[22],[25],[26] |
2028-03
|
[8],[11],[12] |
Investment, basis spread, variable rate |
|
0.00%
|
[22],[23],[25],[26] |
0.00%
|
[7],[8],[11],[12] |
0.00%
|
[22],[23],[25],[26] |
0.00%
|
[22],[23],[25],[26] |
0.00%
|
[7],[8],[11],[12] |
Investment, interest rate, floor |
|
7.50%
|
[22],[23],[25],[26] |
7.50%
|
[7],[8],[11],[12] |
7.50%
|
[22],[23],[25],[26] |
7.50%
|
[22],[23],[25],[26] |
7.50%
|
[7],[8],[11],[12] |
Investment, interest rate, paid in kind |
|
2.00%
|
[22],[23],[25],[26] |
2.00%
|
[7],[8],[11],[12] |
2.00%
|
[22],[23],[25],[26] |
2.00%
|
[22],[23],[25],[26] |
2.00%
|
[7],[8],[11],[12] |
Investment exit fee |
|
2.25%
|
[22],[23],[25],[26] |
2.25%
|
[7],[8],[11],[12] |
2.25%
|
[22],[23],[25],[26] |
2.25%
|
[22],[23],[25],[26] |
2.25%
|
[7],[8],[11],[12] |
Principal amount |
|
$ 50,987
|
[22],[25],[26] |
$ 50,733
|
[8],[11],[12] |
|
|
|
|
|
|
Investment cost |
|
50,838
|
[2],[22],[25],[26] |
50,496
|
[5],[8],[11],[12] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 51,220
|
[22],[25],[26] |
$ 51,357
|
[8],[11],[12] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime + 1.25%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[26] |
2028-03
|
|
|
|
2028-03
|
|
2028-03
|
|
|
|
Investment, basis spread, variable rate |
[23],[25],[26] |
1.25%
|
|
|
|
1.25%
|
|
1.25%
|
|
|
|
Investment, interest rate, floor |
[23],[25],[26] |
7.50%
|
|
|
|
7.50%
|
|
7.50%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[25],[26] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
Investment exit fee |
[23],[25],[26] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
Principal amount |
[25],[26] |
$ 25,276
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[26] |
25,141
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[26] |
$ 25,048
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime +1.25%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[11] |
|
|
2028-03
|
|
|
|
|
|
2028-03
|
|
Investment, basis spread, variable rate |
[7],[8],[11] |
|
|
1.25%
|
|
|
|
|
|
1.25%
|
|
Investment, interest rate, floor |
[7],[8],[11] |
|
|
7.50%
|
|
|
|
|
|
7.50%
|
|
Investment, interest rate, paid in kind |
[7],[8],[11] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
Investment exit fee |
[7],[8],[11] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
Principal amount |
[8],[11] |
|
|
$ 25,150
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[11] |
|
|
24,968
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[11] |
|
|
$ 25,082
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.00%, Floor rate 9.00% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[26],[31] |
2027-12
|
|
|
|
2027-12
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[26],[31] |
8.00%
|
|
|
|
8.00%
|
|
8.00%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[26],[31] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
Principal amount |
[1],[26],[31] |
$ 65,173
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[26],[31] |
63,986
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[26],[31] |
$ 64,584
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.01%, Floor rate 9.01% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[11],[19] |
|
|
2027-12
|
|
|
|
|
|
2027-12
|
|
Investment, basis spread, variable rate |
[6],[7],[11],[19] |
|
|
8.01%
|
|
|
|
|
|
8.01%
|
|
Investment, interest rate, floor |
[6],[7],[11],[19] |
|
|
9.01%
|
|
|
|
|
|
9.01%
|
|
Principal amount |
[6],[11],[19] |
|
|
$ 65,336
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[11],[19] |
|
|
64,061
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[11],[19] |
|
|
$ 65,263
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Behavox Limited, Senior Secured, Maturity Date September 2027, Prime - 0.55%, Floor rate 7.45%, PIK Interest 3.00%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-09
|
[25],[26],[27],[28] |
2027-09
|
[8],[9],[10] |
2027-09
|
[25],[26],[27],[28] |
2027-09
|
[25],[26],[27],[28] |
2027-09
|
[8],[9],[10] |
Investment, basis spread, variable rate |
|
(0.55%)
|
[23],[25],[26],[27],[28] |
(0.55%)
|
[7],[8],[9],[10] |
(0.55%)
|
[23],[25],[26],[27],[28] |
(0.55%)
|
[23],[25],[26],[27],[28] |
(0.55%)
|
[7],[8],[9],[10] |
Investment, interest rate, floor |
|
7.45%
|
[23],[25],[26],[27],[28] |
7.45%
|
[7],[8],[9],[10] |
7.45%
|
[23],[25],[26],[27],[28] |
7.45%
|
[23],[25],[26],[27],[28] |
7.45%
|
[7],[8],[9],[10] |
Investment, interest rate, paid in kind |
|
3.00%
|
[23],[25],[26],[27],[28] |
3.00%
|
[7],[8],[9],[10] |
3.00%
|
[23],[25],[26],[27],[28] |
3.00%
|
[23],[25],[26],[27],[28] |
3.00%
|
[7],[8],[9],[10] |
Investment exit fee |
|
4.95%
|
[23],[25],[26],[27],[28] |
4.95%
|
[7],[8],[9],[10] |
4.95%
|
[23],[25],[26],[27],[28] |
4.95%
|
[23],[25],[26],[27],[28] |
4.95%
|
[7],[8],[9],[10] |
Principal amount |
|
$ 10,626
|
[25],[26],[27],[28] |
$ 10,550
|
[8],[9],[10] |
|
|
|
|
|
|
Investment cost |
|
10,618
|
[2],[25],[26],[27],[28] |
10,534
|
[5],[8],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 10,475
|
[25],[26],[27],[28] |
$ 10,360
|
[8],[9],[10] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date September 2028, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.50%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-09
|
[21],[25] |
2028-09
|
[8],[15] |
2028-09
|
[21],[25] |
2028-09
|
[21],[25] |
2028-09
|
[8],[15] |
Investment, basis spread, variable rate |
|
1.35%
|
[21],[23],[25] |
1.35%
|
[7],[8],[15] |
1.35%
|
[21],[23],[25] |
1.35%
|
[21],[23],[25] |
1.35%
|
[7],[8],[15] |
Investment, interest rate, floor |
|
9.85%
|
[21],[23],[25] |
9.85%
|
[7],[8],[15] |
9.85%
|
[21],[23],[25] |
9.85%
|
[21],[23],[25] |
9.85%
|
[7],[8],[15] |
Investment, interest rate, paid in kind |
|
2.50%
|
[21],[23],[25] |
2.50%
|
[7],[8],[15] |
2.50%
|
[21],[23],[25] |
2.50%
|
[21],[23],[25] |
2.50%
|
[7],[8],[15] |
Investment exit fee |
|
3.95%
|
[21],[23],[25] |
3.95%
|
[7],[8],[15] |
3.95%
|
[21],[23],[25] |
3.95%
|
[21],[23],[25] |
3.95%
|
[7],[8],[15] |
Principal amount |
|
$ 32,209
|
[21],[25] |
$ 32,009
|
[8],[15] |
|
|
|
|
|
|
Investment cost |
|
31,984
|
[2],[21],[25] |
31,704
|
[5],[8],[15] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 32,171
|
[21],[25] |
$ 31,984
|
[8],[15] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Carbyne, Inc., Senior Secured, Maturity Date February 2029, Prime + 3.50%, Floor rate 10.00%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2029-02
|
|
|
|
2029-02
|
|
2029-02
|
|
|
|
Investment, basis spread, variable rate |
[23] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
Investment, interest rate, floor |
[23] |
10.00%
|
|
|
|
10.00%
|
|
10.00%
|
|
|
|
Investment exit fee |
[23] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
Principal amount |
|
$ 7,450
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
7,367
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 7,367
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 3-month SOFR + 8.99%, Floor rate 9.89% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
[31] |
2026-09
|
[11],[19] |
2026-09
|
[31] |
2026-09
|
[31] |
2026-09
|
[11],[19] |
Investment, basis spread, variable rate |
|
8.99%
|
[23],[31] |
8.99%
|
[7],[11],[19] |
8.99%
|
[23],[31] |
8.99%
|
[23],[31] |
8.99%
|
[7],[11],[19] |
Investment, interest rate, floor |
|
9.89%
|
[23],[31] |
9.89%
|
[7],[11],[19] |
9.89%
|
[23],[31] |
9.89%
|
[23],[31] |
9.89%
|
[7],[11],[19] |
Principal amount |
|
$ 22,762
|
[31] |
$ 22,762
|
[11],[19] |
|
|
|
|
|
|
Investment cost |
|
22,548
|
[2],[31] |
22,515
|
[5],[11],[19] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 22,146
|
[31] |
$ 22,183
|
[11],[19] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[14] |
|
|
2025-03
|
|
|
|
|
|
2025-03
|
|
Investment, basis spread, variable rate |
[7],[8],[14] |
|
|
4.50%
|
|
|
|
|
|
4.50%
|
|
Investment, interest rate, floor |
[7],[8],[14] |
|
|
8.25%
|
|
|
|
|
|
8.25%
|
|
Investment, interest rate, cap |
[7],[8],[14] |
|
|
10.25%
|
|
|
|
|
|
10.25%
|
|
Investment, interest rate, paid in kind |
[7],[8],[14] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
Investment exit fee |
[7],[8],[14] |
|
|
4.50%
|
|
|
|
|
|
4.50%
|
|
Principal amount |
[8],[14] |
|
|
$ 8,515
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[14] |
|
|
8,839
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[14] |
|
|
$ 8,839
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and CoreView USA, Inc., Senior Secured, Maturity Date January 2029, Prime +2.75%, Floor rate 9.25%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2029-01
|
[26],[38] |
2029-01
|
[11],[37] |
2029-01
|
[26],[38] |
2029-01
|
[26],[38] |
2029-01
|
[11],[37] |
Investment, basis spread, variable rate |
|
2.75%
|
[23],[26],[38] |
2.75%
|
[7],[11],[37] |
2.75%
|
[23],[26],[38] |
2.75%
|
[23],[26],[38] |
2.75%
|
[7],[11],[37] |
Investment, interest rate, floor |
|
9.25%
|
[23],[26],[38] |
9.25%
|
[7],[11],[37] |
9.25%
|
[23],[26],[38] |
9.25%
|
[23],[26],[38] |
9.25%
|
[7],[11],[37] |
Investment exit fee |
|
4.95%
|
[23],[26],[38] |
4.95%
|
[7],[11],[37] |
4.95%
|
[23],[26],[38] |
4.95%
|
[23],[26],[38] |
4.95%
|
[7],[11],[37] |
Principal amount |
|
$ 25,000
|
[26],[38] |
$ 25,000
|
[11],[37] |
|
|
|
|
|
|
Investment cost |
|
24,805
|
[2],[26],[38] |
24,731
|
[5],[11],[37] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 24,805
|
[26],[38] |
$ 24,731
|
[11],[37] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Coronet Cyber Security Ltd., Senior Secured, Maturity Date October 2028, Prime - 2.95%, Floor rate 3.55%, PIK Interest 5.85% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-10
|
[25],[26] |
2028-10
|
[8],[11] |
2028-10
|
[25],[26] |
2028-10
|
[25],[26] |
2028-10
|
[8],[11] |
Investment, basis spread, variable rate |
|
(2.95%)
|
[23],[25],[26] |
(2.95%)
|
[7],[8],[11] |
(2.95%)
|
[23],[25],[26] |
(2.95%)
|
[23],[25],[26] |
(2.95%)
|
[7],[8],[11] |
Investment, interest rate, floor |
|
3.55%
|
[23],[25],[26] |
3.55%
|
[7],[8],[11] |
3.55%
|
[23],[25],[26] |
3.55%
|
[23],[25],[26] |
3.55%
|
[7],[8],[11] |
Investment, interest rate, paid in kind |
|
5.85%
|
[23],[25],[26] |
5.85%
|
[7],[8],[11] |
5.85%
|
[23],[25],[26] |
5.85%
|
[23],[25],[26] |
5.85%
|
[7],[8],[11] |
Principal amount |
|
$ 8,718
|
[25],[26] |
$ 8,591
|
[8],[11] |
|
|
|
|
|
|
Investment cost |
|
8,579
|
[2],[25],[26] |
8,446
|
[5],[8],[11] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 8,359
|
[25],[26] |
$ 8,446
|
[8],[11] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee, 1 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[10],[12] |
|
|
2025-10
|
|
|
|
|
|
2025-10
|
|
Investment, basis spread, variable rate |
[7],[9],[10],[12] |
|
|
5.20%
|
|
|
|
|
|
5.20%
|
|
Investment, interest rate, floor |
[7],[9],[10],[12] |
|
|
9.95%
|
|
|
|
|
|
9.95%
|
|
Investment exit fee |
[7],[9],[10],[12] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
Principal amount |
[9],[10],[12] |
|
|
$ 5,500
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[10],[12] |
|
|
5,667
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10],[12] |
|
|
$ 5,667
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee, 2 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[10] |
|
|
2025-10
|
|
|
|
|
|
2025-10
|
|
Investment, basis spread, variable rate |
[7],[9],[10] |
|
|
5.20%
|
|
|
|
|
|
5.20%
|
|
Investment, interest rate, floor |
[7],[9],[10] |
|
|
9.95%
|
|
|
|
|
|
9.95%
|
|
Investment exit fee |
[7],[9],[10] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
Principal amount | £ |
[9],[10] |
|
|
|
|
|
|
|
|
£ 1,250
|
|
Investment cost |
[5],[9],[10] |
|
|
$ 1,612
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10] |
|
|
$ 1,594
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 6.28% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-12
|
[21],[24],[25],[26],[32] |
2027-12
|
[8],[11],[14],[15],[18] |
2027-12
|
[21],[24],[25],[26],[32] |
2027-12
|
[21],[24],[25],[26],[32] |
2027-12
|
[8],[11],[14],[15],[18] |
Investment, basis spread, variable rate |
|
3.05%
|
[21],[23],[24],[25],[26],[32] |
3.05%
|
[7],[8],[11],[14],[15],[18] |
3.05%
|
[21],[23],[24],[25],[26],[32] |
3.05%
|
[21],[23],[24],[25],[26],[32] |
3.05%
|
[7],[8],[11],[14],[15],[18] |
Investment, interest rate, floor |
|
11.55%
|
[21],[23],[24],[25],[26],[32] |
11.55%
|
[7],[8],[11],[14],[15],[18] |
11.55%
|
[21],[23],[24],[25],[26],[32] |
11.55%
|
[21],[23],[24],[25],[26],[32] |
11.55%
|
[7],[8],[11],[14],[15],[18] |
Investment, interest rate, paid in kind |
|
1.10%
|
[21],[23],[24],[25],[26],[32] |
1.10%
|
[7],[8],[11],[14],[15],[18] |
1.10%
|
[21],[23],[24],[25],[26],[32] |
1.10%
|
[21],[23],[24],[25],[26],[32] |
1.10%
|
[7],[8],[11],[14],[15],[18] |
Investment exit fee |
|
6.28%
|
[21],[23],[24],[25],[26],[32] |
6.28%
|
[7],[8],[11],[14],[15],[18] |
6.28%
|
[21],[23],[24],[25],[26],[32] |
6.28%
|
[21],[23],[24],[25],[26],[32] |
6.28%
|
[7],[8],[11],[14],[15],[18] |
Principal amount |
|
$ 45,601
|
[21],[24],[25],[26],[32] |
$ 45,476
|
[8],[11],[14],[15],[18] |
|
|
|
|
|
|
Investment cost |
|
46,814
|
[2],[21],[24],[25],[26],[32] |
46,450
|
[5],[8],[11],[14],[15],[18] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 47,902
|
[21],[24],[25],[26],[32] |
$ 47,708
|
[8],[11],[14],[15],[18] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-04
|
[26],[31] |
2028-04
|
[11],[19] |
2028-04
|
[26],[31] |
2028-04
|
[26],[31] |
2028-04
|
[11],[19] |
Investment, basis spread, variable rate |
|
8.01%
|
[23],[26],[31] |
8.01%
|
[7],[11],[19] |
8.01%
|
[23],[26],[31] |
8.01%
|
[23],[26],[31] |
8.01%
|
[7],[11],[19] |
Investment, interest rate, floor |
|
8.76%
|
[23],[26],[31] |
8.76%
|
[7],[11],[19] |
8.76%
|
[23],[26],[31] |
8.76%
|
[23],[26],[31] |
8.76%
|
[7],[11],[19] |
Principal amount |
|
$ 8,628
|
[26],[31] |
$ 8,896
|
[11],[19] |
|
|
|
|
|
|
Investment cost |
|
8,478
|
[2],[26],[31] |
8,758
|
[5],[11],[19] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 8,312
|
[26],[31] |
$ 8,641
|
[11],[19] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and DocPlanner, Senior Secured, Maturity Date January 2030, Prime + 2.75%, Floor rate 9.75%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[2],[26],[27],[28] |
2030-01
|
|
|
|
2030-01
|
|
2030-01
|
|
|
|
Investment, basis spread, variable rate |
[2],[23],[26],[27],[28] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
Investment, interest rate, floor |
[2],[23],[26],[27],[28] |
9.75%
|
|
|
|
9.75%
|
|
9.75%
|
|
|
|
Investment exit fee |
[2],[23],[26],[27],[28] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
Principal amount | € |
[2],[26],[27],[28] |
|
|
|
|
|
|
€ 68,200
|
|
|
|
Investment cost |
[2],[26],[27],[28] |
$ 69,353
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[2],[26],[27],[28] |
$ 73,090
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Dragos, Inc., Senior Secured, Maturity Date July 2027, Prime + 2.00%, Floor rate 8.75%, PIK Interest 2.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
[25],[26] |
2027-07
|
[8],[11] |
2027-07
|
[25],[26] |
2027-07
|
[25],[26] |
2027-07
|
[8],[11] |
Investment, basis spread, variable rate |
|
2.00%
|
[23],[25],[26] |
2.00%
|
[7],[8],[11] |
2.00%
|
[23],[25],[26] |
2.00%
|
[23],[25],[26] |
2.00%
|
[7],[8],[11] |
Investment, interest rate, floor |
|
8.75%
|
[23],[25],[26] |
8.75%
|
[7],[8],[11] |
8.75%
|
[23],[25],[26] |
8.75%
|
[23],[25],[26] |
8.75%
|
[7],[8],[11] |
Investment, interest rate, paid in kind |
|
2.00%
|
[23],[25],[26] |
2.00%
|
[7],[8],[11] |
2.00%
|
[23],[25],[26] |
2.00%
|
[23],[25],[26] |
2.00%
|
[7],[8],[11] |
Investment exit fee |
|
2.00%
|
[23],[25],[26] |
2.00%
|
[7],[8],[11] |
2.00%
|
[23],[25],[26] |
2.00%
|
[23],[25],[26] |
2.00%
|
[7],[8],[11] |
Principal amount |
|
$ 13,079
|
[25],[26] |
$ 13,022
|
[8],[11] |
|
|
|
|
|
|
Investment cost |
|
12,512
|
[2],[25],[26] |
12,383
|
[5],[8],[11] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 12,544
|
[25],[26] |
$ 12,431
|
[8],[11] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and DroneDeploy, Inc., Senior Secured, Maturity Date November 2028, Prime + 2.45%, Floor rate 9.95%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-11
|
[21],[26] |
2028-11
|
[11],[15] |
2028-11
|
[21],[26] |
2028-11
|
[21],[26] |
2028-11
|
[11],[15] |
Investment, basis spread, variable rate |
|
2.45%
|
[21],[23],[26] |
2.45%
|
[7],[11],[15] |
2.45%
|
[21],[23],[26] |
2.45%
|
[21],[23],[26] |
2.45%
|
[7],[11],[15] |
Investment, interest rate, floor |
|
9.95%
|
[21],[23],[26] |
9.95%
|
[7],[11],[15] |
9.95%
|
[21],[23],[26] |
9.95%
|
[21],[23],[26] |
9.95%
|
[7],[11],[15] |
Investment exit fee |
|
5.00%
|
[21],[23],[26] |
5.00%
|
[7],[11],[15] |
5.00%
|
[21],[23],[26] |
5.00%
|
[21],[23],[26] |
5.00%
|
[7],[11],[15] |
Principal amount |
|
$ 9,375
|
[21],[26] |
$ 9,375
|
[11],[15] |
|
|
|
|
|
|
Investment cost |
|
9,292
|
[2],[21],[26] |
9,255
|
[5],[11],[15] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 9,286
|
[21],[26] |
$ 9,274
|
[11],[15] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Earnix, Inc., Senior Secured, Maturity Date June 2029, Prime - 1.15%, Floor rate 5.35%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2029-06
|
[25],[26],[32] |
2029-06
|
[8],[11],[14] |
2029-06
|
[25],[26],[32] |
2029-06
|
[25],[26],[32] |
2029-06
|
[8],[11],[14] |
Investment, basis spread, variable rate |
|
(1.15%)
|
[23],[25],[26],[32] |
(1.15%)
|
[7],[8],[11],[14] |
(1.15%)
|
[23],[25],[26],[32] |
(1.15%)
|
[23],[25],[26],[32] |
(1.15%)
|
[7],[8],[11],[14] |
Investment, interest rate, floor |
|
5.35%
|
[23],[25],[26],[32] |
5.35%
|
[7],[8],[11],[14] |
5.35%
|
[23],[25],[26],[32] |
5.35%
|
[23],[25],[26],[32] |
5.35%
|
[7],[8],[11],[14] |
Investment, interest rate, paid in kind |
|
4.45%
|
[23],[25],[26],[32] |
4.45%
|
[7],[8],[11],[14] |
4.45%
|
[23],[25],[26],[32] |
4.45%
|
[23],[25],[26],[32] |
4.45%
|
[7],[8],[11],[14] |
Principal amount |
|
$ 19,380
|
[25],[26],[32] |
$ 19,166
|
[8],[11],[14] |
|
|
|
|
|
|
Investment cost |
|
19,082
|
[2],[25],[26],[32] |
18,856
|
[5],[8],[11],[14] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 19,161
|
[25],[26],[32] |
$ 18,838
|
[8],[11],[14] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date April 2029, Prime + 1.75%, Floor rate 9.25%, PIK Interest 1.30%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[24],[32] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
Investment, basis spread, variable rate |
[23],[24],[32] |
1.75%
|
|
|
|
1.75%
|
|
1.75%
|
|
|
|
Investment, interest rate, floor |
[23],[24],[32] |
9.25%
|
|
|
|
9.25%
|
|
9.25%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[24],[32] |
1.30%
|
|
|
|
1.30%
|
|
1.30%
|
|
|
|
Investment exit fee |
[23],[24],[32] |
3.95%
|
|
|
|
3.95%
|
|
3.95%
|
|
|
|
Principal amount |
[24],[32] |
$ 13,456
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[24],[32] |
13,020
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[24],[32] |
$ 13,020
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[14],[18] |
|
|
2026-03
|
|
|
|
|
|
2026-03
|
|
Investment, basis spread, variable rate |
[7],[8],[14],[18] |
|
|
4.25%
|
|
|
|
|
|
4.25%
|
|
Investment, interest rate, floor |
[7],[8],[14],[18] |
|
|
9.00%
|
|
|
|
|
|
9.00%
|
|
Investment, interest rate, paid in kind |
[7],[8],[14],[18] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
Investment exit fee |
[7],[8],[14],[18] |
|
|
3.95%
|
|
|
|
|
|
3.95%
|
|
Principal amount |
[8],[14],[18] |
|
|
$ 12,878
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[14],[18] |
|
|
12,860
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[14],[18] |
|
|
$ 13,215
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.80%, Floor rate 8.70% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[11],[19] |
|
|
2027-10
|
|
|
|
|
|
2027-10
|
|
Investment, basis spread, variable rate |
[7],[11],[19] |
|
|
7.80%
|
|
|
|
|
|
7.80%
|
|
Investment, interest rate, floor |
[7],[11],[19] |
|
|
8.70%
|
|
|
|
|
|
8.70%
|
|
Principal amount |
[11],[19] |
|
|
$ 7,297
|
|
|
|
|
|
|
|
Investment cost |
[5],[11],[19] |
|
|
7,145
|
|
|
|
|
|
|
|
Investments, at fair value: |
[11],[19] |
|
|
$ 7,271
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 1-month SOFR + 7.64%, Floor rate 8.54% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-12
|
[26],[31],[32] |
2027-12
|
[11],[14],[19] |
2027-12
|
[26],[31],[32] |
2027-12
|
[26],[31],[32] |
2027-12
|
[11],[14],[19] |
Investment, basis spread, variable rate |
|
7.64%
|
[23],[26],[31],[32] |
7.64%
|
[7],[11],[14],[19] |
7.64%
|
[23],[26],[31],[32] |
7.64%
|
[23],[26],[31],[32] |
7.64%
|
[7],[11],[14],[19] |
Investment, interest rate, floor |
|
8.54%
|
[23],[26],[31],[32] |
8.54%
|
[7],[11],[14],[19] |
8.54%
|
[23],[26],[31],[32] |
8.54%
|
[23],[26],[31],[32] |
8.54%
|
[7],[11],[14],[19] |
Principal amount |
|
$ 6,983
|
[26],[31],[32] |
$ 7,000
|
[11],[14],[19] |
|
|
|
|
|
|
Investment cost |
|
6,873
|
[2],[26],[31],[32] |
6,882
|
[5],[11],[14],[19] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 6,919
|
[26],[31],[32] |
$ 6,950
|
[11],[14],[19] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Harness, Inc., Senior Secured, Maturity Date March 2029, Prime - 2.25%, Floor rate 5.25%, Cap rate 6.50%, PIK Interest 6.25%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2029-03
|
[24],[25],[26] |
2029-03
|
[8],[11],[18] |
2029-03
|
[24],[25],[26] |
2029-03
|
[24],[25],[26] |
2029-03
|
[8],[11],[18] |
Investment, basis spread, variable rate |
|
(2.25%)
|
[23],[24],[25],[26] |
(2.25%)
|
[7],[8],[11],[18] |
(2.25%)
|
[23],[24],[25],[26] |
(2.25%)
|
[23],[24],[25],[26] |
(2.25%)
|
[7],[8],[11],[18] |
Investment, interest rate, floor |
|
5.25%
|
[23],[24],[25],[26] |
5.25%
|
[7],[8],[11],[18] |
5.25%
|
[23],[24],[25],[26] |
5.25%
|
[23],[24],[25],[26] |
5.25%
|
[7],[8],[11],[18] |
Investment, interest rate, cap |
|
6.50%
|
[23],[24],[25],[26] |
6.50%
|
[7],[8],[11],[18] |
6.50%
|
[23],[24],[25],[26] |
6.50%
|
[23],[24],[25],[26] |
6.50%
|
[7],[8],[11],[18] |
Investment, interest rate, paid in kind |
|
6.25%
|
[23],[24],[25],[26] |
6.25%
|
[7],[8],[11],[18] |
6.25%
|
[23],[24],[25],[26] |
6.25%
|
[23],[24],[25],[26] |
6.25%
|
[7],[8],[11],[18] |
Investment exit fee |
|
1.00%
|
[23],[24],[25],[26] |
1.00%
|
[7],[8],[11],[18] |
1.00%
|
[23],[24],[25],[26] |
1.00%
|
[23],[24],[25],[26] |
1.00%
|
[7],[8],[11],[18] |
Principal amount |
|
$ 29,994
|
[24],[25],[26] |
$ 18,132
|
[8],[11],[18] |
|
|
|
|
|
|
Investment cost |
|
29,677
|
[2],[24],[25],[26] |
17,947
|
[5],[8],[11],[18] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 29,811
|
[24],[25],[26] |
$ 18,060
|
[8],[11],[18] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Khoros, Senior Secured, Maturity Date January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-01
|
[25],[41],[42] |
2025-01
|
[8],[43] |
2025-01
|
[25],[41],[42] |
2025-01
|
[25],[41],[42] |
2025-01
|
[8],[43] |
Investment, basis spread, variable rate |
|
4.50%
|
[23],[25],[41],[42] |
4.50%
|
[7],[8],[43] |
4.50%
|
[23],[25],[41],[42] |
4.50%
|
[23],[25],[41],[42] |
4.50%
|
[7],[8],[43] |
Investment, interest rate, floor |
|
5.50%
|
[23],[25],[41],[42] |
5.50%
|
[7],[8],[43] |
5.50%
|
[23],[25],[41],[42] |
5.50%
|
[23],[25],[41],[42] |
5.50%
|
[7],[8],[43] |
Investment, interest rate, paid in kind |
|
4.50%
|
[23],[25],[41],[42] |
4.50%
|
[7],[8],[43] |
4.50%
|
[23],[25],[41],[42] |
4.50%
|
[23],[25],[41],[42] |
4.50%
|
[7],[8],[43] |
Principal amount |
|
$ 61,341
|
[25],[41],[42] |
$ 61,341
|
[8],[43] |
|
|
|
|
|
|
Investment cost |
|
61,317
|
[2],[25],[41],[42] |
61,317
|
[5],[8],[43] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 16,180
|
[25],[41],[42] |
$ 18,231
|
[8],[43] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Leapwork ApS, Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.00%, PIK Interest 1.95%, 2.70% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[10],[12] |
|
|
2026-02
|
|
|
|
|
|
2026-02
|
|
Investment, basis spread, variable rate |
[7],[8],[9],[10],[12] |
|
|
0.25%
|
|
|
|
|
|
0.25%
|
|
Investment, interest rate, floor |
[7],[8],[9],[10],[12] |
|
|
7.00%
|
|
|
|
|
|
7.00%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9],[10],[12] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
Investment exit fee |
[7],[8],[9],[10],[12] |
|
|
2.70%
|
|
|
|
|
|
2.70%
|
|
Principal amount |
[8],[9],[10],[12] |
|
|
$ 8,890
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[9],[10],[12] |
|
|
8,883
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[9],[10],[12] |
|
|
$ 9,117
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.00%, PIK Interest 1.95%, 2.70% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[25],[27],[28] |
2026-02
|
|
|
|
2026-02
|
|
2026-02
|
|
|
|
Investment, basis spread, variable rate |
[22],[23],[25],[27],[28] |
0.25%
|
|
|
|
0.25%
|
|
0.25%
|
|
|
|
Investment, interest rate, floor |
[22],[23],[25],[27],[28] |
7.00%
|
|
|
|
7.00%
|
|
7.00%
|
|
|
|
Investment, interest rate, paid in kind |
[22],[23],[25],[27],[28] |
1.95%
|
|
|
|
1.95%
|
|
1.95%
|
|
|
|
Investment exit fee |
[22],[23],[25],[27],[28] |
2.70%
|
|
|
|
2.70%
|
|
2.70%
|
|
|
|
Principal amount |
[22],[25],[27],[28] |
$ 8,929
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[22],[25],[27],[28] |
8,974
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[22],[25],[27],[28] |
$ 8,974
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and LinenMaster, LLC, Senior Secured, Maturity Date August 2028, 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[11],[12] |
|
|
2028-08
|
|
|
|
|
|
2028-08
|
|
Investment, basis spread, variable rate |
[7],[8],[11],[12] |
|
|
6.25%
|
|
|
|
|
|
6.25%
|
|
Investment, interest rate, floor |
[7],[8],[11],[12] |
|
|
7.25%
|
|
|
|
|
|
7.25%
|
|
Investment, interest rate, paid in kind |
[7],[8],[11],[12] |
|
|
2.15%
|
|
|
|
|
|
2.15%
|
|
Principal amount |
[8],[11],[12] |
|
|
$ 15,428
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[11],[12] |
|
|
15,189
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[11],[12] |
|
|
$ 15,481
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and LinenMaster, LLC., Senior Secured, Maturity Date August 2028, 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[25],[26] |
2028-08
|
|
|
|
2028-08
|
|
2028-08
|
|
|
|
Investment, basis spread, variable rate |
[22],[23],[25],[26] |
6.25%
|
|
|
|
6.25%
|
|
6.25%
|
|
|
|
Investment, interest rate, floor |
[22],[23],[25],[26] |
7.25%
|
|
|
|
7.25%
|
|
7.25%
|
|
|
|
Investment, interest rate, paid in kind |
[22],[23],[25],[26] |
2.15%
|
|
|
|
2.15%
|
|
2.15%
|
|
|
|
Principal amount |
[22],[25],[26] |
$ 15,512
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[22],[25],[26] |
15,285
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[22],[25],[26] |
$ 15,515
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[26],[31] |
2028-03
|
|
|
|
2028-03
|
|
2028-03
|
|
|
|
Investment, basis spread, variable rate |
[23],[26],[31] |
7.88%
|
|
|
|
7.88%
|
|
7.88%
|
|
|
|
Investment, interest rate, floor |
[23],[26],[31] |
8.88%
|
|
|
|
8.88%
|
|
8.88%
|
|
|
|
Principal amount |
[26],[31] |
$ 27,206
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[26],[31] |
26,757
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[26],[31] |
$ 27,206
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and LogRhythm, Inc., Senior Secured, Maturity Date July 2029, 1-month SOFR + 7.50%, Floor rate 8.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[11] |
|
|
2029-07
|
|
|
|
|
|
2029-07
|
|
Investment, basis spread, variable rate |
[7],[11] |
|
|
7.50%
|
|
|
|
|
|
7.50%
|
|
Investment, interest rate, floor |
[7],[11] |
|
|
8.50%
|
|
|
|
|
|
8.50%
|
|
Principal amount |
[11] |
|
|
$ 25,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[11] |
|
|
24,305
|
|
|
|
|
|
|
|
Investments, at fair value: |
[11] |
|
|
$ 24,305
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and LogRhythm, Inc., Senior Secured, Maturity Date July 2029, 3-month SOFR + 7.50%, Floor rate 8.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[26] |
2029-07
|
|
|
|
2029-07
|
|
2029-07
|
|
|
|
Investment, basis spread, variable rate |
[23],[26] |
7.50%
|
|
|
|
7.50%
|
|
7.50%
|
|
|
|
Investment, interest rate, floor |
[23],[26] |
8.50%
|
|
|
|
8.50%
|
|
8.50%
|
|
|
|
Principal amount |
[26] |
$ 25,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[26] |
24,334
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[26] |
$ 24,346
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.93%, Floor rate 9.93% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[26],[31] |
2027-07
|
|
|
|
2027-07
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[23],[26],[31] |
8.93%
|
|
|
|
8.93%
|
|
8.93%
|
|
|
|
Investment, interest rate, floor |
[23],[26],[31] |
9.93%
|
|
|
|
9.93%
|
|
9.93%
|
|
|
|
Principal amount |
[26],[31] |
$ 13,111
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[26],[31] |
12,955
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[26],[31] |
$ 13,111
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Marigold Group, Inc. (p.k.a. Campaign Monitor Limited), Senior Secured, Maturity Date November 2026, PIK Interest 6-month SOFR + 10.55%, Floor rate 11.55% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[15],[18] |
|
|
2026-11
|
|
|
|
|
|
2026-11
|
|
Investment, basis spread, variable rate |
[7],[8],[15],[18] |
|
|
10.55%
|
|
|
|
|
|
10.55%
|
|
Investment, interest rate, floor |
[7],[8],[15],[18] |
|
|
11.55%
|
|
|
|
|
|
11.55%
|
|
Principal amount |
[8],[15],[18] |
|
|
$ 38,828
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[15],[18] |
|
|
38,336
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[15],[18] |
|
|
$ 32,773
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Marigold Group, Inc., Senior Secured, Maturity Date November 2026, PIK Interest 6-month SOFR + 10.55%, Floor rate 11.55% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[21],[24],[25] |
2026-11
|
|
|
|
2026-11
|
|
2026-11
|
|
|
|
Investment, basis spread, variable rate |
[21],[23],[24],[25] |
10.55%
|
|
|
|
10.55%
|
|
10.55%
|
|
|
|
Investment, interest rate, floor |
[21],[23],[24],[25] |
11.55%
|
|
|
|
11.55%
|
|
11.55%
|
|
|
|
Principal amount |
[21],[24],[25] |
$ 40,264
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[21],[24],[25] |
39,822
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[21],[24],[25] |
$ 34,001
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month SOFR + 9.21%, Floor rate 10.06% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[19] |
|
|
2025-12
|
|
|
|
|
|
2025-12
|
|
Investment, basis spread, variable rate |
[7],[19] |
|
|
9.21%
|
|
|
|
|
|
9.21%
|
|
Investment, interest rate, floor |
[7],[19] |
|
|
10.06%
|
|
|
|
|
|
10.06%
|
|
Principal amount |
[19] |
|
|
$ 18,366
|
|
|
|
|
|
|
|
Investment cost |
[5],[19] |
|
|
18,237
|
|
|
|
|
|
|
|
Investments, at fair value: |
[19] |
|
|
$ 17,616
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 6-month SOFR + 9.31%, Floor rate 10.06% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[31] |
2025-12
|
|
|
|
2025-12
|
|
2025-12
|
|
|
|
Investment, basis spread, variable rate |
[23],[31] |
9.31%
|
|
|
|
9.31%
|
|
9.31%
|
|
|
|
Investment, interest rate, floor |
[23],[31] |
10.06%
|
|
|
|
10.06%
|
|
10.06%
|
|
|
|
Principal amount |
[31] |
$ 18,366
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[31] |
18,270
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[31] |
$ 17,716
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Morphisec Information Security 2014 Ltd., Senior Secured, Maturity Date October 2027, Prime + 3.45%, Floor rate 11.70%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-10
|
[27],[28] |
2027-10
|
[9],[10] |
2027-10
|
[27],[28] |
2027-10
|
[27],[28] |
2027-10
|
[9],[10] |
Investment, basis spread, variable rate |
|
3.45%
|
[23],[27],[28] |
3.45%
|
[7],[9],[10] |
3.45%
|
[23],[27],[28] |
3.45%
|
[23],[27],[28] |
3.45%
|
[7],[9],[10] |
Investment, interest rate, floor |
|
11.70%
|
[23],[27],[28] |
11.70%
|
[7],[9],[10] |
11.70%
|
[23],[27],[28] |
11.70%
|
[23],[27],[28] |
11.70%
|
[7],[9],[10] |
Investment exit fee |
|
5.95%
|
[23],[27],[28] |
5.95%
|
[7],[9],[10] |
5.95%
|
[23],[27],[28] |
5.95%
|
[23],[27],[28] |
5.95%
|
[7],[9],[10] |
Principal amount |
|
$ 10,000
|
[27],[28] |
$ 10,000
|
[9],[10] |
|
|
|
|
|
|
Investment cost |
|
9,926
|
[2],[27],[28] |
9,861
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 9,926
|
[27],[28] |
9,861
|
[9],[10] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Morphisec Information Security 2014 Ltd., Warrant, Acquisition Date 10/1/2024, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[10] |
|
|
104
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10] |
|
|
$ 108
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[9],[10],[44] |
|
|
Oct. 01, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[9],[10] |
|
|
200,115
|
|
|
|
|
|
200,115
|
|
Investment, Identifier [Axis]: Debt Investments Software and New Relic, Inc., Senior Secured, Maturity Date November 2030, 1-month SOFR + 6.75%, Floor rate 7.75% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[11] |
|
|
2030-11
|
|
|
|
|
|
2030-11
|
|
Investment, basis spread, variable rate |
[7],[11] |
|
|
6.75%
|
|
|
|
|
|
6.75%
|
|
Investment, interest rate, floor |
[7],[11] |
|
|
7.75%
|
|
|
|
|
|
7.75%
|
|
Principal amount |
[11] |
|
|
$ 21,890
|
|
|
|
|
|
|
|
Investment cost |
[5],[11] |
|
|
21,402
|
|
|
|
|
|
|
|
Investments, at fair value: |
[11] |
|
|
$ 21,644
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and New Relic, Inc., Senior Secured, Maturity Date November 2030, 3-month SOFR + 6.75%, Floor rate 7.75% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[26] |
2030-11
|
|
|
|
2030-11
|
|
2030-11
|
|
|
|
Investment, basis spread, variable rate |
[23],[26] |
6.75%
|
|
|
|
6.75%
|
|
6.75%
|
|
|
|
Investment, interest rate, floor |
[23],[26] |
7.75%
|
|
|
|
7.75%
|
|
7.75%
|
|
|
|
Principal amount |
[26] |
$ 21,890
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[26] |
21,417
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[26] |
$ 21,346
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
[26],[31],[32] |
2027-07
|
[11],[14],[19] |
2027-07
|
[26],[31],[32] |
2027-07
|
[26],[31],[32] |
2027-07
|
[11],[14],[19] |
Investment, basis spread, variable rate |
|
8.05%
|
[23],[26],[31],[32] |
8.05%
|
[7],[11],[14],[19] |
8.05%
|
[23],[26],[31],[32] |
8.05%
|
[23],[26],[31],[32] |
8.05%
|
[7],[11],[14],[19] |
Investment, interest rate, floor |
|
9.05%
|
[23],[26],[31],[32] |
9.05%
|
[7],[11],[14],[19] |
9.05%
|
[23],[26],[31],[32] |
9.05%
|
[23],[26],[31],[32] |
9.05%
|
[7],[11],[14],[19] |
Principal amount |
|
$ 7,631
|
[26],[31],[32] |
$ 7,669
|
[11],[14],[19] |
|
|
|
|
|
|
Investment cost |
|
7,493
|
[2],[26],[31],[32] |
7,518
|
[5],[11],[14],[19] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 7,631
|
[26],[31],[32] |
$ 7,669
|
[11],[14],[19] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and PayIt, LLC, Senior Secured, Maturity Date December 2028, Prime + 1.45%, Floor rate 7.95%, PIK Interest 1.50%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-12
|
[1],[24],[25],[26],[38] |
2028-12
|
[6],[8],[11],[18],[37] |
2028-12
|
[1],[24],[25],[26],[38] |
2028-12
|
[1],[24],[25],[26],[38] |
2028-12
|
[6],[8],[11],[18],[37] |
Investment, basis spread, variable rate |
|
1.45%
|
[1],[23],[24],[25],[26],[38] |
1.45%
|
[6],[7],[8],[11],[18],[37] |
1.45%
|
[1],[23],[24],[25],[26],[38] |
1.45%
|
[1],[23],[24],[25],[26],[38] |
1.45%
|
[6],[7],[8],[11],[18],[37] |
Investment, interest rate, floor |
|
7.95%
|
[1],[23],[24],[25],[26],[38] |
7.95%
|
[6],[7],[8],[11],[18],[37] |
7.95%
|
[1],[23],[24],[25],[26],[38] |
7.95%
|
[1],[23],[24],[25],[26],[38] |
7.95%
|
[6],[7],[8],[11],[18],[37] |
Investment, interest rate, paid in kind |
|
1.50%
|
[1],[23],[24],[25],[26],[38] |
1.50%
|
[6],[7],[8],[11],[18],[37] |
1.50%
|
[1],[23],[24],[25],[26],[38] |
1.50%
|
[1],[23],[24],[25],[26],[38] |
1.50%
|
[6],[7],[8],[11],[18],[37] |
Investment exit fee |
|
5.00%
|
[1],[23],[24],[25],[26],[38] |
5.00%
|
[6],[7],[8],[11],[18],[37] |
5.00%
|
[1],[23],[24],[25],[26],[38] |
5.00%
|
[1],[23],[24],[25],[26],[38] |
5.00%
|
[6],[7],[8],[11],[18],[37] |
Principal amount |
|
$ 12,048
|
[1],[24],[25],[26],[38] |
$ 12,003
|
[6],[8],[11],[18],[37] |
|
|
|
|
|
|
Investment cost |
|
11,961
|
[1],[2],[24],[25],[26],[38] |
11,881
|
[5],[6],[8],[11],[18],[37] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 11,961
|
[1],[24],[25],[26],[38] |
$ 11,881
|
[6],[8],[11],[18],[37] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Pindrop Security, Inc., Senior Secured, Maturity Date June 2029, Prime + 3.50%, Floor rate 10.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2029-06
|
[1],[26] |
2029-06
|
[6],[11] |
2029-06
|
[1],[26] |
2029-06
|
[1],[26] |
2029-06
|
[6],[11] |
Investment, basis spread, variable rate |
|
3.50%
|
[1],[23],[26] |
3.50%
|
[6],[7],[11] |
3.50%
|
[1],[23],[26] |
3.50%
|
[1],[23],[26] |
3.50%
|
[6],[7],[11] |
Investment, interest rate, floor |
|
10.00%
|
[1],[23],[26] |
10.00%
|
[6],[7],[11] |
10.00%
|
[1],[23],[26] |
10.00%
|
[1],[23],[26] |
10.00%
|
[6],[7],[11] |
Investment exit fee |
|
2.00%
|
[1],[23],[26] |
2.00%
|
[6],[7],[11] |
2.00%
|
[1],[23],[26] |
2.00%
|
[1],[23],[26] |
2.00%
|
[6],[7],[11] |
Principal amount |
|
$ 31,000
|
[1],[26] |
$ 31,000
|
[6],[11] |
|
|
|
|
|
|
Investment cost |
|
30,611
|
[1],[2],[26] |
30,566
|
[5],[6],[11] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 30,849
|
[1],[26] |
$ 30,671
|
[6],[11] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Remodel Health Holdco, LLC, Senior Secured, Maturity Date December 2028, Prime + 2.35%, Floor rate 10.35%, 6.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[37] |
|
|
2028-12
|
|
|
|
|
|
2028-12
|
|
Investment, basis spread, variable rate |
[6],[7],[37] |
|
|
2.35%
|
|
|
|
|
|
2.35%
|
|
Investment, interest rate, floor |
[6],[7],[37] |
|
|
10.35%
|
|
|
|
|
|
10.35%
|
|
Investment exit fee |
[6],[7],[37] |
|
|
6.50%
|
|
|
|
|
|
6.50%
|
|
Principal amount |
[6],[37] |
|
|
$ 25,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[37] |
|
|
24,723
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[37] |
|
|
$ 24,723
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Remodel Health Holdco, LLC., Senior Secured, Maturity Date December 2028 ,Prime + 2.35%, Floor rate 10.35%, 6.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[38] |
2028-12
|
|
|
|
2028-12
|
|
2028-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[38] |
2.35%
|
|
|
|
2.35%
|
|
2.35%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[38] |
10.35%
|
|
|
|
10.35%
|
|
10.35%
|
|
|
|
Investment exit fee |
[1],[23],[38] |
6.50%
|
|
|
|
6.50%
|
|
6.50%
|
|
|
|
Principal amount |
[1],[38] |
$ 25,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[38] |
24,818
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[38] |
$ 24,399
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Reveleer, Senior Secured, Maturity Date February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.05% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[8] |
|
|
2027-02
|
|
|
|
|
|
2027-02
|
|
Investment, basis spread, variable rate |
[6],[7],[8] |
|
|
0.65%
|
|
|
|
|
|
0.65%
|
|
Investment, interest rate, floor |
[6],[7],[8] |
|
|
9.15%
|
|
|
|
|
|
9.15%
|
|
Investment, interest rate, paid in kind |
[6],[7],[8] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
Investment exit fee |
[6],[7],[8] |
|
|
5.05%
|
|
|
|
|
|
5.05%
|
|
Principal amount |
[6],[8] |
|
|
$ 36,345
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[8] |
|
|
36,403
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[8] |
|
|
$ 36,525
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Semperis Technologies Inc., Senior Secured, Maturity Date April 2028, Prime - 1.75%, Floor rate 6.75%, PIK Interest 3.25% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-04
|
[24],[25],[26],[32] |
2028-04
|
[8],[14],[18] |
2028-04
|
[24],[25],[26],[32] |
2028-04
|
[24],[25],[26],[32] |
2028-04
|
[8],[14],[18] |
Investment, basis spread, variable rate |
|
(1.75%)
|
[23],[24],[25],[26],[32] |
(1.75%)
|
[7],[8],[14],[18] |
(1.75%)
|
[23],[24],[25],[26],[32] |
(1.75%)
|
[23],[24],[25],[26],[32] |
(1.75%)
|
[7],[8],[14],[18] |
Investment, interest rate, floor |
|
6.75%
|
[23],[24],[25],[26],[32] |
6.75%
|
[7],[8],[14],[18] |
6.75%
|
[23],[24],[25],[26],[32] |
6.75%
|
[23],[24],[25],[26],[32] |
6.75%
|
[7],[8],[14],[18] |
Investment, interest rate, paid in kind |
|
3.25%
|
[23],[24],[25],[26],[32] |
3.25%
|
[7],[8],[14],[18] |
3.25%
|
[23],[24],[25],[26],[32] |
3.25%
|
[23],[24],[25],[26],[32] |
3.25%
|
[7],[8],[14],[18] |
Principal amount |
|
$ 22,936
|
[24],[25],[26],[32] |
$ 22,754
|
[8],[14],[18] |
|
|
|
|
|
|
Investment cost |
|
22,787
|
[2],[24],[25],[26],[32] |
22,596
|
[5],[8],[14],[18] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 23,464
|
[24],[25],[26],[32] |
$ 23,066
|
[8],[14],[18] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 3-month SOFR + 8.88%, Floor rate 9.78% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-12
|
[26],[31] |
2026-12
|
[11],[19] |
2026-12
|
[26],[31] |
2026-12
|
[26],[31] |
2026-12
|
[11],[19] |
Investment, basis spread, variable rate |
|
8.88%
|
[23],[26],[31] |
8.88%
|
[7],[11],[19] |
8.88%
|
[23],[26],[31] |
8.88%
|
[23],[26],[31] |
8.88%
|
[7],[11],[19] |
Investment, interest rate, floor |
|
9.78%
|
[23],[26],[31] |
9.78%
|
[7],[11],[19] |
9.78%
|
[23],[26],[31] |
9.78%
|
[23],[26],[31] |
9.78%
|
[7],[11],[19] |
Principal amount |
|
$ 6,000
|
[26],[31] |
$ 6,000
|
[11],[19] |
|
|
|
|
|
|
Investment cost |
|
5,927
|
[2],[26],[31] |
5,918
|
[5],[11],[19] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 5,925
|
[26],[31] |
$ 5,953
|
[11],[19] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-03
|
[22],[25] |
2027-03
|
[8],[12] |
2027-03
|
[22],[25] |
2027-03
|
[22],[25] |
2027-03
|
[8],[12] |
Investment, basis spread, variable rate |
|
1.00%
|
[22],[23],[25] |
1.00%
|
[7],[8],[12] |
1.00%
|
[22],[23],[25] |
1.00%
|
[22],[23],[25] |
1.00%
|
[7],[8],[12] |
Investment, interest rate, floor |
|
8.75%
|
[22],[23],[25] |
8.75%
|
[7],[8],[12] |
8.75%
|
[22],[23],[25] |
8.75%
|
[22],[23],[25] |
8.75%
|
[7],[8],[12] |
Investment, interest rate, paid in kind |
|
1.95%
|
[22],[23],[25] |
1.95%
|
[7],[8],[12] |
1.95%
|
[22],[23],[25] |
1.95%
|
[22],[23],[25] |
1.95%
|
[7],[8],[12] |
Investment exit fee |
|
2.95%
|
[22],[23],[25] |
2.95%
|
[7],[8],[12] |
2.95%
|
[22],[23],[25] |
2.95%
|
[22],[23],[25] |
2.95%
|
[7],[8],[12] |
Principal amount |
|
$ 12,919
|
[22],[25] |
$ 13,087
|
[8],[12] |
|
|
|
|
|
|
Investment cost |
|
13,020
|
[2],[22],[25] |
13,152
|
[5],[8],[12] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 12,881
|
[22],[25] |
$ 13,175
|
[8],[12] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Sisense Ltd., Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
[25],[27],[28] |
2027-07
|
[8],[9],[10] |
2027-07
|
[25],[27],[28] |
2027-07
|
[25],[27],[28] |
2027-07
|
[8],[9],[10] |
Investment, basis spread, variable rate |
|
1.50%
|
[23],[25],[27],[28] |
1.50%
|
[7],[8],[9],[10] |
1.50%
|
[23],[25],[27],[28] |
1.50%
|
[23],[25],[27],[28] |
1.50%
|
[7],[8],[9],[10] |
Investment, interest rate, floor |
|
9.50%
|
[23],[25],[27],[28] |
9.50%
|
[7],[8],[9],[10] |
9.50%
|
[23],[25],[27],[28] |
9.50%
|
[23],[25],[27],[28] |
9.50%
|
[7],[8],[9],[10] |
Investment, interest rate, paid in kind |
|
1.95%
|
[23],[25],[27],[28] |
1.95%
|
[7],[8],[9],[10] |
1.95%
|
[23],[25],[27],[28] |
1.95%
|
[23],[25],[27],[28] |
1.95%
|
[7],[8],[9],[10] |
Investment exit fee |
|
5.95%
|
[23],[25],[27],[28] |
5.95%
|
[7],[8],[9],[10] |
5.95%
|
[23],[25],[27],[28] |
5.95%
|
[23],[25],[27],[28] |
5.95%
|
[7],[8],[9],[10] |
Principal amount |
|
$ 33,638
|
[25],[27],[28] |
$ 33,760
|
[8],[9],[10] |
|
|
|
|
|
|
Investment cost |
|
34,189
|
[2],[25],[27],[28] |
34,152
|
[5],[8],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 34,212
|
[25],[27],[28] |
$ 34,193
|
[8],[9],[10] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-03
|
[21],[26],[31],[32] |
2028-03
|
[11],[14],[15],[19] |
2028-03
|
[21],[26],[31],[32] |
2028-03
|
[21],[26],[31],[32] |
2028-03
|
[11],[14],[15],[19] |
Investment, basis spread, variable rate |
|
7.25%
|
[21],[23],[26],[31],[32] |
7.25%
|
[7],[11],[14],[15],[19] |
7.25%
|
[21],[23],[26],[31],[32] |
7.25%
|
[21],[23],[26],[31],[32] |
7.25%
|
[7],[11],[14],[15],[19] |
Investment, interest rate, floor |
|
8.25%
|
[21],[23],[26],[31],[32] |
8.25%
|
[7],[11],[14],[15],[19] |
8.25%
|
[21],[23],[26],[31],[32] |
8.25%
|
[21],[23],[26],[31],[32] |
8.25%
|
[7],[11],[14],[15],[19] |
Principal amount |
|
$ 17,600
|
[21],[26],[31],[32] |
$ 17,600
|
[11],[14],[15],[19] |
|
|
|
|
|
|
Investment cost |
|
17,342
|
[2],[21],[26],[31],[32] |
17,324
|
[5],[11],[14],[15],[19] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 17,514
|
[21],[26],[31],[32] |
$ 17,688
|
[11],[14],[15],[19] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date March 2030, 3-month SOFR + 6.50%, Floor rate 7.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[11] |
|
|
2030-05
|
|
|
|
|
|
2030-05
|
|
Investment, basis spread, variable rate |
[7],[11] |
|
|
6.50%
|
|
|
|
|
|
6.50%
|
|
Investment, interest rate, floor |
[7],[11] |
|
|
7.50%
|
|
|
|
|
|
7.50%
|
|
Principal amount |
[11] |
|
|
$ 23,000
|
|
|
|
|
|
|
|
Investment cost |
[5],[11] |
|
|
22,521
|
|
|
|
|
|
|
|
Investments, at fair value: |
[11] |
|
|
$ 23,113
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date May 2030, 6-month SOFR + 6.50%, Floor rate 7.50% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[26] |
2030-05
|
|
|
|
2030-05
|
|
2030-05
|
|
|
|
Investment, basis spread, variable rate |
[23],[26] |
6.50%
|
|
|
|
6.50%
|
|
6.50%
|
|
|
|
Investment, interest rate, floor |
[23],[26] |
7.50%
|
|
|
|
7.50%
|
|
7.50%
|
|
|
|
Principal amount |
[26] |
$ 23,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[26] |
22,537
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[26] |
$ 22,625
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Suzy, Inc., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[8],[11],[37] |
|
|
2027-08
|
|
|
|
|
|
2027-08
|
|
Investment, basis spread, variable rate |
[6],[7],[8],[11],[37] |
|
|
1.75%
|
|
|
|
|
|
1.75%
|
|
Investment, interest rate, floor |
[6],[7],[8],[11],[37] |
|
|
10.00%
|
|
|
|
|
|
10.00%
|
|
Investment, interest rate, paid in kind |
[6],[7],[8],[11],[37] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
Investment exit fee |
[6],[7],[8],[11],[37] |
|
|
3.45%
|
|
|
|
|
|
3.45%
|
|
Principal amount |
[6],[8],[11],[37] |
|
|
$ 24,345
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[8],[11],[37] |
|
|
24,031
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[8],[11],[37] |
|
|
$ 24,935
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Suzy, Inc.., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[25],[26],[38] |
2027-08
|
|
|
|
2027-08
|
|
2027-08
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[25],[26],[38] |
1.75%
|
|
|
|
1.75%
|
|
1.75%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[25],[26],[38] |
10.00%
|
|
|
|
10.00%
|
|
10.00%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[23],[25],[26],[38] |
1.95%
|
|
|
|
1.95%
|
|
1.95%
|
|
|
|
Investment exit fee |
[1],[23],[25],[26],[38] |
3.45%
|
|
|
|
3.45%
|
|
3.45%
|
|
|
|
Principal amount |
[1],[25],[26],[38] |
$ 24,460
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[25],[26],[38] |
24,237
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[25],[26],[38] |
$ 24,686
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and TaxCalc, Senior Secured, Maturity Date November 2029, 3-month SONIA + 8.05%, Floor rate 8.55% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[10],[11],[19] |
|
|
2029-11
|
|
|
|
|
|
2029-11
|
|
Investment, basis spread, variable rate |
[7],[9],[10],[11],[19] |
|
|
8.05%
|
|
|
|
|
|
8.05%
|
|
Investment, interest rate, floor |
[7],[9],[10],[11],[19] |
|
|
8.55%
|
|
|
|
|
|
8.55%
|
|
Principal amount |
[9],[10],[11],[19] |
|
|
$ 7,500
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[10],[11],[19] |
|
|
9,518
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10],[11],[19] |
|
|
$ 9,198
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and TaxCalc., Senior Secured, Maturity Date November 2029, Daily SONIA + 8.17%, Floor rate 8.67% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[26],[27],[28],[31] |
2029-11
|
|
|
|
2029-11
|
|
2029-11
|
|
|
|
Investment, basis spread, variable rate |
[23],[26],[27],[28],[31] |
8.17%
|
|
|
|
8.17%
|
|
8.17%
|
|
|
|
Investment, interest rate, floor |
[23],[26],[27],[28],[31] |
8.67%
|
|
|
|
8.67%
|
|
8.67%
|
|
|
|
Principal amount | £ |
[26],[27],[28],[31] |
|
|
|
|
£ 7,500
|
|
|
|
|
|
Investment cost |
[2],[26],[27],[28],[31] |
$ 9,527
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[26],[27],[28],[31] |
$ 9,502
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 3-month SOFR + 9.15%, Floor rate 10.00% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-05
|
[31] |
2026-05
|
[19] |
2026-05
|
[31] |
2026-05
|
[31] |
2026-05
|
[19] |
Investment, basis spread, variable rate |
|
9.15%
|
[23],[31] |
9.15%
|
[7],[19] |
9.15%
|
[23],[31] |
9.15%
|
[23],[31] |
9.15%
|
[7],[19] |
Investment, interest rate, floor |
|
10.00%
|
[23],[31] |
10.00%
|
[7],[19] |
10.00%
|
[23],[31] |
10.00%
|
[23],[31] |
10.00%
|
[7],[19] |
Principal amount |
|
$ 12,254
|
[31] |
$ 12,324
|
[19] |
|
|
|
|
|
|
Investment cost |
|
12,158
|
[2],[31] |
12,208
|
[5],[19] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 12,241
|
[31] |
$ 12,324
|
[19] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.00%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[10] |
|
|
2027-04
|
|
|
|
|
|
2027-04
|
|
Investment, basis spread, variable rate |
[7],[8],[9],[10] |
|
|
0.45%
|
|
|
|
|
|
0.45%
|
|
Investment, interest rate, floor |
[7],[8],[9],[10] |
|
|
6.45%
|
|
|
|
|
|
6.45%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9],[10] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
Investment exit fee |
[7],[8],[9],[10] |
|
|
3.75%
|
|
|
|
|
|
3.75%
|
|
Principal amount |
[8],[9],[10] |
|
|
$ 42,670
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[9],[10] |
|
|
42,379
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[9],[10] |
|
|
43,448
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[33] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
Investment, basis spread, variable rate |
[23],[33] |
0.45%
|
|
|
|
0.45%
|
|
0.45%
|
|
|
|
Investment, interest rate, floor |
[23],[33] |
6.45%
|
|
|
|
6.45%
|
|
6.45%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[33] |
2.30%
|
|
|
|
2.30%
|
|
2.30%
|
|
|
|
Principal amount |
[33] |
$ 75,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[33] |
74,571
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[33] |
$ 74,571
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[33] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
Investment, basis spread, variable rate |
[23],[33] |
0.45%
|
|
|
|
0.45%
|
|
0.45%
|
|
|
|
Investment, interest rate, floor |
[23],[33] |
6.45%
|
|
|
|
6.45%
|
|
6.45%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[33] |
2.30%
|
|
|
|
2.30%
|
|
2.30%
|
|
|
|
Investment exit fee |
[23],[33] |
3.75%
|
|
|
|
3.75%
|
|
3.75%
|
|
|
|
Principal amount |
[33] |
$ 42,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[33] |
41,763
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[33] |
41,763
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Total Armis, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
76,263
|
|
75,883
|
|
|
|
|
|
|
|
Investment cost |
|
75,979
|
[2] |
75,464
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
76,268
|
|
76,439
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Total Cutover, Inc., |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
7,279
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 7,261
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Total Tipalti Solutions Ltd. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
117,000
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
116,334
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 116,334
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-12
|
[21],[26],[27],[28],[31] |
2027-12
|
[9],[10],[11],[15],[19] |
2027-12
|
[21],[26],[27],[28],[31] |
2027-12
|
[21],[26],[27],[28],[31] |
2027-12
|
[9],[10],[11],[15],[19] |
Investment, basis spread, variable rate |
|
8.03%
|
[21],[23],[26],[27],[28],[31] |
8.03%
|
[7],[9],[10],[11],[15],[19] |
8.03%
|
[21],[23],[26],[27],[28],[31] |
8.03%
|
[21],[23],[26],[27],[28],[31] |
8.03%
|
[7],[9],[10],[11],[15],[19] |
Investment, interest rate, floor |
|
9.03%
|
[21],[23],[26],[27],[28],[31] |
9.03%
|
[7],[9],[10],[11],[15],[19] |
9.03%
|
[21],[23],[26],[27],[28],[31] |
9.03%
|
[21],[23],[26],[27],[28],[31] |
9.03%
|
[7],[9],[10],[11],[15],[19] |
Principal amount |
|
$ 12,696
|
[21],[26],[27],[28],[31] |
$ 12,729
|
[9],[10],[11],[15],[19] |
|
|
|
|
|
|
Investment cost |
|
12,505
|
[2],[21],[26],[27],[28],[31] |
12,522
|
[5],[9],[10],[11],[15],[19] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 12,667
|
[21],[26],[27],[28],[31] |
$ 12,756
|
[9],[10],[11],[15],[19] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-05
|
[26],[31] |
2027-05
|
[11],[19] |
2027-05
|
[26],[31] |
2027-05
|
[26],[31] |
2027-05
|
[11],[19] |
Investment, basis spread, variable rate |
|
8.31%
|
[23],[26],[31] |
8.31%
|
[7],[11],[19] |
8.31%
|
[23],[26],[31] |
8.31%
|
[23],[26],[31] |
8.31%
|
[7],[11],[19] |
Investment, interest rate, floor |
|
9.31%
|
[23],[26],[31] |
9.31%
|
[7],[11],[19] |
9.31%
|
[23],[26],[31] |
9.31%
|
[23],[26],[31] |
9.31%
|
[7],[11],[19] |
Principal amount |
|
$ 14,790
|
[26],[31] |
$ 14,790
|
[11],[19] |
|
|
|
|
|
|
Investment cost |
|
14,633
|
[2],[26],[31] |
14,618
|
[5],[11],[19] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 14,370
|
[26],[31] |
$ 14,444
|
[11],[19] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and iGrafx, LLC, Senior Secured, Maturity Date May 2027, 1-month SOFR + 8.61%, Floor rate 9.51%, 0.47% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-05
|
[31] |
2027-05
|
[19] |
2027-05
|
[31] |
2027-05
|
[31] |
2027-05
|
[19] |
Investment, basis spread, variable rate |
|
8.61%
|
[23],[31] |
8.61%
|
[7],[19] |
8.61%
|
[23],[31] |
8.61%
|
[23],[31] |
8.61%
|
[7],[19] |
Investment, interest rate, floor |
|
9.51%
|
[23],[31] |
9.51%
|
[7],[19] |
9.51%
|
[23],[31] |
9.51%
|
[23],[31] |
9.51%
|
[7],[19] |
Investment exit fee |
|
0.47%
|
[23],[31] |
0.47%
|
[7],[19] |
0.47%
|
[23],[31] |
0.47%
|
[23],[31] |
0.47%
|
[7],[19] |
Principal amount |
|
$ 4,937
|
[31] |
$ 4,950
|
[19] |
|
|
|
|
|
|
Investment cost |
|
4,875
|
[2],[31] |
4,879
|
[5],[19] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 4,856
|
[31] |
$ 4,869
|
[19] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and iSpot.tv, Inc., Senior Secured, Maturity Date January 2029, Prime + 2.25%, Floor rate 8.75%, PIK Interest 1.00%, 5.70% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[24],[25],[26] |
2029-01
|
|
|
|
2029-01
|
|
2029-01
|
|
|
|
Investment, basis spread, variable rate |
[23],[24],[25],[26] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
Investment, interest rate, floor |
[23],[24],[25],[26] |
8.75%
|
|
|
|
8.75%
|
|
8.75%
|
|
|
|
Investment, interest rate, paid in kind |
[23],[24],[25],[26] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
Investment exit fee |
[23],[24],[25],[26] |
5.70%
|
|
|
|
5.70%
|
|
5.70%
|
|
|
|
Principal amount |
[24],[25],[26] |
$ 8,257
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[24],[25],[26] |
8,178
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[24],[25],[26] |
$ 8,178
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Space Technologies (2.30%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
2.30%
|
|
|
|
|
|
2.30%
|
|
Investment cost |
[5] |
|
|
$ 45,302
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 45,690
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Space Technologies (2.47%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
2.47%
|
|
|
|
2.47%
|
|
2.47%
|
|
|
|
Investment cost |
[2] |
$ 45,767
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 49,505
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Space Technologies and Voyager Space Holdings, Inc., Senior Secured, Maturity Date July 2028, Prime + 1.25%, Floor rate 9.75%, PIK Interest 2.50%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[25],[32] |
2028-07
|
|
|
|
2028-07
|
|
2028-07
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[25],[32] |
1.25%
|
|
|
|
1.25%
|
|
1.25%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[25],[32] |
9.75%
|
|
|
|
9.75%
|
|
9.75%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[23],[25],[32] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
Investment exit fee |
[1],[23],[25],[32] |
5.50%
|
|
|
|
5.50%
|
|
5.50%
|
|
|
|
Principal amount |
[1],[25],[32] |
$ 45,724
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[25],[32] |
45,767
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[25],[32] |
$ 49,505
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Space Technologies and Voyager Technologies, Inc., Senior Secured, Maturity Date July 2028, Prime + 1.25%, Floor rate 9.75%, PIK Interest 2.50%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[8],[14] |
|
|
2028-07
|
|
|
|
|
|
2028-07
|
|
Investment, basis spread, variable rate |
[6],[7],[8],[14] |
|
|
1.25%
|
|
|
|
|
|
1.25%
|
|
Investment, interest rate, floor |
[6],[7],[8],[14] |
|
|
9.75%
|
|
|
|
|
|
9.75%
|
|
Investment, interest rate, paid in kind |
[6],[7],[8],[14] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
Investment exit fee |
[6],[7],[8],[14] |
|
|
5.50%
|
|
|
|
|
|
5.50%
|
|
Principal amount |
[6],[8],[14] |
|
|
$ 45,439
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[8],[14] |
|
|
45,302
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[8],[14] |
|
|
$ 45,690
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.99%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.99%
|
|
|
|
0.99%
|
|
0.99%
|
|
|
|
Investment cost |
[2] |
$ 19,866
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 19,903
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (1.27%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.27%
|
|
|
|
|
|
1.27%
|
|
Investment cost |
[5] |
|
|
$ 25,086
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 25,243
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[15] |
|
|
2025-05
|
|
|
|
|
|
2025-05
|
|
Investment, basis spread, variable rate |
[7],[8],[15] |
|
|
4.70%
|
|
|
|
|
|
4.70%
|
|
Investment, interest rate, floor |
[7],[8],[15] |
|
|
7.95%
|
|
|
|
|
|
7.95%
|
|
Investment, interest rate, paid in kind |
[7],[8],[15] |
|
|
1.45%
|
|
|
|
|
|
1.45%
|
|
Investment exit fee |
[7],[8],[15] |
|
|
3.95%
|
|
|
|
|
|
3.95%
|
|
Principal amount |
[8],[15] |
|
|
$ 3,984
|
|
|
|
|
|
|
|
Investment cost |
[5],[8],[15] |
|
|
4,102
|
|
|
|
|
|
|
|
Investments, at fair value: |
[8],[15] |
|
|
$ 4,141
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Electric Hydrogen Co., Senior Secured, Maturity Date May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 4.89% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[8],[18] |
|
|
2028-05
|
|
|
|
|
|
2028-05
|
|
Investment, basis spread, variable rate |
[6],[7],[8],[18] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
Investment, interest rate, floor |
[6],[7],[8],[18] |
|
|
10.75%
|
|
|
|
|
|
10.75%
|
|
Investment, interest rate, paid in kind |
[6],[7],[8],[18] |
|
|
1.25%
|
|
|
|
|
|
1.25%
|
|
Investment exit fee |
[6],[7],[8],[18] |
|
|
4.89%
|
|
|
|
|
|
4.89%
|
|
Principal amount |
[6],[8],[18] |
|
|
$ 20,127
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[8],[18] |
|
|
19,687
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[8],[18] |
|
|
$ 19,830
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Electric Hydrogen Co., Senior Secured, May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 4.89% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[24],[25] |
2028-05
|
|
|
|
2028-05
|
|
2028-05
|
|
|
|
Investment, basis spread, variable rate |
[1],[23],[24],[25] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
Investment, interest rate, floor |
[1],[23],[24],[25] |
10.75%
|
|
|
|
10.75%
|
|
10.75%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[23],[24],[25] |
1.25%
|
|
|
|
1.25%
|
|
1.25%
|
|
|
|
Investment exit fee |
[1],[23],[24],[25] |
4.89%
|
|
|
|
4.89%
|
|
4.89%
|
|
|
|
Principal amount |
[1],[24],[25] |
$ 20,190
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[24],[25] |
19,866
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[24],[25] |
19,903
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and SUNation Energy, Inc. (p.k.a. Pineapple Energy LLC), Senior Secured, Maturity Date June 2027, FIXED 10.00% |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Maturity Date |
[18] |
|
|
2027-06
|
|
|
|
|
|
2027-06
|
|
Investment, interest rate, paid in cash |
[7],[18] |
|
|
10.00%
|
|
|
|
|
|
10.00%
|
|
Principal amount |
[18] |
|
|
$ 1,296
|
|
|
|
|
|
|
|
Investment cost |
[5],[18] |
|
|
1,297
|
|
|
|
|
|
|
|
Investments, at fair value: |
[18] |
|
|
$ 1,272
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Total Marathon Health, LLC |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
173,301
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
172,702
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 173,880
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments (6.47%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
6.47%
|
|
|
|
|
|
6.47%
|
|
Investment cost |
[5] |
|
|
$ 157,712
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 128,657
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments (7.34%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
7.34%
|
|
|
|
7.34%
|
|
7.34%
|
|
|
|
Investment cost |
[2] |
$ 173,998
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 146,750
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Biotechnology Tools (0.05%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.05%
|
|
|
|
0.05%
|
|
0.05%
|
|
|
|
Investment cost |
[2] |
$ 1,500
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
970
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Biotechnology Tools (0.07%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.07%
|
|
|
|
|
|
0.07%
|
|
Investment cost |
[5] |
|
|
$ 1,500
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
1,423
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Biotechnology Tools and Alamar Biosciences, Inc., Equity, Acquisition Date 2/21/2024, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,500
|
[2] |
1,500
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 970
|
|
$ 1,423
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Feb. 21, 2024
|
[3] |
Feb. 21, 2024
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
503,778
|
|
503,778
|
|
503,778
|
|
503,778
|
|
503,778
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.02%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.02%
|
|
|
|
0.02%
|
|
0.02%
|
|
|
|
Investment cost |
[2] |
$ 1,675
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
366
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.04%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.04%
|
|
|
|
|
|
0.04%
|
|
Investment cost |
[5] |
|
|
$ 1,675
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
783
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc. Equity, Acquisition Date 7/16/2013, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
1,101
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 299
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Jul. 16, 2013
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
130,191
|
|
|
|
|
|
130,191
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
128
|
[2] |
$ 128
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 19
|
|
$ 46
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 30, 2010
|
[3] |
Apr. 30, 2010
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
42,989
|
|
42,989
|
|
42,989
|
|
42,989
|
|
42,989
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 1,101
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 172
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jul. 16, 2013
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
130,191
|
|
|
|
130,191
|
|
130,191
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 433
|
[2],[3] |
$ 433
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 17
|
[3] |
$ 17
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 30, 2021
|
[3] |
Apr. 30, 2021
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
12,260
|
[3] |
12,260
|
[44] |
12,260
|
[3] |
12,260
|
[3] |
12,260
|
[44] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 13
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 421
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Apr. 30, 2010
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
172,328
|
|
|
|
|
|
172,328
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 13
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 158
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Apr. 30, 2010
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
172,328
|
|
|
|
172,328
|
|
172,328
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Total Fabletics, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,229
|
[2] |
$ 1,229
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 191
|
|
$ 345
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
173,180
|
|
173,180
|
|
173,180
|
|
173,180
|
|
173,180
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.38%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.38%
|
|
|
|
|
|
0.38%
|
|
Investment cost |
[5] |
|
|
$ 26,410
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
7,502
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.40%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.40%
|
|
|
|
0.40%
|
|
0.40%
|
|
|
|
Investment cost |
[2] |
$ 26,973
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
8,073
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,151
|
[2],[27],[28] |
1,151
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 632
|
[27],[28] |
$ 627
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 15, 2021
|
[3],[27],[28] |
Dec. 15, 2021
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
216,073
|
[27],[28] |
216,073
|
[9],[10] |
216,073
|
[27],[28] |
216,073
|
[27],[28] |
216,073
|
[9],[10] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Jobandtalent USA, Inc., Equity, Acquisition Date 2/11/2025, Series Preferred Series F |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28] |
$ 563
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28] |
$ 563
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[27],[28] |
Feb. 11, 2025
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[27],[28] |
47,754
|
|
|
|
47,754
|
|
47,754
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 5,263
|
[2],[3] |
$ 5,263
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,196
|
[3] |
$ 1,299
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 26, 2018
|
[3] |
Dec. 26, 2018
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
100,738
|
[3] |
100,738
|
[44] |
100,738
|
[3] |
100,738
|
[3] |
100,738
|
[44] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[44] |
|
|
$ 1,000
|
|
|
|
|
|
|
|
Investments, at fair value: |
[44] |
|
|
$ 162
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Sep. 17, 2021
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[44] |
|
|
100,000
|
|
|
|
|
|
100,000
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 1,000
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 142
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Sep. 17, 2021
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
100,000
|
|
|
|
100,000
|
|
100,000
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,663
|
[2] |
$ 1,663
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 405
|
|
$ 467
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 25, 2016
|
[3] |
Oct. 25, 2016
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
286,080
|
|
286,080
|
|
286,080
|
|
286,080
|
|
286,080
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 632
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 154
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Oct. 25, 2016
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
108,710
|
|
|
|
108,710
|
|
108,710
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 577
|
[2],[3] |
$ 577
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 266
|
[3] |
$ 188
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 28, 2013
|
[3] |
Jun. 28, 2013
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
48,365
|
[3] |
48,365
|
[44] |
48,365
|
[3] |
48,365
|
[3] |
48,365
|
[44] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 39
|
[2] |
$ 39
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jul. 31, 2020
|
[3] |
Jul. 31, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
3,095
|
|
3,095
|
|
3,095
|
|
3,095
|
|
3,095
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2] |
$ 1,000
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jan. 24, 2022
|
[3] |
Jan. 24, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
7,063
|
|
7,063
|
|
7,063
|
|
7,063
|
|
7,063
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 13,263
|
[2],[34] |
$ 13,263
|
[5],[16] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,729
|
[34] |
$ 3,606
|
[16] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 29, 2023
|
[3],[34] |
Dec. 29, 2023
|
[16],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
3,235,298
|
[34] |
3,235,298
|
[16] |
3,235,298
|
[34] |
3,235,298
|
[34] |
3,235,298
|
[16] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 900
|
[2],[34] |
$ 900
|
[5],[16] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 2
|
[34] |
$ 7
|
[16] |
|
|
|
|
|
|
Investments owned acquisition date |
|
May 23, 2018
|
[3],[34] |
May 23, 2018
|
[16],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
414,994,863
|
[34] |
414,994,863
|
[16] |
414,994,863
|
[34] |
414,994,863
|
[34] |
414,994,863
|
[16] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 0
|
[2],[34] |
$ 0
|
[5],[16] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 7
|
[34] |
$ 17
|
[16] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 06, 2016
|
[3],[34] |
Jun. 06, 2016
|
[16],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,000,000
|
[34] |
1,000,000
|
[16] |
1,000,000
|
[34] |
1,000,000
|
[34] |
1,000,000
|
[16] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total OfferUp, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,295
|
[2] |
$ 2,295
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 559
|
|
$ 644
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
394,790
|
|
394,790
|
|
394,790
|
|
394,790
|
|
394,790
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total Tectura Corporation |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 14,163
|
[2] |
$ 14,163
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,738
|
|
$ 3,630
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
419,230,161
|
|
419,230,161
|
|
419,230,161
|
|
419,230,161
|
|
419,230,161
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Worldremit Group Limited, Equity, Acquisition Date 6/24/2024, Series Preferred Series X |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 922
|
[2],[27],[28] |
$ 922
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 977
|
[27],[28] |
$ 952
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 24, 2024
|
[3],[27],[28] |
Jun. 24, 2024
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
9,737
|
[27],[28] |
9,737
|
[9],[10] |
9,737
|
[27],[28] |
9,737
|
[27],[28] |
9,737
|
[9],[10] |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (2.70%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
2.70%
|
|
|
|
|
|
2.70%
|
|
Investment cost |
[5] |
|
|
$ 34,444
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
53,645
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (3.38%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
3.38%
|
|
|
|
3.38%
|
|
3.38%
|
|
|
|
Investment cost |
[2] |
$ 46,444
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
67,583
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Acquisition, Equity, Acquisition Date 3/1/2018, Series Member Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[16],[35] |
|
|
34,006
|
|
|
|
|
|
|
|
Investments, at fair value: |
[16],[35] |
|
|
$ 23,051
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[16],[35],[44] |
|
|
Mar. 01, 2018
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[16],[35] |
|
|
1
|
|
|
|
|
|
1
|
|
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Equity, Acquisition Date 3/1/2018, Series Member Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[34],[36] |
34,006
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[34],[36] |
$ 22,110
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[34],[36] |
Mar. 01, 2018
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[34],[36] |
1
|
|
|
|
1
|
|
1
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 12,035
|
[2],[34],[45] |
$ 35
|
[5],[16],[17] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 45,017
|
[34],[45] |
$ 30,190
|
[16],[17] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 26, 2021
|
[3],[34],[45] |
Mar. 26, 2021
|
[16],[17],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1
|
[34],[45] |
1
|
[16],[17] |
1
|
[34],[45] |
1
|
[34],[45] |
1
|
[16],[17] |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 403
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 456
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Sep. 30, 2021
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
210,282
|
|
|
|
210,282
|
|
210,282
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services, Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 403
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 404
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Sep. 30, 2021
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
210,282
|
|
|
|
|
|
210,282
|
|
Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.00%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.00%
|
[20] |
0.00%
|
[4] |
0.00%
|
[20] |
0.00%
|
[20] |
0.00%
|
[4] |
Investment cost |
|
$ 3,638
|
[2] |
$ 3,638
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
8
|
|
10
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,500
|
[2],[3] |
1,500
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1
|
[3] |
$ 1
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 28, 2014
|
[3] |
Mar. 28, 2014
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
680
|
[3] |
680
|
[44] |
680
|
[3] |
680
|
[3] |
680
|
[44] |
Investment, Identifier [Axis]: Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500
|
[2] |
$ 500
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 08, 2015
|
[3] |
Dec. 08, 2015
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
165,000
|
|
165,000
|
|
165,000
|
|
165,000
|
|
165,000
|
|
Investment, Identifier [Axis]: Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 309
|
[2],[3] |
$ 309
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3
|
[3] |
$ 4
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 06, 2015
|
[3] |
Apr. 06, 2015
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
2,498
|
[3] |
2,498
|
[44] |
2,498
|
[3] |
2,498
|
[3] |
2,498
|
[44] |
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc, Equity, Acquisition Date 12/10/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 1,329
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 4
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Dec. 10, 2018
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
8,836
|
|
|
|
8,836
|
|
8,836
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[44] |
|
|
$ 1,329
|
|
|
|
|
|
|
|
Investments, at fair value: |
[44] |
|
|
$ 5
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Dec. 10, 2018
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[44] |
|
|
8,836
|
|
|
|
|
|
8,836
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (1.56%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.56%
|
|
|
|
|
|
1.56%
|
|
Investment cost |
[5] |
|
|
$ 36,566
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
31,020
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (1.81%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
1.81%
|
|
|
|
1.81%
|
|
1.81%
|
|
|
|
Investment cost |
[2] |
$ 38,817
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
36,181
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 3/8/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,000
|
[2],[3],[27] |
1,000
|
[5],[9],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,396
|
[3],[27] |
$ 959
|
[9],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 08, 2024
|
[3],[27] |
Mar. 08, 2024
|
[9],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
34,483
|
[3],[27] |
34,483
|
[9],[44] |
34,483
|
[3],[27] |
34,483
|
[3],[27] |
34,483
|
[9],[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Arcus Biosciences, Inc., Equity, Acquisition Date 2/19/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3],[27] |
$ 2,250
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3],[27] |
$ 1,606
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[27] |
Feb. 19, 2025
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3],[27] |
204,545
|
|
|
|
204,545
|
|
204,545
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2],[3] |
$ 1,000
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[3] |
$ 0
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 19, 2014
|
[3] |
Aug. 19, 2014
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
42
|
[3] |
42
|
[44] |
42
|
[3] |
42
|
[3] |
42
|
[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3],[27],[33] |
$ 4,165
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3],[27],[33] |
$ 14,815
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[27],[33] |
May 09, 2022
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3],[27],[33] |
127,021
|
|
|
|
127,021
|
|
127,021
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc.., Equity, Acquisition Date 5/9/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[13],[44] |
|
|
$ 4,165
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[13],[44] |
|
|
$ 10,747
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[9],[13],[44] |
|
|
May 09, 2022
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[9],[13],[44] |
|
|
127,021
|
|
|
|
|
|
127,021
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/05/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[10],[44] |
|
|
$ 1,871
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10],[44] |
|
|
$ 1,373
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[9],[10],[44] |
|
|
Oct. 05, 2020
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[9],[10],[44] |
|
|
98,100
|
|
|
|
|
|
98,100
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3],[27],[28] |
$ 1,871
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3],[27],[28] |
$ 833
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[27],[28] |
Oct. 05, 2020
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3],[27],[28] |
98,100
|
|
|
|
98,100
|
|
98,100
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,255
|
[2],[3] |
$ 2,255
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 7,997
|
[3] |
$ 6,348
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 21, 2018
|
[3] |
Jun. 21, 2018
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
231,329
|
[3] |
231,329
|
[44] |
231,329
|
[3] |
231,329
|
[3] |
231,329
|
[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc., Equity, Acquisition Date 4/06/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[44] |
|
|
$ 42
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[44] |
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[9],[44] |
|
|
Apr. 06, 2021
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[9],[44] |
|
|
134
|
|
|
|
|
|
134
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2],[3] |
$ 1,000
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3
|
[3] |
$ 4
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jan. 08, 2015
|
[3] |
Jan. 08, 2015
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,129
|
[3] |
1,129
|
[44] |
1,129
|
[3] |
1,129
|
[3] |
1,129
|
[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 550
|
[2],[3],[27] |
$ 550
|
[5],[9],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 259
|
[3],[27] |
$ 256
|
[9],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jul. 22, 2015
|
[3],[27] |
Jul. 22, 2015
|
[9],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
20,000
|
[3],[27] |
20,000
|
[9],[44] |
20,000
|
[3],[27] |
20,000
|
[3],[27] |
20,000
|
[9],[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, Acquisition Date 7/25/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500
|
[2],[3] |
$ 500
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 803
|
[3] |
$ 558
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jul. 25, 2023
|
[3] |
Jul. 25, 2023
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
364,963
|
[3] |
364,963
|
[44] |
364,963
|
[3] |
364,963
|
[3] |
364,963
|
[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,250
|
[1],[2] |
$ 4,250
|
[5],[6] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 217
|
[1] |
$ 328
|
[6] |
|
|
|
|
|
|
Investments owned acquisition date |
|
May 07, 2021
|
[1],[3] |
May 07, 2021
|
[6],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
3,466,840
|
[1] |
3,466,840
|
[6] |
3,466,840
|
[1] |
3,466,840
|
[1] |
3,466,840
|
[6] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 4,000
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 341
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
May 03, 2022
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
235,295
|
|
|
|
235,295
|
|
235,295
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, Acquisition Date 5/3/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[44] |
|
|
$ 4,000
|
|
|
|
|
|
|
|
Investments, at fair value: |
[44] |
|
|
$ 487
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
May 03, 2022
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[44] |
|
|
235,295
|
|
|
|
|
|
235,295
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 550
|
[2],[3],[27] |
$ 550
|
[5],[9],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 316
|
[3],[27] |
$ 417
|
[9],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 16, 2023
|
[3],[27] |
Jun. 16, 2023
|
[9],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
47,826
|
[3],[27] |
47,826
|
[9],[44] |
47,826
|
[3],[27] |
47,826
|
[3],[27] |
47,826
|
[9],[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, Acquisition Date 9/29/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 774
|
[2],[3],[27] |
$ 773
|
[5],[9],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,689
|
[3],[27] |
$ 1,574
|
[9],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 29, 2023
|
[3],[27] |
Sep. 29, 2023
|
[9],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
5,100
|
[3],[27] |
5,100
|
[9],[44] |
5,100
|
[3],[27] |
5,100
|
[3],[27] |
5,100
|
[9],[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000
|
[2],[27],[28] |
$ 2,000
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,134
|
[27],[28] |
$ 1,241
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 15, 2021
|
[27],[28] |
Dec. 15, 2021
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
983
|
[27],[28] |
983
|
[9],[10] |
983
|
[27],[28] |
983
|
[27],[28] |
983
|
[9],[10] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,730
|
[2],[3],[27],[33] |
$ 1,730
|
[5],[9],[13],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 923
|
[3],[27],[33] |
$ 1,196
|
[9],[13],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 09, 2023
|
[3],[27],[33] |
Jun. 09, 2023
|
[9],[13],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
147,233
|
[3],[27],[33] |
147,233
|
[9],[13],[44] |
147,233
|
[3],[27],[33] |
147,233
|
[3],[27],[33] |
147,233
|
[9],[13],[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rafael Holdings, Inc. (p.k.a. Cyclo Therapeutics, Inc.), Equity, Acquisition Date 4/6/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3],[27] |
$ 42
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3],[27] |
$ 0
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[27] |
Apr. 06, 2021
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3],[27] |
47
|
|
|
|
47
|
|
47
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,500
|
[2],[3] |
$ 1,500
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 6
|
[3] |
$ 12
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 22, 2007
|
[3] |
Aug. 22, 2007
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
944
|
[3] |
944
|
[44] |
944
|
[3] |
944
|
[3] |
944
|
[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 203
|
[2],[3] |
$ 203
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 31
|
[3] |
$ 34
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 11, 2015
|
[3] |
Aug. 11, 2015
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
11,119
|
[3] |
11,119
|
[44] |
11,119
|
[3] |
11,119
|
[3] |
11,119
|
[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Valo Health LLC |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 4,000
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,378
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
680,410
|
|
|
|
680,410
|
|
680,410
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Valo Health, LLC |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 4,000
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 1,896
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
680,410
|
|
|
|
|
|
680,410
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2] |
$ 1,000
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 630
|
|
$ 762
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 31, 2022
|
[3] |
Oct. 31, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
170,102
|
|
170,102
|
|
170,102
|
|
170,102
|
|
170,102
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 3,000
|
[2] |
$ 3,000
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 748
|
|
$ 1,134
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 11, 2020
|
[3] |
Dec. 11, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
510,308
|
|
510,308
|
|
510,308
|
|
510,308
|
|
510,308
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 9/6/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,500
|
[2] |
$ 1,500
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,446
|
|
$ 1,519
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 06, 2023
|
[3] |
Sep. 06, 2023
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
208,588
|
|
208,588
|
|
208,588
|
|
208,588
|
|
208,588
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, Acquisition Date 11/6/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 400
|
[2],[3],[27] |
$ 400
|
[5],[9],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 436
|
[3],[27] |
$ 619
|
[9],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 06, 2023
|
[3],[27] |
Nov. 06, 2023
|
[9],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
32,310
|
[3],[27] |
32,310
|
[9],[44] |
32,310
|
[3],[27] |
32,310
|
[3],[27] |
32,310
|
[9],[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,945
|
[2],[3] |
$ 2,945
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 370
|
[3] |
$ 1,149
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 26, 2019
|
[3] |
Nov. 26, 2019
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,566,064
|
[3] |
1,566,064
|
[44] |
1,566,064
|
[3] |
1,566,064
|
[3] |
1,566,064
|
[44] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 332
|
[2],[3],[27],[28] |
$ 332
|
[5],[9],[10],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 182
|
[3],[27],[28] |
$ 303
|
[9],[10],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jan. 31, 2019
|
[3],[27],[28] |
Jan. 31, 2019
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
17,175
|
[3],[27],[28] |
17,175
|
[9],[10],[44] |
17,175
|
[3],[27],[28] |
17,175
|
[3],[27],[28] |
17,175
|
[9],[10],[44] |
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.05%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.05%
|
|
|
|
|
|
0.05%
|
|
Investment cost |
[5] |
|
|
$ 2,150
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
937
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.15%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.15%
|
|
|
|
0.15%
|
|
0.15%
|
|
|
|
Investment cost |
[2] |
$ 4,400
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
3,060
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
650
|
[2] |
650
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 267
|
|
$ 294
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 17, 2022
|
[3] |
Nov. 17, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
15,116
|
|
15,116
|
|
15,116
|
|
15,116
|
|
15,116
|
|
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Shield AI, Inc., Equity, Acquisition Date 2/7/2025, Series Preferred Series F1 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[33] |
$ 2,250
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[33] |
$ 2,250
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[33] |
Feb. 07, 2025
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[33] |
28,900
|
|
|
|
28,900
|
|
28,900
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,500
|
[2] |
$ 1,500
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 543
|
|
$ 643
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 08, 2022
|
[3] |
Mar. 08, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
248,900
|
|
248,900
|
|
248,900
|
|
248,900
|
|
248,900
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.37%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.37%
|
|
|
|
0.37%
|
|
0.37%
|
|
|
|
Investment cost |
[2] |
$ 13,639
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
7,436
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.38%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.38%
|
|
|
|
|
|
0.38%
|
|
Investment cost |
[5] |
|
|
$ 13,417
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
7,503
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
5,094
|
[2] |
5,094
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 134
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 11, 2019
|
[3] |
Mar. 11, 2019
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
41,286
|
|
41,286
|
[44] |
41,286
|
|
41,286
|
|
41,286
|
[44] |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 1,910
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 30, 2021
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
390,809
|
|
|
|
390,809
|
|
390,809
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 1,687
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 2
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Mar. 30, 2021
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
217,880
|
|
|
|
|
|
217,880
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Click Therapeutics, Inc., Equity, Acquisition Date 5/20/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,662
|
[1],[2] |
$ 1,662
|
[5],[6] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,900
|
[1] |
$ 1,825
|
[6] |
|
|
|
|
|
|
Investments owned acquisition date |
|
May 20, 2024
|
[1],[3] |
May 20, 2024
|
[6],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
560,000
|
[1] |
560,000
|
[6] |
560,000
|
[1] |
560,000
|
[1] |
560,000
|
[6] |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Curana Health Holdings, LLC, Equity, Acquisition Date 5/13/2024, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,500
|
[2] |
$ 2,500
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 2,983
|
|
$ 2,603
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
May 13, 2024
|
[3] |
May 13, 2024
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,114,380
|
|
1,114,380
|
|
1,114,380
|
|
1,114,380
|
|
1,114,380
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Main Street Rural, Inc., Equity, Acquisition Date 10/28/2024, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 873
|
[2] |
$ 874
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,018
|
|
$ 874
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 28, 2024
|
[3] |
Oct. 28, 2024
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
496
|
|
496
|
|
496
|
|
496
|
|
496
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and WellBe Senior Medical, LLC, Equity, Acquisition Date 6/10/2024, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,600
|
[2] |
$ 1,600
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,535
|
|
$ 2,065
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 10, 2024
|
[3] |
Jun. 10, 2024
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
181,163
|
|
181,163
|
|
181,163
|
|
181,163
|
|
181,163
|
|
Investment, Identifier [Axis]: Equity Investments Information Services (0.20%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.20%
|
|
|
|
|
|
0.20%
|
|
Investment cost |
[5] |
|
|
$ 3,825
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
3,898
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Information Services (0.23%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.23%
|
|
|
|
0.23%
|
|
0.23%
|
|
|
|
Investment cost |
[2] |
$ 3,825
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
4,604
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
3,825
|
[2] |
3,825
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 4,604
|
|
$ 3,898
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 30, 2021
|
[3] |
Dec. 30, 2021
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
41,021
|
|
41,021
|
|
41,021
|
|
41,021
|
|
41,021
|
|
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.00%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.00%
|
[20] |
0.00%
|
[4] |
0.00%
|
[20] |
0.00%
|
[20] |
0.00%
|
[4] |
Investment cost |
|
$ 250
|
[2] |
$ 250
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
47
|
|
69
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
0
|
[2],[34] |
0
|
[5],[16] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[34] |
$ 0
|
[16] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 15, 2021
|
[3],[34] |
Oct. 15, 2021
|
[16],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
180,000
|
[34] |
180,000
|
[16] |
180,000
|
[34] |
180,000
|
[34] |
180,000
|
[16] |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 250
|
[2],[34] |
$ 250
|
[5],[16] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 47
|
[34] |
$ 69
|
[16] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 15, 2021
|
[3],[34] |
Oct. 15, 2021
|
[16],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
5,000,000
|
[34] |
5,000,000
|
[16] |
5,000,000
|
[34] |
5,000,000
|
[34] |
5,000,000
|
[16] |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Total Coronado Aesthetics, LLC |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 250
|
[2] |
$ 250
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 47
|
|
$ 69
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
5,180,000
|
|
5,180,000
|
|
5,180,000
|
|
5,180,000
|
|
5,180,000
|
|
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.00%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.00%
|
|
|
|
0.00%
|
|
0.00%
|
|
|
|
Investment cost |
[2] |
$ 160
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
97
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.01%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.01%
|
|
|
|
|
|
0.01%
|
|
Investment cost |
[5] |
|
|
$ 160
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
210
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
160
|
[2] |
160
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 97
|
|
$ 210
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jul. 01, 2011
|
[3] |
Jul. 01, 2011
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
277,995
|
|
277,995
|
|
277,995
|
|
277,995
|
|
277,995
|
|
Investment, Identifier [Axis]: Equity Investments Software (0.81%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.81%
|
|
|
|
0.81%
|
|
0.81%
|
|
|
|
Investment cost |
[2] |
$ 22,524
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
16,203
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software (0.99%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.99%
|
|
|
|
|
|
0.99%
|
|
Investment cost |
[5] |
|
|
$ 23,524
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
19,665
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
1,000
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 666
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Aug. 09, 2021
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
1,000,000
|
|
|
|
|
|
1,000,000
|
|
Investment, Identifier [Axis]: Equity Investments Software and Armis, Inc., Equity, Acquisition Date 10/18/2024, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
2,000
|
[2] |
$ 2,000
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,765
|
|
$ 2,000
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 18, 2024
|
[3] |
Oct. 18, 2024
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
294,213
|
|
294,213
|
|
294,213
|
|
294,213
|
|
294,213
|
|
Investment, Identifier [Axis]: Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,406
|
[2],[46] |
$ 2,406
|
[5],[47] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 2,406
|
[46] |
$ 2,406
|
[47] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 24, 2021
|
[3],[46] |
Mar. 24, 2021
|
[44],[47] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
3
|
[46] |
3
|
[47] |
3
|
[46] |
3
|
[46] |
3
|
[47] |
Investment, Identifier [Axis]: Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-3 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 51
|
[2] |
$ 51
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 26, 2012
|
[3] |
Oct. 26, 2012
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
53,614
|
|
53,614
|
|
53,614
|
|
53,614
|
|
53,614
|
|
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500
|
[2],[27],[28] |
$ 500
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 759
|
[27],[28] |
$ 722
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 20, 2018
|
[3],[27],[28] |
Nov. 20, 2018
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
108,500
|
[27],[28] |
108,500
|
[9],[10] |
108,500
|
[27],[28] |
108,500
|
[27],[28] |
108,500
|
[9],[10] |
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 138
|
[2],[27],[28] |
$ 138
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 270
|
[27],[28] |
$ 257
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 22, 2020
|
[3],[27],[28] |
Dec. 22, 2020
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
41,000
|
[27],[28] |
41,000
|
[9],[10] |
41,000
|
[27],[28] |
41,000
|
[27],[28] |
41,000
|
[9],[10] |
Investment, Identifier [Axis]: Equity Investments Software and DNAnexus, Inc, Equity, Acquisition Date 3/21/2014, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 97
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 4
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 21, 2014
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
51,948
|
|
|
|
51,948
|
|
51,948
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software and DNAnexus, Inc., Equity, Acquisition Date 3/21/2014, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 97
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 5
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Mar. 21, 2014
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
51,948
|
|
|
|
|
|
51,948
|
|
Investment, Identifier [Axis]: Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,284
|
[2] |
$ 4,284
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 164
|
|
$ 198
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 29, 2018
|
[3] |
Nov. 29, 2018
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
20,000
|
|
20,000
|
|
20,000
|
|
20,000
|
|
20,000
|
|
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2] |
$ 1,000
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 4,481
|
|
$ 5,194
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 22, 2015
|
[3] |
Oct. 22, 2015
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
458,841
|
|
458,841
|
|
458,841
|
|
458,841
|
|
458,841
|
|
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 300
|
[2] |
$ 300
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 931
|
|
$ 1,075
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 24, 2017
|
[3] |
Aug. 24, 2017
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
93,620
|
|
93,620
|
|
93,620
|
|
93,620
|
|
93,620
|
|
Investment, Identifier [Axis]: Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 307
|
[2] |
$ 307
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jan. 18, 2013
|
[3] |
Jan. 18, 2013
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
190
|
|
190
|
|
190
|
|
190
|
|
190
|
|
Investment, Identifier [Axis]: Equity Investments Software and Leapwork ApS, Equity, Acquisition Date 8/25/2023, Preferred Series B2 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[10] |
|
|
$ 250
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10] |
|
|
$ 132
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[9],[10],[44] |
|
|
Aug. 25, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[9],[10] |
|
|
183,073
|
|
|
|
|
|
183,073
|
|
Investment, Identifier [Axis]: Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B2 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28] |
$ 250
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28] |
$ 113
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[27],[28] |
Aug. 25, 2023
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[27],[28] |
183,073
|
|
|
|
183,073
|
|
183,073
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 265
|
[2] |
$ 265
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 26
|
|
$ 24
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 04, 2020
|
[3] |
Dec. 04, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
38,461
|
|
38,461
|
|
38,461
|
|
38,461
|
|
38,461
|
|
Investment, Identifier [Axis]: Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,854
|
[2],[3] |
$ 4,854
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,559
|
[3] |
$ 2,416
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 01, 2018
|
[3] |
Aug. 01, 2018
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,019,255
|
[3] |
1,019,255
|
[44] |
1,019,255
|
[3] |
1,019,255
|
[3] |
1,019,255
|
[44] |
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000
|
[2] |
$ 2,000
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,850
|
|
$ 1,988
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 25, 2020
|
[3] |
Nov. 25, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
580,983
|
|
580,983
|
|
580,983
|
|
580,983
|
|
580,983
|
|
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 280
|
[2] |
$ 280
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 206
|
|
$ 216
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 12, 2021
|
[3] |
Aug. 12, 2021
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
52,956
|
|
52,956
|
|
52,956
|
|
52,956
|
|
52,956
|
|
Investment, Identifier [Axis]: Equity Investments Software and SirionLabs Pte. Ltd., Equity, Acquisition Date 6/30/2024, Series Preferred Series F1 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,792
|
[2],[27],[28] |
$ 1,792
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,590
|
[27],[28] |
$ 1,996
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 30, 2024
|
[3],[27],[28] |
Jun. 30, 2024
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
152,250
|
[27],[28] |
152,250
|
[9],[10] |
152,250
|
[27],[28] |
152,250
|
[27],[28] |
152,250
|
[9],[10] |
Investment, Identifier [Axis]: Equity Investments Software and Total Contentful Global, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 638
|
[2] |
$ 638
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,029
|
|
$ 979
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
149,500
|
|
149,500
|
|
149,500
|
|
149,500
|
|
149,500
|
|
Investment, Identifier [Axis]: Equity Investments Software and Total Druva Holdings, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,300
|
[2] |
$ 1,300
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 5,412
|
|
$ 6,269
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
552,461
|
|
552,461
|
|
552,461
|
|
552,461
|
|
552,461
|
|
Investment, Identifier [Axis]: Equity Investments Software and Total SingleStore, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,280
|
[2] |
$ 2,280
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 2,056
|
|
$ 2,204
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
633,939
|
|
633,939
|
|
633,939
|
|
633,939
|
|
633,939
|
|
Investment, Identifier [Axis]: Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 2,000
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 79
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jul. 08, 2021
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
23,814
|
|
|
|
23,814
|
|
23,814
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 2,000
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 370
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Jul. 08, 2021
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
952,562
|
|
|
|
|
|
952,562
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.10%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.10%
|
|
|
|
|
|
0.10%
|
|
Investment cost |
[5] |
|
|
$ 10,153
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
1,992
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.11%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.11%
|
|
|
|
0.11%
|
|
0.11%
|
|
|
|
Investment cost |
[2] |
$ 10,153
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
2,122
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
2,000
|
[2] |
2,000
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 115
|
|
$ 106
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
May 10, 2019
|
[3] |
May 10, 2019
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
188,611
|
|
188,611
|
|
188,611
|
|
188,611
|
|
188,611
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500
|
[2] |
$ 500
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 01, 2015
|
[3] |
Jun. 01, 2015
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,035
|
|
1,035
|
|
1,035
|
|
1,035
|
|
1,035
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,500
|
[2] |
$ 4,500
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 2,007
|
|
$ 1,885
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 28, 2021
|
[3] |
Jun. 28, 2021
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
593,080
|
|
593,080
|
|
593,080
|
|
593,080
|
|
593,080
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and SUNation Energy, Inc. (p.k.a. Pineapple Energy LLC), Equity, Acquisition Date 12/10/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[44] |
|
|
$ 3,153
|
|
|
|
|
|
|
|
Investments, at fair value: |
[44] |
|
|
$ 1
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Dec. 10, 2020
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[44] |
|
|
405
|
|
|
|
|
|
405
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and SUNation Energy, Inc., Equity, Acquisition Date 12/10/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 3,153
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 0
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Dec. 10, 2020
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
405
|
|
|
|
405
|
|
405
|
|
|
|
Investment, Identifier [Axis]: Equity, Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 632
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 177
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Oct. 25, 2016
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
108,710
|
|
|
|
|
|
108,710
|
|
Investment, Identifier [Axis]: Investment Fund After Cash & Cash Equivalents (197.46%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
197.46%
|
|
|
|
197.46%
|
|
197.46%
|
|
|
|
Investment cost |
[2] |
$ 4,021,082
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,950,450
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, Series FGTXX/38141W273 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 21,100
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 21,100
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Fund In Cash & Cash Equivalents (1.06%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.06%
|
|
|
|
|
|
1.06%
|
|
Investment cost |
[5] |
|
|
$ 21,100
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 21,100
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Fund In Cash & Cash Equivalents (1.30%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
1.30%
|
|
|
|
1.30%
|
|
1.30%
|
|
|
|
Investment cost |
[2] |
$ 26,000
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 26,000
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.31%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.31%
|
|
|
|
|
|
0.31%
|
|
Investment cost |
[5] |
|
|
$ 4,470
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 6,220
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.35%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.35%
|
|
|
|
0.35%
|
|
0.35%
|
|
|
|
Investment cost |
[2] |
$ 4,470
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 6,993
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.29%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.29%
|
|
|
|
|
|
0.29%
|
|
Investment cost |
[5] |
|
|
$ 4,089
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
5,820
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.33%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.33%
|
|
|
|
0.33%
|
|
0.33%
|
|
|
|
Investment cost |
[2] |
$ 4,089
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
6,623
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
2,847
|
[2],[26],[27],[28] |
2,847
|
[5],[9],[10],[11] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 5,236
|
[26],[27],[28] |
$ 4,382
|
[9],[10],[11] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 16, 2020
|
[3],[26],[27],[28] |
Nov. 16, 2020
|
[9],[10],[11],[44] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,242
|
[2],[26],[27],[28] |
$ 1,242
|
[5],[9],[10],[11] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,387
|
[26],[27],[28] |
$ 1,438
|
[9],[10],[11] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 23, 2022
|
[3],[26],[27],[28] |
Jun. 23, 2022
|
[9],[10],[11],[44] |
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.02%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.02%
|
[20] |
0.02%
|
[4] |
0.02%
|
[20] |
0.02%
|
[20] |
0.02%
|
[4] |
Investment cost |
|
$ 381
|
[2] |
$ 381
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
370
|
|
$ 400
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28] |
381
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28] |
$ 370
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[27],[28] |
Jul. 21, 2022
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds and Cash & Cash Equivalent and GS Financial Square Government Fund, Series FGTXX/38141W273 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 26,000
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 26,000
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investments After Cash & Cash Equivalents (185.02%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
185.02%
|
|
|
|
|
|
185.02%
|
|
Investment cost |
[5] |
|
|
$ 3,729,977
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 3,681,078
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investments before Cash & Cash Equivalents (183.96%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
183.96%
|
|
|
|
|
|
183.96%
|
|
Investment cost |
[5] |
|
|
$ 3,708,877
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 3,659,978
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investments before Cash & Cash Equivalents (196.16%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
196.16%
|
|
|
|
196.16%
|
|
196.16%
|
|
|
|
Investment cost |
[2] |
$ 3,995,082
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,924,450
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investments in Securities (183.64%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
183.64%
|
|
|
|
|
|
183.64%
|
|
Investment cost |
[5] |
|
|
$ 3,704,407
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 3,653,758
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investments in Securities (195.81%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
195.81%
|
|
|
|
195.81%
|
|
195.81%
|
|
|
|
Investment cost |
[2] |
$ 3,990,612
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,917,457
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Total Debt Investments (175.65%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
175.65%
|
|
|
|
|
|
175.65%
|
|
Investment cost |
[5] |
|
|
$ 3,515,541
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 3,494,601
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Total Warrant Investments (1.53%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.53%
|
|
|
|
|
|
1.53%
|
|
Investment cost |
[5] |
|
|
$ 31,154
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 30,500
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments (1.57%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
1.57%
|
|
|
|
1.57%
|
|
1.57%
|
|
|
|
Investment cost |
[2] |
$ 31,324
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 31,473
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools (0.01%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.01%
|
[20] |
0.01%
|
[4] |
0.01%
|
[20] |
0.01%
|
[20] |
0.01%
|
[4] |
Investment cost |
|
$ 496
|
[2] |
$ 496
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
110
|
|
223
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
36
|
[2] |
36
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 60
|
|
$ 122
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 21, 2022
|
[3] |
Jun. 21, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
75,567
|
|
75,567
|
|
75,567
|
|
75,567
|
|
75,567
|
|
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 460
|
[2],[22] |
$ 460
|
[5],[12] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 50
|
[22] |
$ 101
|
[12] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 23, 2022
|
[3],[22] |
Dec. 23, 2022
|
[12],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
53,418
|
[22] |
53,418
|
[12] |
53,418
|
[22] |
53,418
|
[22] |
53,418
|
[12] |
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking (0.01%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.01%
|
[20] |
0.01%
|
[4] |
0.01%
|
[20] |
0.01%
|
[20] |
0.01%
|
[4] |
Investment cost |
|
$ 242
|
[2] |
$ 242
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
158
|
|
209
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
242
|
[2],[22] |
242
|
[5],[12] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 158
|
[22] |
$ 209
|
[12] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 28, 2022
|
[3],[22] |
Jun. 28, 2022
|
[12],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
486,097
|
[22] |
486,097
|
[12] |
486,097
|
[22] |
486,097
|
[22] |
486,097
|
[12] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.04%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.04%
|
[20] |
0.04%
|
[4] |
0.04%
|
[20] |
0.04%
|
[20] |
0.04%
|
[4] |
Investment cost |
|
$ 245
|
[2] |
$ 245
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
773
|
|
714
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
228
|
[2] |
228
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 03, 2014
|
[3] |
Jun. 03, 2014
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,662,441
|
|
1,662,441
|
|
1,662,441
|
|
1,662,441
|
|
1,662,441
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 17
|
[2] |
$ 17
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 773
|
|
$ 714
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 27, 2018
|
[3] |
Jun. 27, 2018
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
686,270
|
|
686,270
|
|
686,270
|
|
686,270
|
|
686,270
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.28%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.28%
|
|
|
|
0.28%
|
|
0.28%
|
|
|
|
Investment cost |
[2] |
$ 4,690
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
5,700
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.32%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.32%
|
|
|
|
|
|
0.32%
|
|
Investment cost |
[5] |
|
|
$ 4,690
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
6,353
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Altumint, Inc., Warrant, Acquisition Date 10/31/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
127
|
[1],[2] |
127
|
[5],[6] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 97
|
[1] |
$ 129
|
[6] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 31, 2024
|
[1],[3] |
Oct. 31, 2024
|
[6],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,701
|
[1] |
1,701
|
[6] |
1,701
|
[1] |
1,701
|
[1] |
1,701
|
[6] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 164
|
[2],[27],[28] |
$ 164
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 46
|
[27],[28] |
$ 55
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 14, 2021
|
[3],[27],[28] |
Dec. 14, 2021
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
174,163
|
[27],[28] |
174,163
|
[9],[10] |
174,163
|
[27],[28] |
174,163
|
[27],[28] |
174,163
|
[9],[10] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 2/13/2024, Series Preferred Series D-4 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 20
|
[2],[27],[28] |
$ 20
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 8
|
[27],[28] |
$ 11
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Feb. 13, 2024
|
[3],[27],[28] |
Feb. 13, 2024
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
109,257
|
[27],[28] |
109,257
|
[9],[10] |
109,257
|
[27],[28] |
109,257
|
[27],[28] |
109,257
|
[9],[10] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 20
|
[2] |
$ 20
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 29, 2019
|
[3] |
Oct. 29, 2019
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
529,661
|
|
529,661
|
|
529,661
|
|
529,661
|
|
529,661
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 116
|
[1],[2] |
$ 116
|
[5],[6] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 101
|
[1] |
$ 115
|
[6] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 12, 2021
|
[1],[3] |
Mar. 12, 2021
|
[6],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
11,806
|
[1] |
11,806
|
[6] |
11,806
|
[1] |
11,806
|
[1] |
11,806
|
[6] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 39
|
[2] |
$ 39
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 8
|
|
$ 10
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 29, 2019
|
[3] |
Mar. 29, 2019
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
127,032
|
|
127,032
|
|
127,032
|
|
127,032
|
|
127,032
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28] |
$ 60
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28] |
$ 28
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[27],[28] |
Oct. 03, 2023
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[27],[28] |
27,298
|
|
|
|
27,298
|
|
27,298
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[10] |
|
|
$ 60
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10] |
|
|
$ 38
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[9],[10],[44] |
|
|
Oct. 03, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[9],[10] |
|
|
27,298
|
|
|
|
|
|
27,298
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
$ 166
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 28
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Dec. 22, 2022
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
117,042
|
|
|
|
117,042
|
|
117,042
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi., Warrant, Acquisition Date 12/22/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
$ 166
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 77
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[6],[44] |
|
|
Dec. 22, 2022
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[6] |
|
|
117,042
|
|
|
|
|
|
117,042
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 470
|
[1],[2] |
$ 470
|
[5],[6] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[1] |
$ 0
|
[6] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 12, 2021
|
[1],[3] |
Mar. 12, 2021
|
[6],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
13,106
|
[1] |
13,106
|
[6] |
13,106
|
[1] |
13,106
|
[1] |
13,106
|
[6] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,242
|
[2],[22],[33] |
$ 1,242
|
[5],[12],[13] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 4,342
|
[22],[33] |
$ 4,901
|
[12],[13] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 12, 2019
|
[3],[22],[33] |
Jun. 12, 2019
|
[12],[13],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,604,724
|
[22],[33] |
1,604,724
|
[12],[13] |
1,604,724
|
[22],[33] |
1,604,724
|
[22],[33] |
1,604,724
|
[12],[13] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 57
|
[2] |
$ 57
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 9
|
|
$ 28
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 14, 2022
|
[3] |
Nov. 14, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,607,143
|
|
1,607,143
|
|
1,607,143
|
|
1,607,143
|
|
1,607,143
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 83
|
[2] |
$ 83
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1
|
|
$ 3
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 23, 2019
|
[3] |
Aug. 23, 2019
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
444,444
|
|
444,444
|
|
444,444
|
|
444,444
|
|
444,444
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 16
|
[2] |
$ 16
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 20, 2020
|
[3] |
Apr. 20, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
600,000
|
|
600,000
|
|
600,000
|
|
600,000
|
|
600,000
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Series Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 782
|
[2] |
$ 782
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 30, 2016
|
[3] |
Jun. 30, 2016
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,800,000
|
|
1,800,000
|
|
1,800,000
|
|
1,800,000
|
|
1,800,000
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 62
|
[2] |
$ 62
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 01, 2018
|
[3] |
Aug. 01, 2018
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,211,537
|
|
1,211,537
|
|
1,211,537
|
|
1,211,537
|
|
1,211,537
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 985
|
[2] |
$ 985
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 938
|
|
$ 878
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
May 01, 2018
|
[3] |
May 01, 2018
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
343,497
|
|
343,497
|
|
343,497
|
|
343,497
|
|
343,497
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Carwow LTD |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 184
|
[2] |
$ 184
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 54
|
|
$ 66
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
283,420
|
|
283,420
|
|
283,420
|
|
283,420
|
|
283,420
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Skyword, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 140
|
[2] |
$ 140
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 10
|
|
$ 31
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
2,051,587
|
|
2,051,587
|
|
2,051,587
|
|
2,051,587
|
|
2,051,587
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 860
|
[2] |
$ 860
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
3,611,537
|
|
3,611,537
|
|
3,611,537
|
|
3,611,537
|
|
3,611,537
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Worldremit Group Limited |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 155
|
[2] |
$ 155
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 90
|
|
$ 95
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
79,083
|
|
79,083
|
|
79,083
|
|
79,083
|
|
79,083
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 126
|
[2],[22] |
$ 126
|
[5],[12] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 4
|
[22] |
$ 13
|
[12] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 31, 2022
|
[3],[22] |
Mar. 31, 2022
|
[12],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
98,428
|
[22] |
98,428
|
[12] |
98,428
|
[22] |
98,428
|
[22] |
98,428
|
[12] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 129
|
[2],[27],[28] |
$ 129
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 90
|
[27],[28] |
$ 95
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Feb. 11, 2021
|
[3],[27],[28] |
Feb. 11, 2021
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
77,215
|
[27],[28] |
77,215
|
[9],[10] |
77,215
|
[27],[28] |
77,215
|
[27],[28] |
77,215
|
[9],[10] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 26
|
[2],[27],[28] |
$ 26
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[27],[28] |
$ 0
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 27, 2021
|
[3],[27],[28] |
Aug. 27, 2021
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,868
|
[27],[28] |
1,868
|
[9],[10] |
1,868
|
[27],[28] |
1,868
|
[27],[28] |
1,868
|
[9],[10] |
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 214
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 460
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Feb. 03, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
522,930
|
|
|
|
|
|
522,930
|
|
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services (0.02%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.02%
|
|
|
|
|
|
0.02%
|
|
Investment cost |
[5] |
|
|
$ 214
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 460
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services (0.07%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.07%
|
|
|
|
0.07%
|
|
0.07%
|
|
|
|
Investment cost |
[2] |
$ 214
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
1,331
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
214
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,331
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Feb. 03, 2023
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
522,930
|
|
|
|
522,930
|
|
522,930
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.35%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.35%
|
|
|
|
|
|
0.35%
|
|
Investment cost |
[5] |
|
|
$ 8,404
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
6,996
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.46%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.46%
|
|
|
|
0.46%
|
|
0.46%
|
|
|
|
Investment cost |
[2] |
$ 8,285
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
9,153
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
330
|
[2],[3],[27] |
330
|
[5],[9],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 812
|
[3],[27] |
$ 519
|
[9],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 15, 2022
|
[3],[27] |
Jun. 15, 2022
|
[9],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
32,129
|
[3],[27] |
32,190
|
[9],[44] |
32,129
|
[3],[27] |
32,129
|
[3],[27] |
32,190
|
[9],[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, Warrant, Acquisition Date 12/27/2022, Series Class A Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
$ 238
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 151
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[6],[44] |
|
|
Dec. 27, 2022
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[6] |
|
|
69,239
|
|
|
|
|
|
69,239
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,290
|
[2],[3],[22],[27],[33] |
$ 1,290
|
[5],[9],[12],[13],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 2,842
|
[3],[22],[27],[33] |
$ 1,528
|
[9],[12],[13],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 25, 2020
|
[3],[22],[27],[33] |
Sep. 25, 2020
|
[9],[12],[13],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
61,004
|
[3],[22],[27],[33] |
61,004
|
[9],[12],[13],[44] |
61,004
|
[3],[22],[27],[33] |
61,004
|
[3],[22],[27],[33] |
61,004
|
[9],[12],[13],[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 278
|
[2],[3],[27],[28] |
$ 278
|
[5],[9],[10],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 21
|
[3],[27],[28] |
$ 48
|
[9],[10],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 30, 2023
|
[3],[27],[28] |
Jun. 30, 2023
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
75,376
|
[3],[27],[28] |
75,376
|
[9],[10],[44] |
75,376
|
[3],[27],[28] |
75,376
|
[3],[27],[28] |
75,376
|
[9],[10],[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 287
|
[1],[2] |
$ 287
|
[5],[6] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 27
|
[1] |
$ 103
|
[6] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 08, 2021
|
[1],[3] |
Dec. 08, 2021
|
[6],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
100,000
|
[1] |
100,000
|
[6] |
100,000
|
[1] |
100,000
|
[1] |
100,000
|
[6] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 37
|
[2],[3] |
$ 37
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[3] |
$ 0
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 14, 2020
|
[3] |
Sep. 14, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
16,112
|
[3] |
16,112
|
[44] |
16,112
|
[3] |
16,112
|
[3] |
16,112
|
[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cuervo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
$ 233
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 154
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[6],[44] |
|
|
Jun. 09, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[6] |
|
|
95,221
|
|
|
|
|
|
95,221
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
$ 233
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 313
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Jun. 09, 2023
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
95,221
|
|
|
|
95,221
|
|
95,221
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc., Warrant, Acquisition Date 2/18/2016, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[44] |
|
|
$ 119
|
|
|
|
|
|
|
|
Investments, at fair value: |
[44] |
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Feb. 18, 2016
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[44] |
|
|
201
|
|
|
|
|
|
201
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 228
|
[1],[2],[3] |
$ 228
|
[5],[6],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 257
|
[1],[3] |
$ 166
|
[6],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 09, 2023
|
[1],[3] |
Aug. 09, 2023
|
[6],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
238,095
|
[1],[3] |
238,095
|
[6],[44] |
238,095
|
[1],[3] |
238,095
|
[1],[3] |
238,095
|
[6],[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 110
|
[2],[3] |
$ 110
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[3] |
$ 0
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 20, 2019
|
[3] |
Dec. 20, 2019
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
2,202
|
[3] |
2,202
|
[44] |
2,202
|
[3] |
2,202
|
[3] |
2,202
|
[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 88
|
[1],[2],[3],[27] |
$ 88
|
[5],[6],[9],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 6
|
[1],[3],[27] |
$ 16
|
[6],[9],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 02, 2022
|
[1],[3],[27] |
Nov. 02, 2022
|
[6],[9],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
14,342
|
[1],[3],[27] |
14,342
|
[6],[9],[44] |
14,342
|
[1],[3],[27] |
14,342
|
[1],[3],[27] |
14,342
|
[6],[9],[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 570
|
[2],[3],[27] |
$ 570
|
[5],[9],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 2,309
|
[3],[27] |
$ 2,133
|
[9],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
May 09, 2022
|
[3],[27] |
May 09, 2022
|
[9],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
13,229
|
[3],[27] |
13,229
|
[9],[44] |
13,229
|
[3],[27] |
13,229
|
[3],[27] |
13,229
|
[9],[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 848
|
[1],[2],[3],[22],[27],[33] |
$ 848
|
[5],[6],[9],[12],[13],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 5
|
[1],[3],[22],[27],[33] |
$ 22
|
[6],[9],[12],[13],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 17, 2021
|
[1],[3],[22],[27],[33] |
Sep. 17, 2021
|
[6],[9],[12],[13],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
64,687
|
[1],[3],[22],[27],[33] |
64,687
|
[6],[9],[12],[13],[44] |
64,687
|
[1],[3],[22],[27],[33] |
64,687
|
[1],[3],[22],[27],[33] |
64,687
|
[6],[9],[12],[13],[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 20
|
[1],[2] |
$ 20
|
[5],[6] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 17
|
[1] |
$ 22
|
[6] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 23, 2022
|
[1],[3] |
Mar. 23, 2022
|
[6],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
475,510
|
[1] |
475,510
|
[6] |
475,510
|
[1] |
475,510
|
[1] |
475,510
|
[6] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 296
|
[2],[3] |
$ 296
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[3] |
$ 2
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
May 14, 2021
|
[3] |
May 14, 2021
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
106,035
|
[3] |
106,035
|
[44] |
106,035
|
[3] |
106,035
|
[3] |
106,035
|
[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and SynOx Therapeutics Limited, Warrant, Acquisition Date 4/18/2024, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 83
|
[2],[27],[28] |
$ 83
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 68
|
[27],[28] |
$ 76
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 18, 2024
|
[3],[27],[28] |
Apr. 18, 2024
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
251,195
|
[27],[28] |
251,195
|
[9],[10] |
251,195
|
[27],[28] |
251,195
|
[27],[28] |
251,195
|
[9],[10] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 12/30/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 721
|
[2],[3],[27] |
$ 721
|
[5],[9],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 2,387
|
[3],[27] |
$ 1,730
|
[9],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 30, 2021
|
[3],[27] |
Dec. 30, 2021
|
[9],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
117,168
|
[3],[27] |
117,168
|
[9],[44] |
117,168
|
[3],[27] |
117,168
|
[3],[27] |
117,168
|
[9],[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 256
|
[2] |
$ 256
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 18
|
|
$ 39
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 15, 2020
|
[3] |
Jun. 15, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
102,216
|
|
102,216
|
|
102,216
|
|
102,216
|
|
102,216
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 510
|
[2],[3] |
$ 510
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 19
|
[3] |
$ 185
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 18, 2019
|
[3] |
Mar. 18, 2019
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,392,787
|
[3] |
1,392,787
|
[44] |
1,392,787
|
[3] |
1,392,787
|
[3] |
1,392,787
|
[44] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and blubird bio, Inc., Warrant, Acquisition Date 3/15/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 1,744
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 0
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 15, 2024
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
111,206
|
|
|
|
111,206
|
|
111,206
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and bluebird bio, Inc., Warrant, Acquisition Date 3/15/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 1,744
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Mar. 15, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
111,206
|
|
|
|
|
|
111,206
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 118
|
[2],[3],[27],[28] |
$ 118
|
[5],[9],[10],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 52
|
[3],[27],[28] |
$ 102
|
[9],[10],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 22, 2023
|
[3],[27],[28] |
Dec. 22, 2023
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
43,689
|
[3],[27],[28] |
43,689
|
[9],[10],[44] |
43,689
|
[3],[27],[28] |
43,689
|
[3],[27],[28] |
43,689
|
[9],[10],[44] |
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.01%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.01%
|
[20] |
0.01%
|
[4] |
0.01%
|
[20] |
0.01%
|
[20] |
0.01%
|
[4] |
Investment cost |
|
$ 692
|
[2] |
$ 692
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
267
|
|
264
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
101
|
[2],[3] |
101
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 21
|
[3] |
$ 1
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 15, 2017
|
[3] |
Mar. 15, 2017
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
49,078
|
[3] |
49,078
|
[44] |
49,078
|
[3] |
49,078
|
[3] |
49,078
|
[44] |
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 34
|
[2] |
$ 34
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 45
|
|
$ 51
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 21, 2022
|
[3] |
Jun. 21, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
8,503
|
|
8,503
|
|
8,503
|
|
8,503
|
|
8,503
|
|
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 557
|
[2] |
$ 557
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 201
|
|
$ 212
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 08, 2021
|
[3] |
Nov. 08, 2021
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
622,255
|
|
622,255
|
|
622,255
|
|
622,255
|
|
622,255
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.11%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.11%
|
[20] |
0.11%
|
[4] |
0.11%
|
[20] |
0.11%
|
[20] |
0.11%
|
[4] |
Investment cost |
|
$ 1,863
|
[2] |
$ 1,863
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
2,209
|
|
2,099
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC, Warrant, Acquisition Date 1/4/2024, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
156
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 492
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Jan. 04, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
447,410
|
|
|
|
|
|
447,410
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC., Warrant, Acquisition Date 1/4/2024, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
156
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 666
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jan. 04, 2024
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
447,410
|
|
|
|
447,410
|
|
447,410
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Modern Life, Inc, Warrant, Acquisition Date 3/30/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 210
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 169
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Mar. 30, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
52,665
|
|
|
|
|
|
52,665
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 210
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 117
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 30, 2023
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
52,665
|
|
|
|
52,665
|
|
52,665
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and NeueHealth, Inc., Warrant, Acquisition Date 6/21/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 716
|
[2],[3],[22] |
$ 716
|
[5],[12],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 940
|
[3],[22] |
$ 1,032
|
[12],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 21, 2024
|
[3],[22] |
Jun. 21, 2024
|
[12],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
185,625
|
[3],[22] |
185,625
|
[12],[44] |
185,625
|
[3],[22] |
185,625
|
[3],[22] |
185,625
|
[12],[44] |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc., Warrant, Acquisition Date 7/3/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 382
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 79
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Jul. 03, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
194,830
|
|
|
|
|
|
194,830
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 382
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 128
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jul. 03, 2023
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
194,830
|
|
|
|
194,830
|
|
194,830
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC, Warrant, Acquisition Date 9/28/2023, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
$ 278
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 325
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[6],[44] |
|
|
Sep. 28, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[6] |
|
|
129,400
|
|
|
|
|
|
129,400
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
$ 278
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 358
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Sep. 28, 2023
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
129,400
|
|
|
|
129,400
|
|
129,400
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 121
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 28, 2022
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
192,431
|
|
|
|
192,431
|
|
192,431
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 121
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 2
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Mar. 28, 2022
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
192,431
|
|
|
|
|
|
192,431
|
|
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.00%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.00%
|
[20] |
0.00%
|
[4] |
0.00%
|
[20] |
0.00%
|
[20] |
0.00%
|
[4] |
Investment cost |
|
$ 413
|
[2] |
$ 413
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
6
|
|
13
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Quid, Inc. (p.k.a NetBase Solutions), Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
356
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Aug. 22, 2017
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
60,000
|
|
|
|
|
|
60,000
|
|
Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Quid, Inc., Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
356
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Aug. 22, 2017
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
60,000
|
|
|
|
60,000
|
|
60,000
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 57
|
[2],[27],[28] |
$ 57
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 6
|
[27],[28] |
$ 13
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 29, 2022
|
[3],[27],[28] |
Jun. 29, 2022
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
129,638
|
[27],[28] |
129,638
|
[9],[10] |
129,638
|
[27],[28] |
129,638
|
[27],[28] |
129,638
|
[9],[10] |
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.04%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.04%
|
|
|
|
0.04%
|
|
0.04%
|
|
|
|
Investment cost |
[2] |
$ 1,102
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
793
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.06%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.06%
|
|
|
|
|
|
0.06%
|
|
Investment cost |
[5] |
|
|
$ 1,065
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
1,162
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
537
|
[2] |
537
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 615
|
|
$ 871
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 31, 2022
|
[3] |
Mar. 31, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
392,308
|
|
392,308
|
|
392,308
|
|
392,308
|
|
392,308
|
|
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 528
|
[2] |
$ 528
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 147
|
|
$ 291
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 23, 2022
|
[3] |
Mar. 23, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,111,111
|
|
1,111,111
|
|
1,111,111
|
|
1,111,111
|
|
1,111,111
|
|
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and VulcanForms Inc., Warrant, Acquisition Date 1/30/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 37
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 31
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jan. 30, 2025
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
83,262
|
|
|
|
83,262
|
|
83,262
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.00%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.00%
|
|
|
|
|
|
0.00%
|
|
Investment cost |
[5] |
|
|
$ 67
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
63
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.01%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.01%
|
|
|
|
0.01%
|
|
0.01%
|
|
|
|
Investment cost |
[2] |
$ 67
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
114
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Series Preferred Series E-1 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
67
|
[2] |
67
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 114
|
|
$ 63
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 30, 2022
|
[3] |
Dec. 30, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
369,370
|
|
369,370
|
|
369,370
|
|
369,370
|
|
369,370
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.03%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.03%
|
[20] |
0.03%
|
[4] |
0.03%
|
[20] |
0.03%
|
[20] |
0.03%
|
[4] |
Investment cost |
|
$ 1,281
|
[2] |
$ 1,281
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
519
|
|
507
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Warrant, Acquisition Date 11/6/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
180
|
[1],[2],[3],[38] |
180
|
[5],[6],[37],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 105
|
[1],[3],[38] |
$ 102
|
[6],[37],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 06, 2024
|
[1],[3],[38] |
Nov. 06, 2024
|
[6],[37],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
52,264
|
[1],[3],[38] |
52,264
|
[6],[37],[44] |
52,264
|
[1],[3],[38] |
52,264
|
[1],[3],[38] |
52,264
|
[6],[37],[44] |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical Inc, Warrant, Acquisition Date 9/27/2013, Series Common stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[44] |
|
|
$ 401
|
|
|
|
|
|
|
|
Investments, at fair value: |
[44] |
|
|
$ 7
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Sep. 27, 2013
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[44] |
|
|
62,794
|
|
|
|
|
|
62,794
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 401
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 4
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Sep. 27, 2013
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
4,185
|
|
|
|
4,185
|
|
4,185
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc, Warrant, Acquisition Date 9/8/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[44] |
|
|
$ 276
|
|
|
|
|
|
|
|
Investments, at fair value: |
[44] |
|
|
$ 203
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Sep. 08, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[44] |
|
|
1,032,718
|
|
|
|
|
|
1,032,718
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 276
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 302
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Sep. 08, 2023
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
1,032,718
|
|
|
|
1,032,718
|
|
1,032,718
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Sight Sciences, Inc., Warrant, Acquisition Date 1/22/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 363
|
[2],[3],[38] |
$ 363
|
[5],[37],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 108
|
[3],[38] |
$ 195
|
[37],[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jan. 22, 2024
|
[3],[38] |
Jan. 22, 2024
|
[37],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
113,247
|
[3],[38] |
113,247
|
[37],[44] |
113,247
|
[3],[38] |
113,247
|
[3],[38] |
113,247
|
[37],[44] |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 61
|
[2],[3] |
$ 61
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[3] |
$ 0
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 31, 2017
|
[3] |
Mar. 31, 2017
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
15,712
|
[3] |
15,712
|
[44] |
15,712
|
[3] |
15,712
|
[3] |
15,712
|
[44] |
Investment, Identifier [Axis]: Warrant Investments and Semiconductors (0.02%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.02%
|
[20] |
0.02%
|
[4] |
0.02%
|
[20] |
0.02%
|
[20] |
0.02%
|
[4] |
Investment cost |
|
$ 99
|
[2] |
$ 99
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
328
|
|
494
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
99
|
[2] |
99
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 328
|
|
$ 494
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 26, 2015
|
[3] |
Jun. 26, 2015
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
750,000
|
|
750,000
|
|
750,000
|
|
750,000
|
|
750,000
|
|
Investment, Identifier [Axis]: Warrant Investments and Software (0.48%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[20] |
0.48%
|
|
|
|
0.48%
|
|
0.48%
|
|
|
|
Investment cost |
[2] |
$ 10,869
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
9,619
|
|
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software (0.53%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.53%
|
|
|
|
|
|
0.53%
|
|
Investment cost |
[5] |
|
|
$ 10,554
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
10,472
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Series Preferred Series G |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
74
|
[2] |
74
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
May 22, 2015
|
[3] |
May 22, 2015
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
231,535
|
|
231,535
|
|
231,535
|
|
231,535
|
|
231,535
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 448
|
[2] |
$ 448
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 277
|
|
$ 421
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 23, 2022
|
[3] |
Sep. 23, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
254,778
|
|
254,778
|
|
254,778
|
|
254,778
|
|
254,778
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 284
|
[2] |
$ 284
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 581
|
|
$ 442
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 18, 2020
|
[3] |
Nov. 18, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
29,691
|
|
29,691
|
|
29,691
|
|
29,691
|
|
29,691
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 215
|
[2] |
$ 215
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 118
|
|
$ 84
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 04, 2021
|
[3] |
Oct. 04, 2021
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
435,396
|
|
435,396
|
|
435,396
|
|
435,396
|
|
435,396
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Carbyne, Inc., Warrant, Acquisition Date 2/24/2025 Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 24
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 19
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Feb. 24, 2025
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
11,408
|
|
|
|
11,408
|
|
11,408
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 117
|
[2] |
$ 117
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 52
|
|
$ 9
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 30, 2020
|
[3] |
Sep. 30, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
211,342
|
|
211,342
|
|
211,342
|
|
211,342
|
|
211,342
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 71
|
[2] |
$ 71
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 06, 2018
|
[3] |
Nov. 06, 2018
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
477,454
|
|
477,454
|
|
477,454
|
|
477,454
|
|
477,454
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 54
|
[2],[27],[28] |
$ 54
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 790
|
[27],[28] |
$ 908
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 10, 2018
|
[3],[27],[28] |
Apr. 10, 2018
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
6,763
|
[27],[28] |
6,763
|
[9],[10] |
6,763
|
[27],[28] |
6,763
|
[27],[28] |
6,763
|
[9],[10] |
Investment, Identifier [Axis]: Warrant Investments and Software and Coronet Cyber Security Ltd., Warrant, Acquisition Date 9/26/2024, Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 254
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 208
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Sep. 26, 2024
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
39,183
|
|
|
|
39,183
|
|
39,183
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Coronet Cyber Security Ltd., Warrant, Acquisition Date 9/26/2024, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 254
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 266
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Sep. 26, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
39,183
|
|
|
|
|
|
39,183
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 462
|
[2],[3] |
$ 462
|
[5],[44] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 698
|
[3] |
$ 686
|
[44] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 25, 2019
|
[3] |
Apr. 25, 2019
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
105,350
|
[3] |
105,350
|
[44] |
105,350
|
[3] |
105,350
|
[3] |
105,350
|
[44] |
Investment, Identifier [Axis]: Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 26
|
[2],[22],[27],[28] |
$ 26
|
[5],[9],[10],[12] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 51
|
[22],[27],[28] |
$ 83
|
[9],[10],[12] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 21, 2022
|
[3],[22],[27],[28] |
Sep. 21, 2022
|
[9],[10],[12],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
102,898
|
[22],[27],[28] |
102,898
|
[9],[10],[12] |
102,898
|
[22],[27],[28] |
102,898
|
[22],[27],[28] |
102,898
|
[9],[10],[12] |
Investment, Identifier [Axis]: Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 461
|
[2] |
$ 461
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,149
|
|
$ 1,102
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 11, 2019
|
[3] |
Mar. 11, 2019
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
770,838
|
|
770,838
|
|
770,838
|
|
770,838
|
|
770,838
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 545
|
[2] |
$ 545
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 74
|
|
$ 234
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 02, 2021
|
[3] |
Aug. 02, 2021
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
727,047
|
|
727,047
|
|
727,047
|
|
727,047
|
|
727,047
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,575
|
[2] |
$ 1,575
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 936
|
|
$ 984
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 28, 2023
|
[3] |
Jun. 28, 2023
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
57,528
|
|
57,528
|
|
57,528
|
|
57,528
|
|
57,528
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 278
|
[2] |
$ 278
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 339
|
|
$ 417
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 30, 2022
|
[3] |
Jun. 30, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
95,911
|
|
95,911
|
|
95,911
|
|
95,911
|
|
95,911
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Earnix, Inc., Warrant, Acquisition Date 6/6/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 219
|
[2] |
$ 220
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 313
|
|
$ 327
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 06, 2024
|
[3] |
Jun. 06, 2024
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
20,762
|
|
20,762
|
|
20,762
|
|
20,762
|
|
20,762
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 739
|
[2] |
$ 583
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 382
|
|
$ 236
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 12, 2022
|
[3] |
Sep. 12, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
612,166
|
|
362,837
|
|
612,166
|
|
612,166
|
|
362,837
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 96
|
[2] |
$ 96
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 10
|
|
$ 33
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
May 10, 2018
|
[3] |
May 10, 2018
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
75,917
|
|
75,917
|
|
75,917
|
|
75,917
|
|
75,917
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 325
|
[2] |
$ 325
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 231
|
|
$ 274
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jul. 29, 2022
|
[3] |
Jul. 29, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
84,995
|
|
84,995
|
|
84,995
|
|
84,995
|
|
84,995
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Harness, Inc., Warrant, Acquisition Date 3/12/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 534
|
[2] |
$ 534
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 480
|
|
$ 632
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 12, 2024
|
[3] |
Mar. 12, 2024
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
193,618
|
|
193,618
|
|
193,618
|
|
193,618
|
|
193,618
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Kore, ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 208
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 142
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Mar. 31, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
64,293
|
|
|
|
|
|
64,293
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 208
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 79
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 31, 2023
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
64,293
|
|
|
|
64,293
|
|
64,293
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 39
|
[2],[22],[27],[28] |
$ 39
|
[5],[9],[10],[12] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 24
|
[22],[27],[28] |
$ 35
|
[9],[10],[12] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jan. 23, 2023
|
[3],[22],[27],[28] |
Jan. 23, 2023
|
[9],[10],[12],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
93,211
|
[22],[27],[28] |
93,211
|
[9],[10],[12] |
93,211
|
[22],[27],[28] |
93,211
|
[22],[27],[28] |
93,211
|
[9],[10],[12] |
Investment, Identifier [Axis]: Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Series Preferred Series LB-2 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 131
|
[2] |
$ 131
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 26
|
|
$ 26
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Feb. 14, 2018
|
[3] |
Feb. 14, 2018
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
86,984
|
|
86,984
|
|
86,984
|
|
86,984
|
|
86,984
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 252
|
[2] |
$ 252
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 275
|
|
$ 264
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 30, 2020
|
[3] |
Sep. 30, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
82,362
|
|
82,362
|
|
82,362
|
|
82,362
|
|
82,362
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Morphisec Information Security 2014 Ltd., Warrant, Acquisition Date 10/1/2024, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28] |
$ 104
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28] |
$ 120
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[27],[28] |
Oct. 01, 2024
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[27],[28] |
200,115
|
|
|
|
200,115
|
|
200,115
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Pindrop Security, Inc., Warrant, Acquisition Date 6/26/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 494
|
[1],[2] |
$ 494
|
[5],[6] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 417
|
[1] |
$ 496
|
[6] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 26, 2024
|
[1],[3] |
Jun. 26, 2024
|
[6],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
134,542
|
[1] |
134,542
|
[6] |
134,542
|
[1] |
134,542
|
[1] |
134,542
|
[6] |
Investment, Identifier [Axis]: Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 215
|
[2] |
$ 215
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 589
|
|
$ 698
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 30, 2020
|
[3] |
Jun. 30, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
69,120
|
|
69,120
|
|
69,120
|
|
69,120
|
|
69,120
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Semperis Technologies Inc., Warrant, Acquisition Date 4/23/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 114
|
[2] |
$ 115
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 191
|
|
$ 213
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 23, 2024
|
[3] |
Apr. 23, 2024
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
72,122
|
|
72,122
|
|
72,122
|
|
72,122
|
|
72,122
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 96
|
[2],[22] |
$ 96
|
[5],[12] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 14
|
[22] |
$ 22
|
[12] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 22, 2023
|
[3],[22] |
Mar. 22, 2023
|
[12],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
77,934
|
[22] |
77,934
|
[12] |
77,934
|
[22] |
77,934
|
[22] |
77,934
|
[12] |
Investment, Identifier [Axis]: Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 103
|
[2] |
$ 103
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 452
|
|
$ 551
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 28, 2020
|
[3] |
Apr. 28, 2020
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
312,596
|
|
312,596
|
|
312,596
|
|
312,596
|
|
312,596
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28] |
$ 174
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28] |
$ 62
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[27],[28] |
Jun. 08, 2023
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[27],[28] |
321,956
|
|
|
|
321,956
|
|
321,956
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/8/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[10] |
|
|
$ 174
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10] |
|
|
$ 61
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[9],[10],[44] |
|
|
Jun. 08, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[9],[10] |
|
|
321,956
|
|
|
|
|
|
321,956
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Suzy Inc, Warrant, Acquisition Date 8/24/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[6],[37] |
|
|
$ 367
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6],[37] |
|
|
$ 291
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[6],[37],[44] |
|
|
Aug. 24, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[6],[37] |
|
|
292,936
|
|
|
|
|
|
292,936
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[38] |
$ 367
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[38] |
$ 256
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3],[38] |
Aug. 24, 2023
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1],[38] |
292,936
|
|
|
|
292,936
|
|
292,936
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 360
|
[2],[27],[33] |
$ 359
|
[5],[9],[10] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 274
|
[27],[33] |
$ 395
|
[9],[10] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 22, 2023
|
[3],[27],[33] |
Mar. 22, 2023
|
[9],[10],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
509,753
|
[27],[33] |
509,753
|
[9],[10] |
509,753
|
[27],[33] |
509,753
|
[27],[33] |
509,753
|
[9],[10] |
Investment, Identifier [Axis]: Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/27/2025, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[33] |
$ 136
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[33] |
$ 128
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[33] |
Mar. 27, 2025
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[33] |
473,266
|
|
|
|
473,266
|
|
473,266
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Total Tipalti Solutions Ltd. |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 496
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 402
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
983,019
|
|
|
|
983,019
|
|
983,019
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,275
|
[1],[2] |
$ 1,275
|
[5],[6] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 4
|
[1] |
$ 32
|
[6] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Jan. 21, 2022
|
[1],[3] |
Jan. 21, 2022
|
[6],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
152,048
|
[1] |
152,048
|
[6] |
152,048
|
[1] |
152,048
|
[1] |
152,048
|
[6] |
Investment, Identifier [Axis]: Warrant Investments and Space Technologies (0.00%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.00%
|
[20] |
0.00%
|
[4] |
0.00%
|
[20] |
0.00%
|
[20] |
0.00%
|
[4] |
Investment cost |
|
$ 207
|
[2] |
$ 207
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
22
|
|
10
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Space Technologies and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
207
|
[1],[2] |
207
|
[5],[6] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 22
|
[1] |
$ 10
|
[6] |
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 21, 2021
|
[1],[3] |
Oct. 21, 2021
|
[6],[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
176,200
|
[1] |
176,200
|
[6] |
176,200
|
[1] |
176,200
|
[1] |
176,200
|
[6] |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.02%) |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.02%
|
[20] |
0.02%
|
[4] |
0.02%
|
[20] |
0.02%
|
[20] |
0.02%
|
[4] |
Investment cost |
|
$ 559
|
[2] |
$ 622
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
371
|
|
461
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
|
52
|
[2] |
52
|
[5] |
|
|
|
|
|
|
Investments, at fair value: |
|
$ 83
|
|
$ 67
|
|
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 15, 2022
|
[3] |
Apr. 15, 2022
|
[44] |
|
|
|
|
|
|
Shares (in shares) | shares |
|
18,472
|
|
18,472
|
|
18,472
|
|
18,472
|
|
18,472
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
$ 507
|
|
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 394
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[6],[44] |
|
|
Mar. 27, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[6] |
|
|
246,618
|
|
|
|
|
|
246,618
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
$ 507
|
|
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 288
|
|
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Mar. 27, 2024
|
|
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
246,618
|
|
|
|
246,618
|
|
246,618
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 63
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[44] |
|
|
Apr. 07, 2015
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
144,914
|
|
|
|
|
|
144,914
|
|
Investment, Identifier [Axis]: nvestment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[9],[10] |
|
|
$ 381
|
|
|
|
|
|
|
|
Investments, at fair value: |
[9],[10] |
|
|
$ 400
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[9],[10],[44] |
|
|
Jul. 21, 2022
|
|
|
|
|
|
|
|
|
|